Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40174,0.101626568306071,0.00251468004815697,0.0966977954116832,0.106555341200459,0
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40122,0.182016689302201,0.00409266161449458,0.173995072537791,0.19003830606661,0
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40095,0.128194922135298,0.0024103540567414,0.123470628184085,0.132919216086511,0
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40071,0.075887620589471,0.00253895915550885,0.0709112606446737,0.0808639805342684,6.17534750650293e-191
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37737,0.0775083129270215,0.00298334098586347,0.0716609645947291,0.0833556612593139,3.38332364943476e-145
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,40274,0.100996410598505,0.0043822244869382,0.0924072506041063,0.109585570592904,1.25956335138133e-115
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,40040,0.14739281584855,0.00639832719217061,0.134852094551896,0.159933537145204,1.70509098855328e-115
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40274,0.0482181367662982,0.00213191007675666,0.0440395930158551,0.0523966805167412,1.70238040319485e-111
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40248,0.058152194737126,0.00271706520087896,0.0528267469434033,0.0634776425308488,3.33426890216916e-100
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40164,0.067602877273802,0.00348902031100261,0.0607643974642369,0.0744413570833671,1.13456321415096e-82
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40068,0.0481418923360612,0.00250544119041598,0.0432312276028459,0.0530525570692765,2.40744208656454e-81
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,40248,0.100486102781726,0.00550866437946679,0.0896891205979712,0.111283084965481,1.37617805165138e-73
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37808,0.0327508687937681,0.00180819991975834,0.0292067969510417,0.0362949406364944,1.86850880879036e-72
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40174,0.061760939806231,0.0034168293485344,0.0550639542831036,0.0684579253293584,2.67841810907181e-72
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39991,0.0535242939942684,0.00298938215922592,0.0476651049621856,0.0593834830263512,5.58393042991909e-71
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40095,0.0411747893058711,0.00231482156189679,0.0366377390445534,0.0457118395671889,4.32885119435942e-70
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39810,0.0786837190852625,0.00450865792799322,0.0698467495463958,0.0875206886241292,1.4977458620883e-67
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,40274,0.0578190237276958,0.00340580158885637,0.0511436526135373,0.0644943948418543,4.51400036395756e-64
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,40274,0.0557783285060654,0.00335646186011844,0.0491996632602332,0.0623569937518975,1.70834416420891e-61
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37737,0.100797370298399,0.00623299059897014,0.0885807087244171,0.11301403187238,2.87786769257369e-58
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,40186,0.0543733995636495,0.00340308143142622,0.0477033599580541,0.0610434391692449,5.13247948495129e-57
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,40126,0.078454715447904,0.0049412562380895,0.0687698532212486,0.0881395776745594,2.4937048895462e-56
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,37470,0.147515015166718,0.00945962896896944,0.128974142387538,0.166055887945898,2.4713928307074e-54
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,40126,0.0338663696936342,0.00221224970339765,0.0295303602749748,0.0382023791122936,1.60747785843635e-52
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,37496,0.0390580169780386,0.00256118555767061,0.0340380932850042,0.044077940671073,4.62821289747721e-52
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39727,0.0686507499448869,0.00454532826967937,0.0597419065363153,0.0775595933534584,3.59067930622773e-51
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39815,0.0503911726609353,0.00335770106835914,0.0438100785669513,0.0569722667549192,1.49278051118974e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37678,0.044580821241461,0.0029751308208002,0.0387495648326926,0.0504120776502294,2.39953591694215e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40117,0.0451332514640705,0.00301741003400984,0.0392191277974112,0.0510473751307298,3.08674439152008e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40141,0.0494211092713518,0.0033212872532657,0.042911386254951,0.0559308322877525,9.69017069751869e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,40215,0.054290506533431,0.00365069022006692,0.0471351537020998,0.0614458593647621,1.09930684408536e-49
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39955,0.0897610329542894,0.0060870907554776,0.0778303350735533,0.101691730835025,6.98356397975601e-49
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37808,-0.0334768102346781,0.00228932354274808,-0.0379638843784644,-0.0289897360908919,4.7094801073335e-48
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40213,0.0336628822883033,0.00231554278227642,0.0291244184350415,0.0382013461415651,1.41829257168718e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40097,0.124633152630875,0.00858058168681847,0.107815212524711,0.14145109273704,1.71362383159872e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,40126,-0.0551529622698837,0.00380466417181802,-0.062610104046647,-0.0476958204931204,2.59282490083553e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,40114,0.0386534736952719,0.00267987863456189,0.0334009115715306,0.0439060358190132,7.34104509623859e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40233,0.0758915971681054,0.00527570051993757,0.0655512241490277,0.086231970187183,1.26524599162857e-46
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40297,0.0342053804265963,0.00238025220236259,0.0295400861099656,0.0388706747432269,1.55468611331974e-46
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39969,0.0609070982380214,0.00429352246953051,0.0524917941977417,0.0693224022783012,2.15558665178042e-45
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39991,-0.0698357438989103,0.00495771514285438,-0.0795528655789049,-0.0601186222189157,8.69888770978853e-45
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,40097,0.045071072275886,0.00321615642315434,0.0387674056865035,0.0513747388652685,2.37460978932296e-44
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40248,0.0328382610896994,0.00237996355080501,0.0281735325301215,0.0375029896492772,4.66957613778665e-43
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39923,0.0526838171162994,0.00383627712814672,0.0451647139451319,0.060202920287467,1.14508448288352e-42
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,40160,0.0346733827769109,0.0025395520734765,0.0296958607128969,0.0396509048409248,3.35746997892415e-42
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40164,0.048034282039729,0.00355023469243784,0.0410758220425508,0.0549927420369071,1.77858906577971e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40065,0.0986097545402526,0.00731806176915224,0.0842663534727142,0.112953155607791,3.73522613539685e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40248,0.0388695394067532,0.00289785175972848,0.0331897499576854,0.044549328855821,8.45920304502072e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40274,0.0322207973611379,0.00242210850033714,0.0274734647004771,0.0369681300217987,3.66446680816934e-40
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40274,0.045885846832765,0.00345499936252612,0.0391140480822138,0.0526576455833162,4.88758556383539e-40
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,37376,0.0863546763738561,0.00655451257128762,0.0735078317341324,0.0992015210135799,2.19697620401456e-39
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37470,0.0464440215936467,0.00353103341580143,0.0395231960986759,0.0533648470886175,2.9067395547737e-39
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40024,-0.0667671821639286,0.00513974629164619,-0.0768410848955551,-0.0566932794323021,2.19650786489754e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37430,0.0279901003483633,0.0021557328258669,0.0237648640096642,0.0322153366870624,2.61058979175582e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40185,0.0498322106122051,0.00384112943008132,0.0423035969292457,0.0573608242951645,2.72478519031674e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40229,0.0360957761864492,0.00278703848107525,0.0306331807635417,0.0415583716093566,3.61550102058328e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40065,0.0332653921356329,0.00256995572256988,0.0282282789193959,0.0383025053518698,3.99308676548195e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37784,0.0376598769333547,0.00292056662761706,0.0319355663432253,0.0433841875234841,8.110747389247e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40095,0.0386759309973129,0.00300536398005854,0.0327854175963982,0.0445664443982276,1.04543447476213e-37
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,40119,0.04210784841963,0.00328175015738187,0.0356756181111616,0.0485400787280985,1.69989025212002e-37
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40100,0.0425890811172987,0.0033311418123073,0.0360600431651764,0.049118119069421,3.04920207018746e-37
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40126,0.0478561312274228,0.00375759509485436,0.0404912448415083,0.0552210176133373,5.69986778852282e-37
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40186,0.071155557206259,0.00563737901866854,0.0601062943296687,0.0822048200828494,2.39304560456919e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37754,0.0380163509548572,0.00301452531420777,0.03210788133901,0.0439248205707044,2.95843825106881e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,40297,0.0276457237159287,0.00220549469953512,0.0233229541048399,0.0319684933270176,7.11444890075597e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40065,0.0462981633821471,0.00369769829355831,0.0390506747267729,0.0535456520375214,8.53527387257496e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,40186,0.0345195174501143,0.00276230285177674,0.0291054038606319,0.0399336310395967,1.14997260097432e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,40174,0.0617934294034877,0.00496304506335098,0.0520658610793198,0.0715209977276556,2.03604308795798e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,40100,0.0345023042699208,0.00280673342418177,0.0290011067585246,0.0400035017813171,1.4315248706595e-34
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40065,0.0395793116600972,0.00324561910909017,0.0332178982062805,0.0459407251139139,4.7392649110472e-34
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39991,0.0286718700004738,0.00236937245720742,0.0240278999843473,0.0333158400166004,1.47615753314899e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40181,0.0319214690954275,0.00265259027892091,0.0267223921487426,0.0371205460421125,3.29164357033183e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,40297,0.019470643169477,0.00161800926429279,0.0162993450114631,0.0226419413274909,3.29828201492482e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37697,-0.0547343828268233,0.00454691565202296,-0.0636463375047883,-0.0458224281488583,3.35526088705711e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,40065,0.0293140148417468,0.00244530239540385,0.0245212221467553,0.0341068075367384,5.73894134436868e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37791,0.0276078681531332,0.00231931983845183,0.0230620012697676,0.0321537350364988,1.65898651905518e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,37102,0.0229370118089528,0.00192812276810421,0.0191578911834685,0.0267161324344371,1.84851475486552e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37784,0.0718455412861897,0.00604306952151993,0.0600011250240106,0.0836899575483687,1.97089239532012e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40122,-0.098858971234098,0.00832816512513878,-0.11518217487937,-0.082535767588826,2.32005649632554e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,40126,0.0238946078661218,0.00202116346016304,0.0199331274842022,0.0278560882480413,4.10338917391327e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40261,0.0522972642095038,0.00444058535683613,0.043593716910105,0.0610008115089027,6.9610557425932e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FST,Follistatin,40160,0.0509917981189391,0.00433704703984593,0.0424911859208411,0.0594924103170371,8.80624446246301e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,40126,-0.0354452721941526,0.0030394161574009,-0.0414025278626584,-0.0294880165256469,2.68807443945417e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40297,0.0235420714417926,0.00202166008934719,0.0195796176666721,0.0275045252169131,3.26374782738276e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40065,0.0657464598687195,0.00564651948289192,0.0546792816822513,0.0768136380551876,3.32419897969027e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,40222,-0.0331891269772934,0.00285540217072929,-0.0387857152319228,-0.027592538722664,4.20281499401193e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,40021,0.0407247049876549,0.00350614790815459,0.0338526550876719,0.0475967548876379,4.63155400104376e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,37470,-0.0210536319992368,0.00181434879296175,-0.0246097556334418,-0.0174975083650317,5.58840136349899e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40095,0.0284068003645384,0.00245278090336341,0.0235993497939461,0.0332142509351307,6.83856860154923e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,40100,0.0587928297219374,0.00507850748636205,0.0488389550486678,0.068746704395207,7.21771752460421e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,40139,0.0194025031924785,0.00167681334049287,0.0161159490451125,0.0226890573398445,7.70700381814575e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40054,0.0276201696328995,0.00238841350167287,0.0229388791696207,0.0323014600961783,8.35232624066801e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40233,0.0430877382735843,0.00372699011827292,0.0357828376417694,0.0503926389053992,8.64169994209973e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40274,0.0257358091312115,0.00222646945543143,0.0213719289985659,0.0300996892638571,8.83501934185619e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40100,0.058195418201435,0.00505597848319984,0.0482857003743633,0.0681051360285067,1.55519325975049e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39815,0.0532854884918675,0.00463667155242243,0.0441976122491196,0.0623733647346155,1.92319619207471e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,40133,0.0269404844913278,0.00234521861181637,0.0223438560121677,0.0315371129704879,2.01988719115173e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,40174,0.0554835059927336,0.00483688463048632,0.0460032121169804,0.0649637998684868,2.43865317456338e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39746,0.0768630324160193,0.00671883530633326,0.0636941152156061,0.0900319496164325,3.50340361772088e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,40233,0.0222204029887915,0.00194449614171222,0.0184091905510355,0.0260316154265475,4.0109992485256e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39904,0.141221215952499,0.0123663846823247,0.116983101975143,0.165459329929856,4.39809940101528e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,40213,0.0493721438578397,0.00433111660467765,0.0408831553126715,0.0578611324030079,5.51750492713149e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40248,0.0548198553362509,0.00484172341880348,0.0453300774353961,0.0643096332371057,1.32216814949645e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39727,0.0431466361661438,0.00381135206836812,0.0356763861121423,0.0506168862201453,1.36184369997814e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37430,0.0294914830607425,0.00260417496031719,0.0243873001385208,0.0345956659829642,1.36324028488823e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,40133,0.0238022699177463,0.00211233914762501,0.0196620851884013,0.0279424546470913,2.44223922958062e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37696,0.0273851500094997,0.00243258898839353,0.0226172755922484,0.0321530244267511,2.88479038730925e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40126,0.0329683044353493,0.00293115614504002,0.0272232383910708,0.0387133704796277,3.08196012471709e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40077,0.0518817399761005,0.00461355347511666,0.0428391751648718,0.0609243047873291,3.15591706986552e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,40126,0.0242091320563861,0.00215959797794802,0.019976320019608,0.0284419440931642,4.69654404365665e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,40233,0.0386651328338046,0.00345529828169472,0.0318927482016829,0.0454375174659262,5.86012904224793e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40274,0.072620467027898,0.00649272740100432,0.0598947213219295,0.0853462127338664,6.20753450806816e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40174,0.0309823976113486,0.00277043784382257,0.0255523394374564,0.0364124557852409,6.33530634173352e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37746,0.0184956300352004,0.001654427960948,0.0152529512317423,0.0217383088386584,6.91392134374368e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,40100,0.0375780634285975,0.00336538409352354,0.0309819106052913,0.0441742162519036,7.68324932472857e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40297,0.0144430840636662,0.00129695272538318,0.0119010567219152,0.0169851114054173,1.06891287547922e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,40095,0.023136595247869,0.00207767551884986,0.0190643512309233,0.0272088392648147,1.07660169437715e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37756,0.0325924650144742,0.00293315156700254,0.0268434879431493,0.0383414420857992,1.46873440150781e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37430,0.0417460080439922,0.00376017611276911,0.0343760628629648,0.0491159532250197,1.64583655266728e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37784,0.0314637947131647,0.0028363023069431,0.0259046421915562,0.0370229472347732,1.80230634497871e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39946,0.0276032848174756,0.00249048475889088,0.0227219346900494,0.0324846349449017,1.92962506035468e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40174,0.0232557499837473,0.00210608501810431,0.0191278233482629,0.0273836766192318,3.03769361149309e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,37470,0.0521436266395828,0.00472948792913128,0.0428738302984854,0.0614134229806801,3.84693677801781e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37768,0.0672216263667769,0.00612966607189733,0.0552074808658581,0.0792357718676956,7.27746620609397e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,40233,0.0215608659565382,0.00197302837140336,0.0176937303485876,0.0254280015644888,1.06671069620193e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39746,0.0328611949301482,0.00300782096709541,0.0269658658346412,0.0387565240256552,1.1048770706183e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,40197,0.0363721756365708,0.00333825244937662,0.0298292008357927,0.042915150437349,1.51743795229836e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39991,0.0672562820336187,0.00617485922796916,0.0551535579467991,0.0793590061204382,1.58323212991981e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37727,0.0584829108839837,0.00536962258017342,0.0479584506268438,0.0690073711411236,1.65520130607425e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37784,0.062186364720308,0.00576800851438304,0.0508810680321172,0.0734916614084987,5.45353162816796e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37782,-0.0423348486609838,0.00396431811763947,-0.0501049121715571,-0.0345647851504104,1.63409580657574e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,40126,0.0298809515889179,0.00281185575099203,0.0243697143169735,0.0353921888608623,2.74900594215561e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39775,0.0273054435232151,0.00256961688189839,0.0222689944346943,0.032341892611736,2.77674703175301e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40233,0.0410058019618698,0.00385936643883198,0.0334414437417592,0.0485701601819805,2.79720544761111e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39947,0.025518502444167,0.00240734987224113,0.0208000966945744,0.0302369081937597,3.65299589134969e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37791,0.0315415136092181,0.00297592192190405,0.0257087066422861,0.03737432057615,3.83027879489422e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39832,0.0265329398108046,0.00250463835957724,0.0216238486260333,0.031442030995576,3.92926925360836e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,40186,0.0677681514760991,0.00640129742874757,0.0552216085157538,0.0803146944364443,4.2077778651218e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39815,0.038675547062741,0.00366505151912726,0.0314920460852515,0.0458590480402304,6.06655214523928e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40297,0.0242275976871963,0.002296562719478,0.0197263347570194,0.0287288606173731,6.22473124973846e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37737,0.0268419132352469,0.00254626834845455,0.021851227272276,0.0318325991982178,7.02276363583329e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,40054,0.0360650917851404,0.00342439830310295,0.0293532711110586,0.0427769124592221,7.52694021725389e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39936,0.0618414075064072,0.0058867067786871,0.0503034622201805,0.0733793527926339,9.97068116424792e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40143,0.0290770071249685,0.0027702455056586,0.0236473259338777,0.0345066883160594,1.09413905708767e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39815,0.0366496810458848,0.00350146079418947,0.0297868178892735,0.0435125442024962,1.49316725270332e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40092,0.0195725228710465,0.00187085559258452,0.0159056459095809,0.0232393998325122,1.57077956647154e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37808,0.0175355225166819,0.00167608400846652,0.0142503978600875,0.0208206471732763,1.61679675280233e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40164,0.0240678252035288,0.00230638397355585,0.0195473126153593,0.0285883377916982,2.07113093231436e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37755,0.0128068139443925,0.00122909702067865,0.0103977837838624,0.0152158441049227,2.52311482108955e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,40126,0.0336287992888182,0.00323694073748701,0.0272843954433437,0.0399732031342927,3.35692709956954e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39783,0.0346513048649118,0.00333730346505441,0.0281101900734051,0.0411924196564184,3.58988490142831e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,40233,0.0194158250659905,0.00187247434513388,0.0157457753495281,0.0230858747824529,4.12782924512336e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39841,0.0296167188145477,0.00285885720848939,0.0240133586859085,0.0352200789431869,4.5744806927698e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,40248,0.0298605139877677,0.00288805257954905,0.0241999309318515,0.0355210970436838,5.61999170878125e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39746,0.0939780373049521,0.00909414620351869,0.0761535107460554,0.111802563863849,5.9803271852638e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39991,0.0352723747985331,0.00342041777135271,0.0285683559666818,0.0419763936303844,7.45625273836854e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39991,0.0417973459581755,0.00406552622243761,0.0338289145621978,0.0497657773541532,1.03083552028074e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40095,-0.0320730855514372,0.00313317586792825,-0.0382141102525765,-0.0259320608502978,1.62407537875726e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40274,0.0277485236188841,0.0027188120499279,0.0224196520010255,0.0330773952367428,2.21531772345869e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39746,0.0462302066559204,0.00453791018181273,0.0373359026995674,0.0551245106122733,2.69443351053724e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37737,0.0270743069917935,0.00265715699162263,0.0218662792882131,0.0322823346953738,2.72170794295585e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40121,0.0324585950335479,0.00319124861625807,0.026203747745682,0.0387134423214137,3.17283493849968e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40065,0.0203576228650046,0.00200397376149346,0.0164298342924774,0.0242854114375318,3.60623558907567e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40095,0.0413040053259168,0.00406651156892785,0.0333336426508182,0.0492743680010154,3.66120638858767e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37696,0.117939061261419,0.0116222745133049,0.0951594032153413,0.140718719307497,4.15726459263493e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40126,0.0261655937426996,0.00258640240810794,0.0210962450228081,0.0312349424625912,5.52529867492955e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39783,0.0408006202825598,0.00404604151749113,0.0328703789082772,0.0487308616568424,7.70978901944308e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37396,0.032344141871758,0.00323178837270352,0.0260098366612591,0.0386784470822569,1.7089010316732e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,40126,0.03344145786435,0.00335056209541184,0.0268743561573428,0.0400085595713572,2.17120552703173e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37784,0.022772886428531,0.00228124532920729,0.0183016455832847,0.0272441272737773,2.19310901667232e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40095,0.0279480103585658,0.0028022232978657,0.022455652694749,0.0334403680223825,2.3374419581787e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37696,0.0223713377401216,0.00224466097416376,0.0179718022307606,0.0267708732494826,2.58164705416586e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,40065,0.0275662705052676,0.00276669664006661,0.0221435450907371,0.0329889959197982,2.58179147795967e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40297,0.0407615355563634,0.00409636601527287,0.0327326581664285,0.0487904129462982,2.93152812142803e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,40160,0.0686646262610295,0.00692986351208408,0.0550820937773447,0.0822471587447143,4.46788902005472e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,40160,0.0242834102094921,0.00245357175515043,0.0194744095693972,0.0290924108495869,5.00114102292404e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37782,0.0325258683197397,0.0032875611036257,0.0260822485566333,0.038969488082846,5.32517021781322e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40207,0.0254343189686837,0.00257335919679257,0.0203905349429703,0.0304781029943972,5.7137421761861e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,40056,0.0247234206635214,0.0025047070219286,0.0198141949005414,0.0296326464265015,6.50422278542404e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40174,0.0304441288908695,0.00309148259121654,0.0243848230120851,0.0365034347696539,8.16070217352915e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40065,0.0339135962331554,0.00344511474838273,0.0271611713263252,0.0406660211399855,8.48005784396569e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40248,0.0265484639775747,0.0027144600913944,0.0212281221984417,0.0318688057567077,1.58373095644747e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40065,0.01741143628048,0.00178189890684029,0.013918914423073,0.020903958137887,1.734738666689e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,40097,0.0736335729534949,0.00755750288980503,0.0588208672894771,0.0884462786175128,2.28551879158784e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,40274,0.0361577809374802,0.00373096090645984,0.028845097560819,0.0434704643141415,3.78412333716848e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37470,0.0306930116556397,0.00317730578743602,0.0244654923122651,0.0369205309990143,5.28093631132937e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39877,0.016748564448133,0.0017357140349026,0.0133465649397239,0.0201505639565421,5.70530346599714e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39810,0.0541202160303839,0.0056093203506881,0.0431259481430352,0.0651144839177325,5.7708101274115e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37696,0.024130751704002,0.00250066579884718,0.0192294467382616,0.0290320566697425,5.82076106318213e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40261,0.0411142538581378,0.00426266772151769,0.0327594251239632,0.0494690825923125,5.92106061001144e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40100,0.0346119345204456,0.00359238778009988,0.0275708544714499,0.0416530145694414,6.55744072321275e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,40106,0.0416426321093796,0.00433138325977924,0.0331531209202122,0.0501321432985469,8.00495881471841e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,40031,0.0310754432938555,0.00323259461382688,0.0247395578507548,0.0374113287369562,8.08854229531155e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40065,0.0843138970166271,0.00877286055146727,0.0671190903357513,0.101508703697503,8.27517961594995e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,40065,0.0410619457189391,0.00428093995030581,0.0326713034163397,0.0494525880215385,9.93575895527421e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,40095,0.0337578904979884,0.0035210246799598,0.0268566821252672,0.0406590988707096,1.03520493170104e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,40143,0.0237427891853038,0.00247931805362111,0.0188833258002064,0.0286022525704011,1.1523711504256e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39889,0.0426994105721538,0.00446595596509242,0.0339461368805727,0.051452684263735,1.33729548299448e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37403,0.0670049236419003,0.00702343353813365,0.0532389939071584,0.0807708533766423,1.6774390675148e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40100,0.0494294774059293,0.00519342213685316,0.0392503700176971,0.0596085847941615,2.02318970045377e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40047,0.0256111545001316,0.00269792780893262,0.0203232159946237,0.0308990930056396,2.56545474088038e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,40186,0.0343890435874017,0.00362391845118984,0.0272861634230696,0.0414919237517338,2.64780839198817e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,40233,0.0235831074364986,0.00249097485332943,0.0187007967239729,0.0284654181490243,3.26531896667424e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,40100,0.0340294679186197,0.00360094565319693,0.0269716144383537,0.0410873213988857,3.85236688925376e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,37470,0.0428804198421451,0.00453823501103439,0.0339854792205177,0.0517753604637725,4.0089253769109e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40140,0.0177319746802284,0.00188038040497703,0.0140464290864734,0.0214175202739834,4.66281177815938e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,40100,0.0306407079561466,0.00325573124048914,0.0242594747247879,0.0370219411875053,5.5670035367351e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40100,0.0431423011566045,0.00458711306320941,0.0341515595527141,0.052133042760495,5.90346467383416e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,40126,0.0619259592372028,0.00659358026211652,0.0490025419234544,0.0748493765509511,6.68965720525805e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37782,0.0221856386483376,0.00236195339047269,0.0175562100030111,0.026815067293664,6.77111293037285e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37784,0.0211719118904581,0.00226290502310108,0.01673661804518,0.0256072057357362,9.57916756153417e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,40100,0.0693495592319366,0.00741548800532268,0.0548152027415041,0.083883915722369,9.74216328247236e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37737,0.0504775266545914,0.00541247584811348,0.039869073992289,0.0610859793168939,1.26923582309806e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,40207,0.028924414942228,0.00310485845901394,0.0228388923625606,0.0350099375218953,1.36643247969284e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40065,0.0301168913437537,0.00323310184014776,0.0237800117370641,0.0364537709504433,1.37677159334097e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,40143,0.0187927045726522,0.00201787187266379,0.0148376757022312,0.0227477334430732,1.40246252919702e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39946,0.0318323760691248,0.00342026375141391,0.0251286591163536,0.0385360930218961,1.48769621576386e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37430,0.0358375403761913,0.00385349397071234,0.0282846921935951,0.0433903885587875,1.62629512504665e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39978,0.073185052828069,0.00787258681160309,0.057754782677327,0.0886153229788111,1.64552496710569e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,40100,0.0412238077811275,0.00444462071557798,0.0325123511785947,0.0499352643836604,2.00391352675601e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37791,0.0173008479827609,0.00186490362419441,0.0136456368793399,0.020956059086182,2.00660747794047e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,40065,0.0606999757410236,0.0065613489736362,0.0478397317526967,0.0735602197293506,2.50316562428021e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37696,0.0260916684130561,0.00282485590965669,0.020554950830129,0.0316283859959832,2.93072995252949e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40160,-0.0654053580602912,0.0070917702364882,-0.0793052277238081,-0.0515054883967744,3.25768776747989e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37552,0.0104231885315411,0.00113118655266717,0.00820606288831348,0.0126403141747688,3.60183313323909e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39746,0.0519025659159236,0.00563818293466764,0.040851727363975,0.0629534044678721,3.83157019330535e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40095,0.0689693048983707,0.00749394069633316,0.0542811811335577,0.0836574286631837,3.9002433278901e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40233,0.0400990119262527,0.00435767752803461,0.0315579639713049,0.0486400598812005,3.94783896381519e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40261,0.0292638583285652,0.00318046087948797,0.0230301550047688,0.0354975616523616,3.97582552935582e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37696,0.0546892737257895,0.00595361983006671,0.0430201788588587,0.0663583685927202,4.68077389964552e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37808,0.0200548669130741,0.00218343523792572,0.0157753338467397,0.0243343999794085,4.71354912323881e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40095,0.0209651216258625,0.0022838348002378,0.0164888054173964,0.0254414378343286,4.84943979861634e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39991,0.026712692670524,0.00291035178601319,0.0210084031699381,0.0324169821711098,4.91085750908905e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37756,-0.0347110012576842,0.0037821926337995,-0.0421240988199312,-0.0272979036954372,5.05523309015656e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37143,0.037868539594504,0.00412850804638186,0.0297766638235955,0.0459604153654124,5.32990537659689e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40202,0.0374041504424786,0.0040805854429218,0.0294062029743519,0.0454020979106054,5.4846536662652e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40100,0.0288378556143386,0.00314831641800393,0.0226671554350509,0.0350085557936263,5.8330130852653e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,40057,0.0363058956562147,0.00396443659479351,0.0285355999304194,0.04407619138201,5.93655459189267e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40100,0.0391916421609105,0.0042807289992682,0.0308014133223448,0.0475818709994762,6.07460518255799e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39746,0.0380206131976006,0.00416847312565801,0.0298504058713109,0.0461908205238904,8.35466394424988e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40065,0.024733460512162,0.00271249822161714,0.0194169639977924,0.0300499570265316,8.54106951022821e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40126,0.0212474322108517,0.00233193424382351,0.0166768410929576,0.0258180233287458,9.08907398516002e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,40297,0.0403769796325362,0.00443299770737267,0.0316883041260858,0.0490656551389867,9.3507215142399e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37808,-0.0502497336605581,0.00552492653781301,-0.0610785896746716,-0.0394208776464446,1.07690789688899e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40037,0.0793396353924195,0.00873059664111666,0.0622276659758308,0.0964516048090081,1.13271961101009e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_E,,40100,0.0218328442033205,0.00241139600202943,0.0171065080393428,0.0265591803672982,1.53749276127358e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39746,0.0399867760711047,0.00441856063239107,0.0313263972316182,0.0486471549105912,1.60293905466904e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40174,0.0161642279525296,0.00178996168628402,0.0126559030474129,0.0196725528576463,1.90391036248264e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37696,0.0776632991906822,0.00860064981557705,0.0608060255521512,0.0945205728292132,1.95240494230005e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,40117,0.0340618650550372,0.00377428026835906,0.0266642757290534,0.041459454381021,2.00696551475224e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40100,0.0248515605227416,0.00275398092229399,0.0194537579150454,0.0302493631304378,2.02300289753883e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39727,0.045167651524236,0.00501015170495795,0.0353477541825184,0.0549875488659536,2.1938923030662e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40174,0.0180325501544338,0.00200308114665025,0.0141065111069993,0.0219585892018683,2.45673605940357e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37696,0.0434971828555269,0.00483055713745218,0.0340292908661207,0.0529650748449332,2.45698477735425e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37362,0.0511015425658196,0.00568166041333401,0.0399654881556849,0.0622375969759542,2.70998852071523e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,40248,0.0828408151555463,0.00921583308262599,0.0647777823135993,0.100903847997493,2.77338964054461e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,40251,0.0201408800409755,0.00225240277003729,0.0157261706117024,0.0245555894702486,4.23976405493619e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40212,0.0259180722676596,0.00289935209205957,0.0202353421672229,0.0316008023680964,4.34480397290422e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,40121,0.0191074564246373,0.00213751104172778,0.0149179347828508,0.0232969780664237,4.35323260373624e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37737,0.0689120128519389,0.00771865283289102,0.0537834532994725,0.0840405724044053,4.9016216187502e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39727,0.0264290069949614,0.00296772902747653,0.0206122581011074,0.0322457558888154,5.90578342396516e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40065,0.0257701146558202,0.00289612695895255,0.0200937058162732,0.0314465234953672,6.29293095462541e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37585,0.031193488984364,0.00350573489015026,0.0243222485996695,0.0380647293690585,6.43184424663754e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40229,0.0610870665029883,0.00686991175240569,0.0476220394682732,0.0745520935377035,6.64281612187673e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40065,0.0257951542743407,0.00290435361389074,0.0201026211911148,0.0314876873575665,7.30029055729223e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40248,0.0448595037220976,0.00507872879078924,0.0349051952921507,0.0548138121520445,1.12630120289807e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39815,0.0625082445542266,0.00707880640113004,0.0486337840080117,0.0763827051004415,1.1546638707194e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40164,0.0225533542295311,0.00255719263794249,0.0175412566591638,0.0275654517998984,1.26775983853401e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40065,0.0166704629451996,0.00189019207712607,0.0129656864740325,0.0203752394163667,1.26991673674465e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36960,-0.0816555269619777,0.00925588450810428,-0.0997970605978621,-0.0635139933260934,1.27217667268191e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37410,0.0416329619518395,0.00472484970054648,0.0323722565387684,0.0508936673649106,1.39074055884036e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,40274,0.0276357935330542,0.0031451188717378,0.0214713605444482,0.0338002265216603,1.69311239825749e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40274,0.0325224571164169,0.00370310302223743,0.0252643751928315,0.0397805390400022,1.76029748796663e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39967,0.0652366824077613,0.00743181553174184,0.0506703239655473,0.0798030408499753,1.83462294921594e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,40126,0.0203670033627502,0.00232057682219913,0.0158186727912399,0.0249153339342605,1.85448226988376e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FURIN,Furin,40174,0.0246127020881615,0.00280748245714572,0.0191100364721559,0.0301153677041671,2.02305248407489e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37808,0.0151938554986487,0.00173441623681324,0.0117943996744948,0.0185933113228027,2.18122520926217e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37737,0.0488397916688858,0.00557775407871502,0.0379073936746044,0.0597721896631673,2.26164865248074e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,40248,0.0266705981202266,0.00304975420326705,0.0206930798818232,0.03264811635863,2.44806609735497e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,37470,0.0192495116001863,0.00220996010523446,0.0149179897939268,0.0235810334064458,3.39200208104742e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40233,-0.0959419525808191,0.0110211568387505,-0.11754341998477,-0.0743404851768682,3.47774738935564e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40152,0.0168316853372433,0.00193431232991377,0.0130404331706123,0.0206229375038743,3.59151835222215e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,37479,0.0152757578560074,0.00176015954749718,0.011825845142913,0.0187256705691019,4.47764611708507e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39991,0.0182384751351125,0.00210415614429678,0.0141143290922909,0.0223626211779342,4.83305920924648e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37808,0.0167724862683569,0.00193582704675219,0.0129782652567226,0.0205667072799912,5.06273839834363e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40204,0.0201386203460214,0.00232746969800414,0.0155767797379333,0.0247004609541095,5.5145985857463e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39811,0.0301920108455305,0.00348935012883296,0.0233528845930179,0.0370311370980431,5.52567914875748e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40143,0.0192903181659987,0.00222990208241316,0.0149197100844689,0.0236609262475285,5.6055231184311e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39942,0.0314096624141522,0.00363534877165782,0.0242843788217029,0.0385349460066015,6.15956418151612e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,40126,0.0254773608176432,0.00295005685826712,0.0196952493754396,0.0312594722598467,6.3622761263962e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40052,0.0248930011271134,0.002885673713258,0.0192370806491277,0.0305489216050991,6.9327778487812e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,37470,0.0326973119613763,0.00379835439415289,0.0252525373488366,0.040142086573916,8.26104095109857e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,40065,0.020402986442708,0.00237336695482273,0.0157511872112554,0.0250547856741605,8.97696934439656e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40100,0.0269289207933811,0.00313443448559348,0.0207854292016179,0.0330724123851444,9.3990788123659e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37696,0.0395819081224929,0.00461748905195456,0.0305316295806619,0.0486321866643238,1.12715596075075e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,40274,0.0365961183834514,0.00427047701041408,0.0282259834430398,0.044966253323863,1.13350121800131e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,40100,0.0636516082415556,0.00742846595943588,0.0490918149610612,0.0782114015220499,1.14399931860549e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39955,0.0170092123475552,0.00198538232117447,0.0131178629980532,0.0209005616970571,1.15872206706824e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37696,0.0649729133392286,0.00758308822246992,0.0501100604231875,0.0798357662552696,1.16715415236264e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37756,0.0339168088627286,0.00395894723719377,0.0261572722778288,0.0416763454476284,1.1767784941484e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40174,0.0417230962553648,0.00487266437933718,0.0321726740718639,0.0512735184388657,1.20354296004003e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40036,0.0193515507612108,0.00226183245205185,0.0149183591551892,0.0237847423672325,1.27939281241778e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40216,0.0187444762988173,0.00219105553341625,0.0144500074533215,0.0230389451443131,1.28582956823998e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40100,0.0388162423095479,0.00454016222377124,0.0299175243509563,0.0477149602681396,1.34882798292148e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37430,0.0600499798262207,0.00703120765985796,0.0462688128128991,0.0738311468395423,1.48430332965241e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,40065,0.0201562274545363,0.00236296118954106,0.0155248235230358,0.0247876313860368,1.59523486246468e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37697,0.0565893316681023,0.00665667223575538,0.0435422540860217,0.0696364092501828,2.0766729617131e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,37430,0.0494109139194493,0.00581800153112231,0.0380076309184496,0.0608141969204491,2.23581272531592e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40297,0.0153676831548925,0.00181009940246725,0.0118198883260567,0.0189154779837283,2.24805047727578e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40100,0.0238831603754392,0.00281445809612262,0.0183668225070389,0.0293994982438396,2.33051684455398e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40274,0.0397074572089443,0.00468114541398445,0.0305324121975347,0.0488825022203538,2.3983205140088e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37784,0.0647846961430185,0.00764615304535026,0.049798236174132,0.079771156111905,2.64374604298066e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40100,-0.0243674196993491,0.00287758175062816,-0.0300074799305803,-0.0187273594681179,2.71518312252901e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37777,0.015819340069076,0.00186777343242197,0.012158504141529,0.0194801759966231,2.71768379097855e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39914,0.0255103536471202,0.00301683473608312,0.0195973575643973,0.0314233497298431,3.01166248106695e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40095,0.027944490211463,0.00330664487013275,0.0214634662660028,0.0344255141569232,3.13952786822898e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39746,0.0405834535176855,0.00481000153604082,0.0311558505070455,0.0500110565283255,3.53506972933189e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39881,0.01941856541081,0.00230237597975855,0.0149059084904832,0.0239312223311367,3.62887899990996e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,37403,0.0213208693787774,0.00252897278527792,0.0163640827196327,0.0262776560379221,3.79876981577621e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39810,0.0242274816273687,0.00287511807353145,0.0185922502032471,0.0298627130514904,3.87068099163648e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,40274,0.0248080490210007,0.00295022396797304,0.0190256100437735,0.0305904879982278,4.48900035764908e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,37403,0.0269275875089006,0.00320417351595271,0.0206474074176332,0.0332077676001679,4.76620984940514e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40174,0.0170578117720116,0.00203215502533578,0.0130747879223534,0.0210408356216697,5.09690705086625e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40248,0.0265276497277066,0.00316708288280337,0.020320167277412,0.0327351321780012,5.92839865216228e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40274,0.0320230695776862,0.00382409783905017,0.0245278378131479,0.0395183013422245,6.0303377655642e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37675,0.061177930206018,0.00730457806063308,0.0468609572071772,0.0754949032048589,6.05999836207345e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40274,0.037998257668797,0.00454051224248294,0.0290988536735304,0.0468976616640636,6.30673152078669e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40122,0.0278413747922684,0.00333549608917836,0.0213038024574789,0.034378947127058,7.58085067671665e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39864,0.0291683759160081,0.00349594807917937,0.0223163176808165,0.0360204341511997,7.819083710032e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40065,0.0552670154403169,0.00662550297648326,0.0422810296064097,0.068253001274224,7.93853487697145e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,40233,0.0180941888330544,0.002169506435048,0.0138419562203604,0.0223464214457485,8.02082052900935e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37609,0.0216193969181778,0.00259204434870576,0.0165389899947146,0.0266998038416411,8.11693694854796e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40121,0.0194961957766252,0.00234120803725974,0.0149074280235962,0.0240849635296543,8.93964204253285e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40065,0.0226101471581229,0.00271565207890638,0.0172874690834664,0.0279328252327794,9.05909242674042e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39991,0.0465785541673769,0.0055948091104872,0.035612728310822,0.0575443800239318,9.10424328647113e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37784,0.0190909001539756,0.00229383501785889,0.0145949835189722,0.0235868167889791,9.42898103934696e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40083,0.016973964992349,0.00204027596921434,0.0129750240926889,0.0209729058920091,9.56010881376698e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40233,0.0203502559902841,0.00244725992569737,0.0155536265359173,0.025146885444651,9.87258287528259e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37739,0.0153841181236613,0.0018532728087784,0.0117517034184557,0.019016532828867,1.13090555330114e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37756,0.0628200428266987,0.00758385336600937,0.0479556902293203,0.077684395424077,1.3108235772146e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40065,0.0847545706546778,0.0102415495138686,0.0646811336074954,0.10482800770186,1.38093155140426e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,40274,0.0181682042806743,0.00219752870004422,0.0138610480285876,0.0224753605327609,1.47486053819466e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40126,0.0206324142591776,0.00249696674495381,0.0157383594390682,0.0255264690792871,1.53330447536102e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36873,0.0169797959748964,0.002055892447447,0.0129502467779003,0.0210093451718926,1.61585315632996e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37696,0.0656511069420162,0.00795007745020631,0.0500689551396118,0.0812332587444205,1.62197257478683e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,37403,0.0574346665821389,0.00695725410926224,0.0437984485279849,0.0710708846362929,1.66024893970755e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40251,0.0338059324180086,0.00409700601731169,0.0257758006240777,0.0418360642119395,1.68824869001425e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39746,0.0462379902341956,0.00560425434935133,0.035253651709467,0.0572223287589242,1.70459184903878e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40065,0.0142324341399847,0.00172676214151551,0.0108479803426143,0.0176168879373551,1.82292543500187e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40297,0.019984016986945,0.00242547776917303,0.0152300805593659,0.0247379534145242,1.86785233578616e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39997,0.0203410406002548,0.00247460820592022,0.0154908085166511,0.0251912726838584,2.19609040395547e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37756,0.0781037699541244,0.00950762060799603,0.0594688335624522,0.0967387063457966,2.3190583844992e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,40186,0.0304638341588062,0.00371098024927395,0.0231903128702292,0.0377373554473831,2.39973152020874e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,40233,0.0233892042146379,0.00285060172244951,0.0178020248386369,0.028976383590639,2.48217512399218e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40229,0.042005498166731,0.0051200974470454,0.031970107170522,0.0520408891629399,2.5021170131119e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40036,0.0230466219780514,0.00281825809202593,0.0175228361176806,0.0285704078384223,3.11655961900288e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C3,Complement C3,37162,0.0321963874855303,0.00394023135915534,0.0244735340215858,0.0399192409494747,3.341081211402e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40065,0.0464793055862132,0.00569320809908498,0.0353206177120066,0.0576379934604198,3.4869276163794e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37784,0.0224841972301733,0.00275543220805602,0.0170835501023835,0.0278848443579632,3.65011529474257e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37696,0.0360988121947062,0.00442959491239621,0.0274168061664096,0.0447808182230028,3.98165377102899e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,40095,0.0318694474966734,0.00391225831300802,0.0242014212031777,0.0395374737901691,4.04191198314658e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39967,0.0200586537097491,0.00246336449695174,0.0152304592957237,0.0248868481237745,4.15431998185665e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39961,0.023085699048412,0.00283536528938221,0.0175283830812229,0.0286430150156011,4.17956093113196e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,37470,0.020151715158503,0.00247680122887165,0.0152971847499145,0.0250062455670914,4.44732915901222e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,37470,0.0387953046077619,0.00477077261501251,0.0294445902823374,0.0481460189331864,4.60775752459435e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40100,0.0415748049326787,0.00511378394691754,0.0315517883967204,0.0515978214686371,4.61390365474958e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37808,0.0183087826325628,0.00225448924513063,0.0138899837121068,0.0227275815530189,5.02531680863773e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39991,0.0235411335483059,0.00290599504136106,0.0178453832672382,0.0292368838293736,5.85859569438649e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,37470,0.0731460253838158,0.00903170939811452,0.0554438749635114,0.0908481758041203,6.04173590597322e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BSG,Basigin,40261,0.0137057820659203,0.00169300271937249,0.0103874967359503,0.0170240673958904,6.11286287277917e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37403,0.0598761840043807,0.00740124400151306,0.0453697457614151,0.0743826222473463,6.49436561310416e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37696,0.0589230972450507,0.00729154612542416,0.0446316668392193,0.073214527650882,6.97656425137069e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40194,0.0228125399617997,0.00282711857463602,0.0172713875555131,0.0283536923680863,7.58396942608406e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37737,0.0179022819100654,0.00222123989368107,0.0135486517184505,0.0222559121016803,8.30566948189653e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40229,0.0198228361495894,0.00246223688825491,0.0149968518486098,0.0246488204505691,8.81206463110444e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,37470,0.0362555033253842,0.00450300918727213,0.0274296053183308,0.0450814013324376,8.89311175336477e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37784,0.0203909821542896,0.00253480817539215,0.015422758130521,0.0253592061780582,9.39597619909998e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,40100,0.0413156931051741,0.00514986600861254,0.0312219557282935,0.0514094304820547,1.10753394049434e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39810,0.0490370681498895,0.00611535958354535,0.0370509633661407,0.0610231729336384,1.14551278738201e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,40126,0.0359619317785921,0.0044857424179199,0.0271698766394691,0.0447539869177151,1.16009328068022e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,40065,0.0515423166376736,0.00643579493970307,0.0389281585558556,0.0641564747194917,1.24056167054955e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39810,0.0273906879623002,0.00342205793141297,0.0206834544167307,0.0340979215078696,1.28841846839312e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,40229,0.0133875901309819,0.00167341058256668,0.0101077053891512,0.0166674748728126,1.32810031692204e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40126,0.0116954917172341,0.00146295902024446,0.00882809203755501,0.0145628913969133,1.39218698722052e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39815,0.022672695310869,0.00283990110395746,0.0171064891471123,0.0282389014746256,1.52097787476733e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40065,0.0207237735765145,0.00259751476910309,0.0156326446290725,0.0258149025239566,1.58588599717503e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40233,0.0153789769419193,0.00192780801595405,0.0116004732306494,0.0191574806531893,1.59587437986889e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39991,0.037263382905211,0.00468406541615313,0.0280826146895508,0.0464441511208711,1.90865928617912e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39746,0.0366804786596726,0.00461882774839386,0.0276275762728206,0.0457333810465246,2.1354580495143e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37609,0.0663784180462841,0.00836304089619701,0.049986857889738,0.0827699782028302,2.23623058816938e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37430,0.0478165218021932,0.0060281140589342,0.0360014182466821,0.0596316253577042,2.32762328263116e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39979,0.0249409423857307,0.00314749073379353,0.0187718605474953,0.031110024223966,2.45370976089686e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37470,0.0322601292749839,0.00407057694342643,0.0242817984658681,0.0402384600840997,2.46237840295757e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37696,0.0591147319311609,0.00746053999722544,0.0444920735365991,0.0737373903257228,2.48973499448832e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37470,0.0491053174553673,0.00619745340034314,0.0369583087906947,0.0612523261200398,2.49675500690384e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37696,0.0389500922247123,0.0049225456867816,0.0293019026786203,0.0485982817708042,2.72019180473674e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37808,-0.0242565681067217,0.00307044561773271,-0.0302746415174778,-0.0182384946959655,3.00586922364721e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39991,0.0358571724865424,0.00453990116026162,0.0269589662124296,0.0447553787606552,3.01724612253684e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40233,0.0524231058090609,0.00664647754449537,0.03939600982185,0.0654502017962719,3.28771935846542e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37756,0.0552700496229611,0.00701973440685418,0.0415113701855269,0.0690287290603953,3.71381617022715e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,40065,0.0365539739811696,0.00464412234580038,0.0274514941834009,0.0456564537789384,3.74737167748276e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37705,0.0270305544070233,0.00343409325554988,0.0202997316261455,0.033761377187901,3.78318313623304e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37784,0.0283534229168653,0.00360311164726446,0.0212913240882269,0.0354155217455036,3.8447950333182e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39727,0.0340286137315572,0.00432815584546917,0.0255454282744376,0.0425117991886767,4.02698921886288e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39991,0.038909283235066,0.00495126947717742,0.0292047950597982,0.0486137714103337,4.1428733623992e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,40243,0.0458048403735792,0.00583373433319101,0.0343707210805248,0.0572389596666336,4.3660085749246e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39991,0.0331839443398263,0.00422953344944181,0.0248940587789204,0.0414738299007323,4.58180194628591e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37791,0.0597003789436971,0.00761136392480046,0.0447821056510882,0.074618652236306,4.71024524828545e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39904,0.0193493337349713,0.0024778714930402,0.0144927056086125,0.02420596186133,6.1399516027415e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37784,0.0188853176297013,0.00242208747066998,0.0141380261871882,0.0236326090722145,6.80181312592622e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37675,0.0272189257364056,0.00349096205045836,0.0203766401175072,0.034061211355304,6.81411071883404e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,37403,0.0283741853824064,0.0036426566109519,0.0212345784249407,0.0355137923398721,7.24268674321949e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40233,0.034934207173679,0.00448730721052317,0.0261390850410536,0.0437293293063044,7.39521786750833e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,40055,0.0708228780159671,0.00910307886395685,0.0529808434426117,0.0886649125893225,7.69839898832205e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39940,0.0173028431913571,0.00222536612470796,0.0129411255869295,0.0216645607957847,7.99981855887402e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,40095,0.0189384386683377,0.00243582022636355,0.0141642310246651,0.0237126463120103,8.01425364167627e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2,Complement C2,40133,0.0156089787345471,0.00200799335840276,0.0116733117520777,0.0195446457170165,8.11156925664731e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,40148,0.0368828470273322,0.00474589455920064,0.027580893691299,0.0461848003633655,8.23290640812024e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37759,0.0289548610944815,0.00372720986510203,0.0216495297588816,0.0362601924300815,8.52135717919025e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40193,0.0180952170310964,0.00233512751696237,0.0135183670978501,0.0226720669643426,9.81453627407574e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39746,0.0477640222830535,0.00616427550245002,0.0356820422982515,0.0598460022678555,9.87879810173866e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,40065,0.0473913207209797,0.00612480325137712,0.0353867063482805,0.0593959350936788,1.07478268512354e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,40164,0.0301080206996858,0.00389574924500813,0.0224723521794698,0.0377436892199017,1.1544207002305e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,40131,0.0183687536950322,0.00237692259047836,0.0137099854176947,0.0230275219723698,1.15883939981592e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39934,0.0377555245593937,0.00489692787393306,0.0281575459264849,0.0473535031923025,1.33394996920029e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,40065,0.0585506644342995,0.0075941644148871,0.0436661021811208,0.0734352266874782,1.33421184649091e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39312,0.024593055599771,0.00319026545792426,0.0183401353022394,0.0308459758973025,1.35047143392766e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40075,0.0122277159821664,0.00158740708144107,0.00911639810254189,0.0153390338617909,1.40911992570723e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37362,0.0408779351673695,0.00530806449103931,0.0304741287649325,0.0512817415698066,1.44707158595488e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39729,0.0383678176272229,0.00498469390864066,0.0285978175662872,0.0481378176881586,1.47649513280765e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40143,0.019135384564872,0.00248660525413186,0.0142616382667735,0.0240091308629704,1.49433500556075e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37756,0.0392683178871813,0.00511336659205568,0.0292461193667521,0.0492905164076104,1.70782395420169e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39730,0.0181074743243593,0.00236225328804198,0.013477457879797,0.0227374907689215,1.8905693751009e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39815,0.0303454456755648,0.00396209141040673,0.0225797465111677,0.038111144839962,1.98608009701581e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,40065,0.0193264372336943,0.00252349447949098,0.014380388053892,0.0242724864134966,1.98957240403119e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,39438,0.014442210627377,0.00188760460211353,0.0107425056072345,0.0181419156475195,2.11403574395872e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39931,0.0248858701595451,0.00325290039485787,0.0185101853856237,0.0312615549334665,2.12180017201334e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39756,0.0317162867217006,0.00415770666932379,0.0235671816498259,0.0398653917935752,2.51811973750881e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37376,0.0758509412400602,0.00995032577700526,0.0563483027171299,0.0953535797629906,2.65195228409062e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37791,0.0164837014330696,0.00216314258472091,0.0122439419670166,0.0207234608991226,2.70220611069701e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37737,0.0246035381620207,0.00322879422030647,0.01827510149022,0.0309319748338213,2.70745745976673e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40126,0.0178625560243238,0.00234467338931231,0.0132669961812716,0.0224581158673759,2.71571033736685e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,37343,0.0248936321029488,0.00327134470756672,0.018481796476118,0.0313054677297796,2.94009877719817e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REN,Renin,40126,-0.0453052758435575,0.00595766565864489,-0.0569823005345015,-0.0336282511526135,3.02108152703047e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39947,0.0369799365353292,0.00486331644707808,0.0274478362990562,0.0465120367716022,3.0389487854982e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37430,0.061834107813419,0.00813970847234482,0.0458802792076232,0.0777879364192149,3.24807837673668e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37697,0.0431355724658728,0.00568062447058669,0.0320015485035229,0.0542695964282228,3.32312498739569e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37737,0.0251501682368467,0.00331228329655462,0.0186580929755997,0.0316422434980937,3.33413959297848e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,40095,-0.0170566206236056,0.00224867524296686,-0.0214640240998206,-0.0126492171473905,3.50639969502239e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,40233,0.0369516731560102,0.00487170517443201,0.0274031310141235,0.046500215297897,3.51091704302432e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37470,0.0439355601794904,0.00579495761277384,0.0325774432584537,0.0552936771005272,3.64160327490829e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,40035,-0.0218427070849191,0.00288643676795463,-0.0275001231501102,-0.016185291019728,4.02138677132008e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,40100,0.052376105759925,0.0069262406550073,0.0388006740761107,0.0659515374437393,4.18968624979443e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39746,0.0390518255053219,0.00516955342135376,0.0289195007994686,0.0491841502111753,4.45257366222315e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40041,0.0162137425745809,0.00214660877634644,0.0120063893729419,0.0204210957762199,4.48239738944004e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,40137,0.0186860198108346,0.00247452853605535,0.0138359438801661,0.0235360957415031,4.54459970400711e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40248,0.0215826525357552,0.00286608992319368,0.0159651162862956,0.0272001887852148,5.33359084903462e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37697,0.0346020635947801,0.00459513019383049,0.0255956084148723,0.0436085187746878,5.39541129481143e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40251,0.020177027795169,0.00268103296798735,0.0149222031779137,0.0254318524124242,5.5200919257766e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,40248,0.0282537296480204,0.00375540034017836,0.0208931449812708,0.0356143143147699,5.61986095438571e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39727,0.0425154296201089,0.00565372065347475,0.0314341371392984,0.0535967221009194,5.78608820863882e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37737,0.023183646877943,0.00308485078532832,0.0171373393386995,0.0292299544171865,6.04001498116991e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,40143,0.0206455435994979,0.00275316978175743,0.0152493308272534,0.0260417563717425,6.7830829035364e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37788,0.0121408738068879,0.00162100986009849,0.0089636944810949,0.015318053132681,7.33676391882756e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39991,0.0209967009984665,0.00280647435987687,0.0154960112531079,0.0264973907438252,7.73930936498567e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40186,0.0424049915702688,0.00567468132707424,0.0312826161692033,0.0535273669713343,8.27141034367885e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40126,0.0398537919371779,0.00534792198107393,0.029371864854273,0.0503357190200828,9.65820997513992e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,40100,0.0350553982058938,0.00471101181385164,0.0258218150507446,0.0442889813610431,1.04986199712239e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,40137,0.0186394523224134,0.00250525425409251,0.013729153984392,0.0235497506604347,1.05782335382726e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,40248,0.0282526724471779,0.00380475691343826,0.0207953488968389,0.0357099959975169,1.17978631029999e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39810,0.0521865875094102,0.00704099907167588,0.0383862293289255,0.0659869456898949,1.3107136844995e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,40025,0.0150226992602855,0.00203209603818976,0.0110397910254335,0.0190056074951374,1.51176514773221e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37791,0.0141973874471871,0.0019201931594033,0.0104338088547566,0.0179609660396176,1.51275687178111e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39786,0.0345683316214932,0.00467703224355187,0.0254013484241316,0.0437353148188549,1.53151448558852e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40164,0.0274768690603698,0.00371997816669418,0.0201857118536492,0.0347680262670904,1.58549895120607e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39746,0.0484405375225437,0.00656585855534612,0.0355714547540653,0.0613096202910221,1.69393957170345e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37430,0.0329461435647075,0.00447820914724567,0.024168853636106,0.041723433493309,1.9940274677506e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,40248,0.0404357596097039,0.0054988719514048,0.0296579705849505,0.0512135486344573,2.02603752406455e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37737,0.0658004437250318,0.008950834790752,0.0482568075351579,0.0833440799149058,2.0773531169553e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40248,0.0208192522981404,0.00283255786378611,0.0152674388851197,0.0263710657111612,2.07932854894851e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40065,0.0279185885084657,0.00380048839624757,0.0204696312518205,0.035367545765111,2.14233953253771e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40095,0.0359405870905884,0.00489279306489494,0.0263507126833943,0.0455304614977824,2.14909950427818e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37737,0.0382498822155187,0.00520770770725374,0.0280427751093014,0.048456989321736,2.17975707065486e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37756,0.0418970165855262,0.00570617908207647,0.0307129055846563,0.053081127586396,2.21995621299804e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37470,0.0334964988982978,0.00456569392917321,0.0245477387971183,0.0424452589994773,2.32127058642334e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40194,0.0369436149558638,0.00503813069584979,0.0270688787919982,0.0468183511197294,2.36354701757504e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37808,0.0153805068009201,0.00209757543634436,0.0112692589456851,0.019491754656155,2.38869862239912e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37696,0.0470523688265924,0.00642157881572041,0.0344660743477804,0.0596386633054044,2.48563179166364e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,40248,0.0345550054291091,0.00472886943841063,0.0252864213298243,0.043823589528394,2.8571091694516e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37470,0.0436136620274183,0.00597075056217487,0.0319109909255556,0.0553163331292811,2.94376304499024e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40075,0.0247158925059756,0.00338945349958053,0.0180725636467978,0.0313592213651534,3.20029227258849e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39746,0.0181264071931473,0.00248690633336343,0.013252070779755,0.0230007436065397,3.2817461019694e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,40059,-0.038860291978764,0.00533505536552141,-0.049317000495186,-0.0284035834623421,3.39666903904625e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40065,0.0524224759195938,0.00720349991652698,0.0383036160832009,0.0665413357559867,3.56610009827052e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37515,0.0784890486762585,0.0107856386186371,0.0573491969837297,0.0996289003687872,3.60331954592491e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40233,0.016629362848407,0.00228737810727779,0.0121461017581426,0.0211126239386715,3.76189089501938e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,40174,0.0166866476535335,0.00229897388554859,0.0121806588378582,0.0211926364692087,4.10305251288024e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39967,0.0321210045724146,0.00442940334014515,0.0234393740257302,0.0408026351190991,4.3079153210624e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40040,0.0155623221497603,0.00214636432263347,0.0113554480773987,0.0197691962221219,4.34575646346005e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39815,0.0174332095502503,0.00240502495646551,0.0127193606355779,0.0221470584649227,4.40955230970829e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40186,0.0124338838923992,0.00171559606207984,0.00907131561072273,0.0157964521740757,4.4405652212243e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,40140,0.04100501585221,0.00566540898170803,0.0299008142480623,0.0521092174563578,4.77198530633645e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40274,0.0605466035856444,0.008369460681776,0.0441424606493634,0.0769507465219253,4.89637986139661e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40233,0.0210185307455519,0.0029065285202994,0.0153217348457651,0.0267153266453388,4.99647270716609e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40100,0.0675947902933596,0.00934950429420203,0.0492697618767237,0.0859198187099956,5.06176084013668e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,40065,0.0361746847195119,0.00500687279780924,0.0263612140358058,0.045988155403218,5.24244014399689e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,40233,0.0359422602185277,0.00497500477354096,0.0261912508623874,0.045693269574668,5.25677421987885e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40195,0.0417269930086492,0.00577674823308386,0.0304045664718048,0.0530494195454935,5.30774965852464e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39815,0.0230513708274936,0.00319166047064608,0.0167957163050273,0.0293070253499599,5.34844375513664e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37737,0.0164850673325627,0.00228821400467111,0.0120001678834073,0.0209699667817181,6.14701463150785e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,40274,0.032947707756221,0.00457912092952924,0.0239726307343437,0.0419227847780983,6.51650389271552e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39727,0.0161213064449654,0.00224125937993745,0.011728438060288,0.0205141748296428,6.63418383262831e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39815,0.0307395903866559,0.00427986400531253,0.0223510569362434,0.0391281238370685,7.16545254593231e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39746,0.022881237313879,0.00318873909203674,0.0166313086934869,0.029131165934271,7.52763993309884e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40126,0.0154598660520394,0.00215503341336691,0.0112360005618403,0.0196837315422385,7.6185796641296e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,40186,-0.0374245497605066,0.00523066487865163,-0.0476766529226638,-0.0271724465983494,8.74677051743071e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37697,0.0213219809411477,0.00298100499337863,0.0154792111541256,0.0271647507281698,8.96116815047205e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40100,0.0495175440639551,0.00693091765165807,0.0359329454667053,0.0631021426612049,9.43461220193514e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39967,0.014462073054631,0.00202676470124129,0.010489614240198,0.0184345318690639,1.00670204211524e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40186,0.0168768148034813,0.002366276936391,0.0122389120081549,0.0215147175988076,1.03061556657976e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40032,0.0138723031409105,0.00194573675860082,0.0100586590940529,0.0176859471877681,1.05090770836847e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,37403,0.0544773230723668,0.00764486661074482,0.0394933845153069,0.0694612616294266,1.08797512866169e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37670,0.0339805519448927,0.00477293649841238,0.0246255964080045,0.043335507481781,1.13978403539945e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40126,0.0160064590550902,0.00224921624961806,0.0115979952058388,0.0204149229043416,1.15532110542336e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39810,0.0334966758473981,0.00470687980240831,0.0242711914346779,0.0427221602601184,1.15570517250582e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40160,0.0308388561113024,0.00433565391656206,0.0223409744348408,0.0393367377877641,1.18575582767302e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40284,0.0328355763830543,0.00461735572512601,0.0237855591618073,0.0418855936043013,1.19838555867382e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37696,0.0235303467447414,0.00331177724426239,0.0170392633459871,0.0300214301434957,1.26428195645958e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,40174,0.0310425158905518,0.00437245159911849,0.0224725107562796,0.0396125210248241,1.30502691303945e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40100,0.0428491379999799,0.00603587510443766,0.0310188227952821,0.0546794532046777,1.30991827018998e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40079,0.0120742997301699,0.00170101079553884,0.00874031857091381,0.0154082808894261,1.31726365785544e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40233,0.0395000737634763,0.00556795298135709,0.0285868859200164,0.0504132616069362,1.35648040944937e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40186,0.0153204939670424,0.00216371273991159,0.0110796169968157,0.0195613709372691,1.49548567449098e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",40248,0.0438269998938166,0.00619433084967996,0.0316861114284439,0.0559678883591893,1.55344576202711e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,40274,0.020236482325619,0.00286660002459972,0.0146179462774035,0.0258550183738344,1.7416999642693e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40248,0.0372661921076415,0.00528137236102147,0.0269147022800394,0.0476176819352436,1.78283012090796e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,40126,0.0266815306481368,0.00378236403143893,0.0192680971465165,0.0340949641497571,1.80866394159273e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39727,0.0185903987070828,0.00263607443456046,0.0134236928153443,0.0237571045988213,1.8352890765601e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,40065,0.0244511411884208,0.00347159464541384,0.0176468156834096,0.0312554666934319,1.95713807169049e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39607,0.0711813868588662,0.0101096004075091,0.0513665700601483,0.0909962036575841,1.99110428689162e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,40229,0.0355613932484515,0.00505260521240775,0.0256582870321323,0.0454644994647707,2.02716359678886e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,40297,0.019062988365616,0.00270969420896285,0.0137519877160488,0.0243739890151832,2.07257671802136e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40186,0.022586665683091,0.00321063125589592,0.016293828421535,0.028879502944647,2.07532537219275e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39901,0.0451213376645236,0.00641537968849511,0.0325471934750732,0.0576954818539741,2.10156328502514e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37784,0.0438463941259958,0.00623586624069397,0.0316240962942356,0.056068691957756,2.14547491795934e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40185,0.0123620947006811,0.00176246310629724,0.00890766701233855,0.0158165223890237,2.40859322444887e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37784,0.0378140544568432,0.00539637074270974,0.0272371678011321,0.0483909411125543,2.5461094725587e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37696,0.0206316681294199,0.00294591369890965,0.014857677279557,0.0264056589792828,2.61718594987516e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40233,0.0383879707620937,0.00548630128314001,0.0276348202471393,0.0491411212770481,2.71904623335686e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,40174,0.017158216393794,0.00245250125991434,0.0123513139243619,0.0219651188632261,2.73588695916231e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39978,0.0263847103007689,0.00377289560601263,0.0189898349129841,0.0337795856885537,2.79597260663324e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37784,0.0360823414086263,0.00516592259067092,0.0259571331309113,0.0462075496863413,2.99034926481559e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,40115,0.031565951845861,0.00452088442602489,0.0227050183708522,0.0404268853208698,3.02159389505867e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40126,0.0198552535044171,0.00284794765563723,0.0142732760993681,0.025437230909466,3.25456170869032e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40065,0.0128605344451252,0.0018447880632764,0.0092447498411035,0.016476319049147,3.26652060232893e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37756,0.0368091767631366,0.00528144039040173,0.0264575535979492,0.047160799928324,3.32974580043965e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39727,0.0223516220868936,0.00320980861773109,0.0160603971961407,0.0286428469776465,3.45366360031636e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37782,0.0150308324577547,0.00215972588973894,0.0107977697138664,0.0192638952016431,3.57188498498977e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40164,0.0158206417723139,0.00227671778744641,0.011358274908919,0.0202830086357089,3.8266287772154e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40297,0.014662902320243,0.00211374917743999,0.0105199539324607,0.0188058507080254,4.16256131310106e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40033,0.0233053672244534,0.00336284743797728,0.0167141862460179,0.0298965482028889,4.36575386065102e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39815,0.0175373115932007,0.00253198675715161,0.0125746175491835,0.0225000056372178,4.49119162572903e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40092,0.0210733940863683,0.00304290435539033,0.0151093015498032,0.0270374866229333,4.51611835492228e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,40115,0.0441177273793049,0.00637151721729504,0.0316295536334066,0.0566059011252032,4.55452470717982e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37737,0.01749449131811,0.00252659508192513,0.0125423649575367,0.0224466176786832,4.5880090080537e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37430,0.0527500388814417,0.00762286632238779,0.0378092208895616,0.0676908568733217,4.7293785805875e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37784,0.0561932837167951,0.00812881509701563,0.0402608061266444,0.0721257613069457,4.96622520177837e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37756,0.0446267421222943,0.00645722504359398,0.0319705810368501,0.0572829032077385,5.02698055397066e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39746,0.0476517604710358,0.00689813609155103,0.0341314137315958,0.0611721072104759,5.11217940019009e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,40174,0.0333149929714982,0.00482500641935074,0.0238579803895708,0.0427720055534257,5.22530868730603e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40095,-0.0233781384942138,0.0033901879259568,-0.0300229068290891,-0.0167333701593385,5.56037712714982e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40028,0.0154225778792918,0.00223748634269413,0.0110371046476114,0.0198080511109723,5.67988390382442e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40065,0.0517017402608601,0.00750294958988243,0.0369959590646906,0.0664075214570297,5.75790764516765e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37470,-0.0175955787664857,0.00255329388489534,-0.0226000347808806,-0.0125911227520908,5.78198018691459e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37696,0.0487237537686431,0.0070722331744182,0.0348621767467834,0.0625853307905028,5.85419688775592e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39810,0.0289260700621418,0.00420420778740467,0.0206858227988286,0.037166317325455,6.20500304275016e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37403,0.0231788930149673,0.00336979786002441,0.0165740892093194,0.0297836968206151,6.32990379645801e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37697,0.0498874412572891,0.00725297734230275,0.0356716056663757,0.0641032768482025,6.33337663105557e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37662,0.0249832961683061,0.00363434713349009,0.0178599757866655,0.0321066165499467,6.51297676907326e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39967,0.0299392735428595,0.00435904584398661,0.0213955436886458,0.0384830033970733,6.74357649550663e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,40071,0.038657424765863,0.00563328377207601,0.027616188572594,0.0496986609591319,7.02963807019364e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37714,0.0342492343374901,0.00499097936869887,0.0244669147748403,0.0440315539001399,7.08063867087494e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,40065,0.0430009924369443,0.00626834028350573,0.0307150454812731,0.0552869393926155,7.143343854295e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40186,0.0717858846603658,0.0104651004401152,0.0512742877977401,0.0922974815229915,7.16518217485148e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,37430,0.0325000951469206,0.00473760696636433,0.0232143854928465,0.0417858048009947,7.19715366178999e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40278,0.0155864744041609,0.00227485982468935,0.0111277491477698,0.020045199660552,7.57110469653321e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,40274,0.0538649091113448,0.00786575762584946,0.0384480241646798,0.0692817940580097,7.76322312422317e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,40124,0.0359020815863565,0.00524319883134937,0.0256254118769118,0.0461787512958013,7.80187726118331e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39991,0.0276682212442123,0.00404206451622297,0.0197457747924153,0.0355906676960094,7.92982637487789e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37358,0.0484257440803838,0.00707528279912192,0.0345581897941049,0.0622932983666628,8.02932033905133e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,40105,-0.0343536177548287,0.00502136680589323,-0.0441954966943794,-0.0245117388152779,8.12804841906683e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40065,0.0420664939418903,0.00615063233566477,0.0300112545639874,0.0541217333197933,8.24908104394197e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37737,0.0465688625942927,0.00680956741470404,0.0332221104614728,0.0599156147271126,8.33866912193242e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37756,0.0426719287009386,0.00625614245241727,0.0304098894942008,0.0549339679076765,9.44439860607975e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37784,0.0308765918526552,0.00452982338464278,0.0219981380187554,0.039755045686555,9.74392461872691e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39991,0.0235642091582288,0.00345765117377282,0.016787212857634,0.0303412054588235,9.76681777357208e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39741,0.0279781244462198,0.00410805145862169,0.0199263435873213,0.0360299053051183,1.00845759224295e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39746,0.0253266522268878,0.00372499043671414,0.018025670970928,0.0326276334828475,1.0915848205678e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,37470,0.0356168308974844,0.00523980537758428,0.0253468123574192,0.0458868494375496,1.11198917825025e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37737,0.0515720417046152,0.00759297494931851,0.0366898108039509,0.0664542726052795,1.1523706261487e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37403,0.0177257552765789,0.0026115828661511,0.0126070528589227,0.022844457694235,1.19177035850598e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,37470,0.0174861354400167,0.00258172674997012,0.0124259510100753,0.0225463198699581,1.31522437737722e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40065,0.0483689941789776,0.00714880430084891,0.0343573377493137,0.0623806506086415,1.37074961360957e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39746,0.0325061715037266,0.00480779637926693,0.0230828906003634,0.0419294524070897,1.41870154721823e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,37430,0.0306672132193853,0.00453702774798351,0.0217746388333377,0.039559787605433,1.44569230333343e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40233,0.0378917200730087,0.00560849885745966,0.0268990623123877,0.0488843778336296,1.46687501227606e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,40028,0.0319351714897922,0.00473308293429265,0.0226583289385786,0.0412120140410058,1.56012992166706e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39954,-0.0264390300742911,0.00392672742755774,-0.0341354158323042,-0.0187426443162779,1.71925845993261e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40174,0.0153905790312782,0.00228856929036316,0.0109049832221664,0.01987617484039,1.81671097401088e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,40074,0.0384989158579219,0.0057249773886459,0.0272779601761759,0.0497198715396678,1.82022241543559e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39815,0.0405249665450143,0.00603388899516216,0.0286985441144964,0.0523513889755321,1.93036340732183e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39746,0.0333240007208804,0.00496328363724865,0.0235959647918731,0.0430520366498877,1.95889623415429e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37697,0.0231154022462914,0.00344341640661602,0.016366306089324,0.0298644984032588,1.98529011265475e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,37376,0.0230769658013639,0.0034398878460699,0.0163347856230669,0.0298191459796609,2.04631358678642e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39653,0.0307873313319641,0.00459300967605925,0.021785032366888,0.0397896302970403,2.11249530542218e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39815,0.0216504635043211,0.00323104013312544,0.0153176248433953,0.027983302165247,2.14531724124064e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40065,0.0333973127626459,0.00498591347241779,0.023624922356707,0.0431697031685847,2.18011536050383e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40297,0.0233788764895261,0.00349278661581087,0.0165330147225368,0.0302247382565154,2.25247612534858e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37430,0.0484230990002679,0.00723471891238928,0.0342430499319849,0.0626031480685509,2.2738525758546e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40143,0.0187156352506907,0.00279773841840977,0.0132320679506075,0.0241992025507738,2.31414093797346e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37756,0.0423335901490861,0.00633317363376855,0.0299205698268997,0.0547466104712724,2.41084320863888e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37430,0.0572661546932516,0.00857056004111847,0.0404678570126594,0.0740644523738438,2.45779628561982e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40143,0.013390054962892,0.00200460431528401,0.00946103050493534,0.0173190794208486,2.47565474270033e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40100,0.0397552904437538,0.00595735128171735,0.0280788819315878,0.0514316989559198,2.58485084441801e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,40174,0.012019848255034,0.00180131534827756,0.00848927017241001,0.015550426337658,2.59323375266021e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37782,0.0403241026935409,0.00604487133806816,0.0284761548709273,0.0521720505161545,2.64460609789597e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40297,0.0191255042859338,0.00286821928852963,0.0135037944804157,0.0247472140914519,2.67746083240217e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37430,0.0293781253635164,0.00440838698206481,0.0207376868786694,0.0380185638483634,2.76965685099963e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39726,0.0220366864764808,0.00330823932712824,0.0155525373953094,0.0285208355576521,2.80972105703156e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37784,0.0310092030996584,0.00465814458833665,0.0218792397065186,0.0401391664927983,2.90437936491013e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39725,0.0261501655334714,0.00392932247388718,0.0184486934846525,0.0338516375822902,2.926804270502e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37620,0.0162886121539304,0.00244777213009946,0.0114909787789354,0.0210862455289253,2.95585034057542e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,40058,0.0243674344853062,0.00366440148159586,0.0171852075813783,0.0315496613892341,3.0329468559039e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,40065,0.0570849001167243,0.00858604258987603,0.0402562566405673,0.0739135435928813,3.05771198306981e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39815,0.0272900690915304,0.00410666353142295,0.0192410085699414,0.0353391296131194,3.12752192770084e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40126,0.0175244632003664,0.00263730178286412,0.0123553517059528,0.0226935746947801,3.13540179957695e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37782,0.0150510743405391,0.00226611363397919,0.0106094916179399,0.0194926570631383,3.21893206887998e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,40100,0.0372010058296902,0.00560417011401034,0.0262168324062299,0.0481851792531504,3.28215599130274e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40261,0.0210639140482849,0.00317618543123394,0.0148385906030664,0.0272892374935034,3.42305800035543e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40107,0.0314761029847365,0.00474674450321271,0.0221724837584396,0.0407797222110334,3.44117443192319e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37756,0.0241269431803227,0.00363866609727748,0.0169951576296588,0.0312587287309865,3.46970700249869e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39810,0.0415667926190329,0.00627174459427663,0.0292741732142507,0.0538594120238151,3.52483941326435e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37515,0.0307880240403951,0.00464948018686923,0.0216750428741314,0.0399010052066588,3.68680981863071e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40137,0.014912483600614,0.00225387208526667,0.0104948943134914,0.0193300728877367,3.80010352217755e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37462,0.0252638304720753,0.00382076926103297,0.0177751227204507,0.0327525382237,3.93340939459408e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,40258,0.0263379485970274,0.00398444404016546,0.0185284382783031,0.0341474589157517,3.96102663282833e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37470,0.069359642367155,0.0104942599440129,0.0487908928768898,0.0899283918574202,4.01204370751652e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37784,0.049691998713611,0.00752906811397277,0.0349350252102243,0.0644489722169976,4.26649523459307e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37656,0.0597282383140983,0.00905344855418119,0.0419834791479031,0.0774729974802934,4.34702375159826e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37737,0.0196414345124963,0.00297754458105726,0.013805447133624,0.0254774218913685,4.36860143432661e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37696,0.0118548029746756,0.00179996686905597,0.00832686791132587,0.0153827380380253,4.68504762931413e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37380,0.0196585465620716,0.00298480103673299,0.0138083365300749,0.0255087565940683,4.68633186763066e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37808,0.00900891838248049,0.00136819289357049,0.00632726031108232,0.0116905764538787,4.73365504832319e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37791,0.0224669178578718,0.00341339752100076,0.0157766587167103,0.0291571769990332,4.81576618224558e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37515,0.0615248398558006,0.00934820918036053,0.0432023498622939,0.0798473298493072,4.83644849754598e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,37430,0.0335136863760524,0.0050928307564521,0.0235317380934063,0.0434956346586985,4.8667721558556e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39810,0.0512659344474858,0.00779826439277898,0.035981336237639,0.0665505326573326,5.05544562062693e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,40065,-0.0751281373350473,0.0114294263293476,-0.0975298129405686,-0.052726461729526,5.07992827901901e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40095,0.0290387701812138,0.00441965756604457,0.0203762413517664,0.0377012990106611,5.17766997659389e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40174,0.0500694201035724,0.00762075653886342,0.0351327372874001,0.0650061029197447,5.18480193595162e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39727,0.0243321978447468,0.00370435361860544,0.0170716647522802,0.0315927309372135,5.24528066869457e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,37403,0.00929001289045747,0.00141445141033443,0.00651768812620198,0.012062337654713,5.29696790173832e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40213,0.0323464562618489,0.00492891578451395,0.0226857813242016,0.0420071311994963,5.45305322419656e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37782,0.0121859716245302,0.00185700574957605,0.00854624035536118,0.0158257028936993,5.49937846822955e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37717,0.0459061112599221,0.00699566567595069,0.0321946065350588,0.0596176159847854,5.50338713513773e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37732,0.0414133437198028,0.00631446009844396,0.0290370019268527,0.053789685512753,5.6366661855871e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37362,0.037076733783296,0.00567087911487963,0.0259618107181319,0.0481916568484601,6.46532061443917e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37696,0.0416879067089992,0.00637711055141658,0.0291887700282227,0.0541870433897757,6.50151812474382e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37791,0.0612295580137176,0.00936755369686933,0.0428691527678537,0.0795899632595815,6.5333164987032e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37515,0.0230934334676275,0.00353334632261895,0.0161680746752943,0.0300187922599606,6.5596620857111e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37696,0.0300286488304719,0.00459575670705927,0.0210209656846357,0.0390363319763081,6.63807637461768e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37784,0.0254472766835525,0.00389466372195363,0.0178137357885234,0.0330808175785816,6.64143765825156e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39815,0.0377124634129325,0.00577803653751195,0.0263875117994091,0.0490374150264559,6.92646405087832e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39810,0.0293745217245725,0.00450334543483901,0.020547964672288,0.0382010787768569,7.11535760847922e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40070,0.0357243449032866,0.00548057992453263,0.0249824082512026,0.0464662815553705,7.32631865970133e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37696,0.0634573350386965,0.00973501440139303,0.0443767068119661,0.0825379632654268,7.36050245933482e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37737,0.0339219301447344,0.00520500889925837,0.023720112702188,0.0441237475872808,7.42318573636585e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37544,0.0153876738915309,0.00236305963648866,0.0107560770040131,0.0200192707790486,7.69879738398775e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39746,0.0270851296701251,0.00416043560433964,0.0189306758856194,0.0352395834546308,7.74060118155717e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,40194,0.0337799582820043,0.00518986712396603,0.0236078187190309,0.0439520978449777,7.80284319188608e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39815,0.0298411990781503,0.00458490607811378,0.0208547831650473,0.0388276149912533,7.82181791709327e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39810,0.0195462075539741,0.00301246854485992,0.0136417692060486,0.0254506459018995,8.93874637147821e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39967,0.0215517639703447,0.00332293345774834,0.015038814393158,0.0280647135475314,9.09534834233471e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,40274,0.0480249368016905,0.00742252649514012,0.0334767848712159,0.0625730887321651,1.00774575125901e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37430,0.0349757653899149,0.0054148499953435,0.0243626593990416,0.0455888713807882,1.08990370739729e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37696,0.0794904280176611,0.0123135042659803,0.0553559596563396,0.103624896378983,1.11586676135583e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37730,0.0252378245876632,0.00391092708581748,0.0175724074994609,0.0329032416758654,1.13347708875107e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,40121,-0.028447596074397,0.00441410572929941,-0.0370992433038238,-0.0197959488449701,1.19210387962601e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37784,0.0415194446237184,0.00644777195550921,0.0288818115909204,0.0541570776565165,1.24102096639817e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,40274,0.0162034697924264,0.00251775201925397,0.0112686758346886,0.0211382637501642,1.26448990014891e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,40233,0.0200761083393073,0.00312036428330028,0.0139601943440387,0.0261920223345758,1.27953744078645e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37737,0.0216311903743582,0.00336238574747601,0.0150409143093053,0.0282214664394112,1.29154860894942e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37513,0.0206849647195563,0.00321901272623902,0.0143756997761279,0.0269942296629848,1.35667544304379e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,37421,0.0356054696082619,0.0055411036336284,0.0247449064863502,0.0464660327301736,1.35853650838808e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37784,0.0573815087494509,0.00894507944801553,0.0398491530313405,0.0749138644675613,1.45704347754515e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40164,0.0383303392935301,0.00597790898783484,0.0266136376773739,0.0500470409096864,1.47724234671024e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39810,0.0203550032725509,0.0031757739043859,0.0141304864199546,0.0265795201251473,1.50292396527907e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39933,0.0151393377472493,0.00236343816510229,0.0105069989436488,0.0197716765508498,1.54059752130879e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37470,0.0378143344234413,0.00590378967396161,0.0262429066624766,0.0493857621844061,1.55443572416918e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37777,0.00997659065627187,0.0015577878526997,0.00692332646498046,0.0130298548475633,1.56099128748011e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37403,0.0260697216740404,0.00407246734947851,0.0180876856690625,0.0340517576790183,1.59210299879524e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,37376,0.0242178170178988,0.00378765460264427,0.016794013996716,0.0316416200390816,1.67290029222426e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39955,0.0345804703257226,0.00541219821130432,0.0239725618315662,0.0451883788198791,1.71336448775554e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37756,0.0407127306278791,0.00637352605787646,0.0282206195544412,0.0532048417013169,1.7390403898001e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37470,0.0466700218212717,0.0073074751973858,0.0323473704343955,0.0609926732081479,1.75365159989321e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40100,0.0139071895710431,0.00217953350150839,0.00963530390808668,0.0181790752339996,1.81105567227518e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37737,0.0398632668007221,0.00626404523434741,0.0275857381414012,0.052140795460043,2.03256374722099e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37696,0.0185241489915063,0.00291509274220377,0.0128105672167869,0.0242377307662257,2.15860964587512e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39955,0.0407037394019758,0.00641124118830302,0.0281377066729019,0.0532697721310497,2.23026056614751e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37470,0.0324780687780724,0.0051232056406837,0.0224365857223323,0.0425195518338124,2.38270304693264e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37470,-0.0133008054598274,0.00209856895440701,-0.0174140006104651,-0.00918761030918961,2.40388030509651e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39815,0.0488915719560698,0.00771793785519481,0.033764413759888,0.0640187301522516,2.44267655133873e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37737,0.0242697778617063,0.00383106540924276,0.0167608896595905,0.0317786660638221,2.45004234934125e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37678,0.0244021896955236,0.00385592379369473,0.016844579059882,0.0319598003311653,2.55553161325855e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37756,0.018385998986766,0.00290536168385534,0.0126914900864095,0.0240805078871224,2.55826476502461e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,40126,0.0189344885917093,0.00299254067552334,0.0130691088676835,0.024799868315735,2.56378810895998e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40297,0.0167269062558041,0.00264494456753864,0.0115428149034284,0.0219109976081799,2.61529883130701e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40065,0.0190006023098142,0.00301213658553595,0.0130968146021637,0.0249043900174646,2.90247160041648e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37470,0.0213869494957302,0.00339121899395703,0.0147401602675744,0.028033738723886,2.94518482208904e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39704,0.0364694237196601,0.00578423197416384,0.025132329050299,0.0478065183890213,2.96176795656182e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40065,0.0727671446570462,0.0115487634317365,0.0501315683308426,0.0954027209832497,3.03932268224616e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39886,0.0357469333646842,0.00567580145537351,0.0246223625121521,0.0468715042172163,3.09414395081506e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40039,0.0318450095815551,0.00505679936086091,0.0219336828342677,0.0417563363288425,3.1066176853173e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39727,0.0276840824694937,0.00440749946775349,0.0190453835126969,0.0363227814262906,3.45216014744599e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39746,0.0398268254847072,0.00634161901478097,0.0273972522157365,0.0522563987536779,3.47206609570685e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40186,0.0549087522681512,0.00875629658041771,0.0377464109705324,0.0720710935657699,3.68634777831132e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39810,0.0248473180772438,0.0039626290440988,0.0170805651508101,0.0326140710036774,3.69721331103246e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39911,0.0243742495992303,0.00388734855181138,0.01675504643768,0.0319934527607806,3.7028493351793e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39746,0.0277519877936626,0.00442758422615206,0.0190739227104046,0.0364300528769207,3.75579494205011e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39815,0.031566654156261,0.00504244202654322,0.0216834677842362,0.0414498405282857,3.94715669006574e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,40126,0.0440578117998861,0.00704073811267973,0.0302579650990339,0.0578576585007384,4.01217793640963e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40050,0.0182684723002632,0.00292080950237956,0.0125436856755993,0.0239932589249272,4.0894245555337e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37222,0.028119398260095,0.00449704222037623,0.0193051955081576,0.0369336010120324,4.15835985015884e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,40065,0.0287817841960501,0.00460497826786879,0.0197560267910273,0.0378075416010729,4.20716691155188e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,40065,0.0430749748578711,0.00690889686103233,0.0295335370102477,0.0566164127054945,4.64249519265415e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40174,0.0290938221836354,0.00466713392127293,0.0199462396979404,0.0382414046693303,4.66970099255265e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37518,0.0131342846260823,0.00210714855649254,0.00900427345535691,0.0172642957968077,4.71049733138151e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,40177,0.0348503415585604,0.00559775243125999,0.0238787467932908,0.0458219363238299,4.91346175310936e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37694,0.014801359233056,0.00237767372565703,0.0101411187307682,0.0194615997353438,4.95641049182126e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,40065,0.0149982645323685,0.00240971544912456,0.0102752222520843,0.0197213068126526,4.96755975188253e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40065,0.0286686191273071,0.00460620689202212,0.0196404536189437,0.0376967846356704,4.97295791643327e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37470,0.0330316414790626,0.00530734704985377,0.0226292412613493,0.043434041696776,5.00282539677305e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37808,-0.0113303660114898,0.00182314564394019,-0.0149037314736126,-0.00775700054936703,5.29400133677854e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39727,0.0409999242860257,0.0065994045497531,0.0280650913685096,0.0539347572035418,5.3441891404331e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40100,0.0434128501114931,0.00699696204872108,0.0296988044959998,0.0571268957269864,5.62416974520613e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,37376,0.0142233206087741,0.00229451261526814,0.00972607588284857,0.0187205653346997,5.86109020098284e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,40186,0.0184103305508685,0.00297111877073926,0.0125869377602195,0.0242337233415174,5.91960525066272e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39727,0.0541440706641582,0.00874745908658247,0.0369990508544566,0.0712890904738599,6.18219792002538e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39746,0.0229229092265684,0.00370609043369373,0.0156589719765287,0.0301868464766081,6.36016873248521e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40083,0.0127364600617012,0.00206008800082867,0.00869868758007701,0.0167742325433254,6.46683734160315e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39974,0.020860286721659,0.00338079867393259,0.0142339213207512,0.0274866521225669,6.98857753329305e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39800,0.0224051498648884,0.00363181473821721,0.0152867929779827,0.0295235067517941,7.03879624694131e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40065,0.0310676525741783,0.005036114921234,0.0211968673285596,0.0409384378197969,7.0430059677914e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40065,0.0433912691858591,0.00703541880142392,0.0296018483350682,0.05718069003665,7.10664415543574e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37696,0.0241237161445358,0.00391137121326248,0.0164574285665414,0.0317900037225303,7.13581321030625e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40186,0.0680643476425259,0.0110480040236351,0.0464102597562012,0.0897184355288506,7.41480571665217e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,40065,0.0232920221030078,0.00378278875568827,0.0158777561418588,0.0307062880641568,7.57740179067497e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37430,0.0293594009799057,0.00476826837933454,0.02001359495641,0.0387052070034014,7.62046880794805e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39991,0.0487908029122188,0.00792575449048044,0.0332563241108771,0.0643252817135604,7.64468349651712e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37696,0.0524604247129256,0.00852203795567198,0.0357572303198086,0.0691636191060427,7.68301728222343e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39746,0.0247412167475509,0.00402198922125051,0.0168581178738999,0.0326243156212019,7.86704717473218e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,37362,0.0306965609959899,0.00498978912321329,0.0209165743144918,0.0404765476774879,7.88353372845631e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39991,0.0316997456211522,0.00515535575484698,0.0215952483416521,0.0418042429006523,7.99324819839226e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37737,0.0454431522672428,0.00739933555463596,0.0309404545801564,0.0599458499543293,8.40679277461576e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37756,0.0394593638028979,0.00642580668495202,0.0268647827003919,0.0520539449054038,8.44633255232169e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37403,0.0165425186195646,0.00269741708448096,0.0112555811339819,0.0218294561051473,8.89001456239701e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40100,0.0273536729946205,0.00446099840221954,0.0186101161262702,0.0360972298629708,8.90120886544147e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,40248,0.023615648523508,0.00385368028480115,0.0160624351652977,0.0311688618817182,9.10589495431261e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,40100,0.0250466815744589,0.00409070426216786,0.0170289012206099,0.0330644619283079,9.41239324070613e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37376,0.0251640006298058,0.00411049577685704,0.017107428907166,0.0332205723524456,9.51502434308064e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37777,0.00752932998177887,0.00123003879366183,0.00511845394620168,0.00994020601735605,9.54718096068791e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37756,0.0527281972475769,0.00861575266181714,0.0358413220304153,0.0696150724647385,9.6218421648228e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37696,0.0405066803042992,0.00661990744176214,0.0275316617184454,0.053481698890153,9.68686367981031e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40278,0.0121733264790616,0.00198972653748387,0.00827346246559325,0.01607319049253,9.69326421826003e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,40065,0.00780581602546743,0.00127652608469142,0.00530382489947225,0.0103078071514626,9.89248517707467e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37515,0.0269831515479507,0.0044132474577905,0.0183331865306813,0.03563311656522,9.98550201377811e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,40012,0.0147023271652371,0.0024060536565858,0.00998646199832889,0.0194181923321452,1.01650090003743e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40100,0.0496582467500289,0.00812908399832155,0.0337252421133186,0.0655912513867391,1.02814228659258e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40100,0.0409419895253937,0.0067091426087902,0.0277920700121649,0.0540919090386225,1.06938475370945e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37782,0.0122928778034204,0.00201442108378209,0.00834461247920754,0.0162411431276333,1.07358712110196e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40100,0.0204696707192114,0.00335879642996519,0.0138864297164796,0.0270529117219432,1.12461591989182e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37756,0.0487603828650035,0.00800741496610792,0.033065849531432,0.0644549161985751,1.16452961571716e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37696,0.0237949077231609,0.0039100041558565,0.0161312995776822,0.0314585158686397,1.1922321812995e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,40174,-0.0203465119855097,0.00334500474476928,-0.0269027212852574,-0.0137903026857619,1.20945700182379e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37403,0.0401449742557605,0.00660767257343653,0.0271939360118249,0.0530960124996961,1.27061146328713e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40121,0.0256258297521692,0.00422280177866271,0.0173491382659903,0.0339025212383482,1.32130533390424e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,40095,0.0120141209366779,0.00198039288651479,0.00813255087910886,0.0158956909942469,1.33710744499879e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,40150,0.0154395091720013,0.00254719883178449,0.0104469994617037,0.0204320188822989,1.38056425658626e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37696,0.0340721482780864,0.00562199383070276,0.023053040369909,0.0450912561862638,1.39374868795663e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39746,0.0354936674133131,0.00586246374728062,0.0240032384686431,0.0469840963579831,1.44242442697522e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40094,0.0491723530386847,0.00813017813591539,0.0332372038922906,0.0651075021850789,1.49874719931471e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39955,0.015805523684281,0.00261426911264922,0.0106815562234885,0.0209294911450735,1.52016895614567e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,40095,0.0270886931602602,0.0044812685002802,0.018305406899711,0.0358719794208094,1.52925211866511e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37725,0.0206033915623301,0.00340866538716505,0.0139224074034866,0.0272843757211736,1.53971974057733e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37791,0.0237816584612374,0.00393634530817603,0.0160664216572124,0.0314968952652624,1.56696738543555e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40164,0.0140199676535893,0.00232159391580803,0.00946964357860557,0.018570291728573,1.58623691426348e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37784,0.028360590377939,0.00470381226368336,0.0191411183411196,0.0375800624147584,1.69046050700258e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37772,0.0243963003761587,0.00404651597069914,0.0164651290735884,0.032327471678729,1.69377208158628e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39991,-0.066384432625558,0.0110254520726068,-0.0879943186878673,-0.0447745465632487,1.77226828877297e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40140,0.0160145347392272,0.00266242864409974,0.0107961745967917,0.0212328948816627,1.83870703081484e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39746,0.0217306288986332,0.00361451059807289,0.0146461881264104,0.0288150696708561,1.87354896961921e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,40233,0.0148116104230731,0.00246392814665404,0.00998231125563115,0.019640909590515,1.88001286073396e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40126,0.0421621668270551,0.00703187638401608,0.0283796891143836,0.0559446445397267,2.06851119393371e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39915,0.0185503475214267,0.00309598900313501,0.0124822090752821,0.0246184859675713,2.12221227662273e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40065,0.0569880163117228,0.00951362862428881,0.0383413042081168,0.0756347284153289,2.14257150011771e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,40077,0.0233982957835978,0.00390892160008257,0.015736809447436,0.0310597821197597,2.19945454536473e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39810,0.0483892299899882,0.00808597527103326,0.032540718458763,0.0642377415212133,2.22100241272818e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40248,0.0156298111419267,0.00261324019117571,0.0105078603672223,0.0207517619166311,2.26544018422726e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40100,0.0412609323116419,0.00690042182222899,0.027736105540073,0.0547857590832107,2.28721101354515e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39810,0.0118193628713601,0.00197829537901456,0.00794190392849159,0.0156968218142286,2.35869555433163e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40095,0.0260994894905707,0.00436997477920947,0.0175343389233201,0.0346646400578212,2.38767981188274e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39815,-0.0219493139034183,0.00367937315231299,-0.0291608852819518,-0.0147377425248849,2.4923581139675e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37737,0.0228562822558793,0.00383147053367004,0.0153466000098861,0.0303659645018726,2.50229743397882e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37430,0.0380050911286369,0.00638659146874289,0.0254873718499009,0.050522810407373,2.73777666731766e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40065,0.0118395369130391,0.00199402968219477,0.00793123873593738,0.0157478350901409,2.9555135342684e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40065,0.0346442892859537,0.00584358299589661,0.0231908666139963,0.046097711957911,3.11962119995882e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37756,0.0284040814376087,0.00479258566195784,0.0190106135401714,0.0377975493350461,3.16786887800058e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,40274,0.00429919176458001,0.000725508571718814,0.00287719496401114,0.00572118856514889,3.17304879327121e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40226,0.0201259591886752,0.00339682746272898,0.0134681773617264,0.026783741015624,3.18936856414198e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37737,0.010913497144603,0.00184193350433079,0.00730330747611467,0.0145236868130914,3.19985432591062e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40186,0.0548134860254849,0.00926560839969926,0.0366528935620743,0.0729740784888954,3.3711671673983e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40297,0.0134264232939813,0.00226959737143543,0.00897801244596786,0.0178748341419948,3.37123057929255e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37756,0.0354777861732398,0.00600200928324544,0.0237138479780787,0.0472417243684009,3.48396967811322e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40174,0.0210489311462376,0.00356161739279984,0.0140681610563499,0.0280297012361253,3.49317041698579e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37808,0.0151350870091204,0.00256096667183844,0.010115592332317,0.0201545816859237,3.50635301303021e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37631,0.0162506126920213,0.00275087661661907,0.0108588945234479,0.0216423308605946,3.56056254855153e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39991,0.0222558511814386,0.00376920822431843,0.0148682030617745,0.0296434993011027,3.6076668024311e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37696,0.0559950737348652,0.00948499510652251,0.0374044833260811,0.0745856641436493,3.64487504884659e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39571,0.013012811356983,0.00220542037378894,0.00869018742435664,0.0173354352896093,3.70423535902982e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40164,0.0257670201658843,0.00436777751830152,0.0172061762300133,0.0343278641017553,3.72448529494348e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37470,0.0406840785299524,0.0068978101908777,0.0271643705558321,0.0542037865040727,3.76803624590187e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,37470,0.0365166299314683,0.00619133123659685,0.0243816207077385,0.0486516391551981,3.77007570907907e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37430,0.0233165866026762,0.00395463284014072,0.0155655062360004,0.031067666969352,3.81636936313953e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37737,0.0226050946707855,0.00383418878984974,0.01509008464268,0.030120104698891,3.82233913984213e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,40071,0.0192910847084658,0.00327381871008398,0.0128744000367012,0.0257077693802303,3.88145171756516e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40095,0.0142596223525287,0.00242375552254185,0.00950906152834665,0.0190101831767107,4.10436673747153e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39991,-0.0254305358289465,0.0043225793084451,-0.0339027912734989,-0.0169582803843941,4.10715924938686e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,40248,0.01407914237483,0.00239357013622339,0.00938774490783216,0.0187705398418278,4.13356464105733e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37545,0.0274647036341829,0.00467023870831728,0.018311035765881,0.0366183715024848,4.18267364982647e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39746,0.0278007658994624,0.00473167988296003,0.0185266733288607,0.037074858470064,4.30448514558256e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,37470,0.0334147621833358,0.00568877967631529,0.0222647540177579,0.0445647703489138,4.36314644060046e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37430,0.0366876469807188,0.00624669153272977,0.0244441315765684,0.0489311623848691,4.38107467720255e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40126,0.0138859907772598,0.0023654229588331,0.00924976177794693,0.0185222197765727,4.43513880629499e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37737,0.0226488020978534,0.00385957901584766,0.015084027226792,0.0302135769689148,4.51037913307445e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,40181,0.0286952913171589,0.00489275766530863,0.019105486293154,0.0382850963411638,4.58553604346471e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37470,0.0110649249129915,0.00188644136494973,0.00736749983769004,0.014762349988293,4.58651211540024e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,37403,0.0170756671265923,0.0029120128326597,0.0113681219745793,0.0227832122786053,4.63226373715627e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,40117,0.0194404877520709,0.00331766956922467,0.0129378553963905,0.0259431201077512,4.73061841700716e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37791,0.0296212386397139,0.0050562671504376,0.0197109550248562,0.0395315222545717,4.78594513847983e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39810,0.0414798743430466,0.00708469746240534,0.0275938673167322,0.0553658813693611,4.87169859767573e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37782,0.0239164816931215,0.00408456030846005,0.0159107434885398,0.0319222198977032,4.87251184710017e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37027,0.0530424206276138,0.00907505946360593,0.0352553040789462,0.0708295371762815,5.19580369421094e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37696,0.053135767767044,0.0090957655515018,0.0353080672861005,0.0709634682479875,5.28484360965222e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39746,0.0204017967265054,0.0034956721254895,0.0135502793605459,0.0272533140924648,5.4452448816359e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40174,0.0354851075279835,0.00609254360390797,0.0235437220643239,0.0474264929916431,5.84547399369318e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40174,0.046438058100353,0.00798368245722301,0.0307900404841959,0.0620860757165101,6.12153326800538e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37430,0.0165857121667642,0.00285278962322433,0.0109942445052445,0.0221771798282839,6.24857726304361e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39746,0.0309068739576953,0.00531678574861802,0.020485973890404,0.0413277740249867,6.25576637354773e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37791,0.0195733986633989,0.00336776269332086,0.01297258378449,0.0261742135423078,6.31460320245607e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39746,0.0396714365436557,0.00682843489960881,0.0262877041404224,0.053055168946889,6.38135127728184e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40071,0.0431619691412154,0.00743861153942012,0.028582290523952,0.0577416477584788,6.66293540909465e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,37362,0.0228966583738602,0.00394595993358559,0.0151625769040324,0.030630739843688,6.68441178098005e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40076,0.0556581055479773,0.00960120002414023,0.0368397535006624,0.0744764575952921,6.88161189484843e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39991,0.026653664570529,0.00459987532917923,0.0176379089253378,0.0356694202157203,6.98801317791463e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37403,0.0256650063522887,0.0044344720092036,0.0169734412142497,0.0343565714903278,7.30474026175506e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40164,-0.0221964167131443,0.00383671633137356,-0.0297163807226365,-0.0146764527036522,7.37761896193073e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39727,0.0364972780610844,0.00630906807481331,0.0241315046344503,0.0488630514877185,7.39790425008322e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,40095,0.0366519740416983,0.0063540061495521,0.0241981219885762,0.0491058260948204,8.15759316934256e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40212,0.014377949818319,0.00249378956774626,0.00949012226553638,0.0192657773711017,8.29387820803788e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40095,0.0166301354465774,0.00288687734443999,0.010971855851475,0.0222884150416798,8.53925831085016e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37515,0.051199855577145,0.0088881119240256,0.0337791562060548,0.0686205549482351,8.57620174902202e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,40138,0.0226143607646366,0.00392665594811227,0.0149181151063366,0.0303106064229367,8.61007762478293e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37622,0.021456569454505,0.00372678399799296,0.0141520728184388,0.0287610660905712,8.73272992359201e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40099,0.0216983806845216,0.00376927683415827,0.0143105980895714,0.0290861632794718,8.74111084133397e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,40126,0.0367992877300706,0.00639787988935695,0.024259443146931,0.0493391323132102,8.99477542650787e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39991,0.0375239176430491,0.00652578088004277,0.0247333871181653,0.0503144481679329,9.08642773900167e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,40186,0.0227861810426515,0.0039671653102788,0.015010537034505,0.0305618250507979,9.43445742536718e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37696,0.0544042008721547,0.00947276279936193,0.0358375857854053,0.0729708159589041,9.49313652300843e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,40130,0.0177911028832327,0.00310306780707966,0.0117090899813566,0.0238731157851088,1.00254132872576e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,40274,0.021911963338077,0.00382579328421396,0.0144134085010176,0.0294105181751364,1.03815651658869e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,40164,0.0146042185608484,0.00255085523994956,0.00960454229054727,0.0196038948311496,1.05183927861712e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37470,0.0378780177348394,0.00661932082863689,0.0249041489107111,0.0508518865589677,1.07380875141055e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37756,0.0346843104727512,0.0060638651652785,0.0227991347488054,0.0465694861966971,1.08922158270071e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37470,0.0122676905047166,0.00214772788043029,0.00805814385907326,0.01647723715036,1.14140118095139e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39815,0.0317148439113959,0.00555945248870116,0.0208183170335416,0.0426113707892502,1.18715908867263e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40174,0.0393884224522917,0.00690695448922168,0.0258507916534172,0.0529260532511662,1.20030465235174e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,40100,0.0434326503106974,0.00761802961794407,0.028501312259527,0.0583639883618678,1.21044410736437e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37808,0.00703369559134607,0.00123359550245314,0.00461584840653791,0.00945154277615423,1.21070020327411e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40274,0.0178325788728306,0.00312855682095971,0.0117006075037496,0.0239645502419117,1.21987686587935e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40126,-0.0188863317807412,0.00331834407987652,-0.0253902861772991,-0.0123823773841832,1.28186485789809e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37606,0.0144819358157918,0.00254547009383106,0.00949281443188288,0.0194710571997006,1.3028258853138e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,40223,0.0142699102980075,0.00250848040799617,0.00935328869833497,0.01918653189768,1.30306759395821e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,40095,0.0186590150097883,0.00328726273156569,0.0122159800559196,0.0251020499636571,1.40198980194673e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37784,0.0475760876279563,0.00839478000856266,0.0311223188111735,0.0640298564447392,1.48033924490701e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37403,-0.0573518160886783,0.0101381468088876,-0.077222583834098,-0.0374810483432585,1.57274944566741e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,40164,0.0273406896095973,0.0048346959423829,0.0178646855625268,0.0368166936566678,1.58466332156694e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39991,0.0384620178873868,0.00680213294460242,0.025129837315966,0.0517941984588075,1.59137685423073e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,40097,0.0172107829696743,0.00304417899022472,0.0112441921488338,0.0231773737905147,1.59800380069991e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40114,0.0440377244885211,0.00779141435663926,0.0287665523495081,0.059308896627534,1.61276549896459e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37470,0.0393391427470649,0.00696425931587936,0.0256891944879413,0.0529890910061884,1.65033763781928e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40100,0.022217575459406,0.00393913734183321,0.014496866269413,0.0299382846493991,1.72777192923468e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37696,0.0489109140137546,0.00867200096262651,0.0319137921270066,0.0659080359005026,1.73433452202491e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40233,0.0303623934595166,0.00538803450943588,0.0198018458210223,0.040922941098011,1.77893104905603e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39991,0.0175868084663481,0.00312125179253694,0.0114691549529757,0.0237044619797205,1.78574906267015e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40186,0.0127907141510041,0.00227185475406918,0.00833787883302848,0.0172435494689797,1.83207407753958e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37430,0.0262506483887277,0.00466950212535192,0.0170984242230379,0.0354028725544175,1.9296040171361e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39746,0.0272597386599393,0.00485587737584021,0.0177422190032925,0.0367772583165861,2.01415078051605e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40274,0.0326440844888278,0.00581536737382398,0.0212459644361328,0.0440422045415228,2.0169982801467e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37403,0.0360112907787164,0.00642319424671679,0.0234218300551515,0.0486007515022813,2.10745634415545e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37376,0.032361865880994,0.0057731381166717,0.0210465151723174,0.0436772165896705,2.11791799943448e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40174,-0.0162950097987923,0.00290785453856139,-0.0219944046943726,-0.010595614903212,2.13233092909278e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39810,0.0179054178282789,0.00319566181341392,0.0116419206739877,0.0241689149825702,2.14243416613031e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37784,0.0421214858976088,0.00751893500201009,0.027384373293669,0.0568585985015485,2.1601837720191e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39746,0.0279305778469889,0.00498686514475128,0.0181563221632764,0.0377048335307014,2.1700319910297e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPART,Spartin,37470,0.0362108282974799,0.00647049256275094,0.023528662874488,0.0488929937204717,2.23394431210028e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39746,0.0295228078582964,0.00528091767365632,0.0191722092179301,0.0398734064986628,2.30328544004895e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39946,0.0325278242696093,0.00582133437337271,0.0211180088977988,0.0439376396414198,2.33982596321666e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40174,0.0161213593755503,0.00288663732390887,0.010463550220689,0.0217791685304117,2.37812625155737e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39746,0.0168429405835255,0.00302004480861975,0.0109236527586308,0.0227622284084202,2.48775072629374e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37376,0.0379368083442559,0.00680550512823745,0.0245980182929105,0.0512755983956013,2.53317221138282e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37696,0.0357844682450658,0.00641987341806399,0.0232015163456603,0.0483674201444712,2.53798648554935e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37697,0.045819068819436,0.00822431132176654,0.0296994186287736,0.0619387190100984,2.57962125722254e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39983,0.0133353328448558,0.00239949229558435,0.00863232794551051,0.0180383377442012,2.78065322061541e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40274,0.0341601911522302,0.00615111956605593,0.0221039968027606,0.0462163855016999,2.84527166913502e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40058,0.0200815453297826,0.00362099396295619,0.0129843971623885,0.0271786934971768,2.97252848092543e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37430,0.0286010966030628,0.00515929308908828,0.0184888821484498,0.0387133110576758,3.02086095202572e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39815,0.025441738336209,0.00459160846904633,0.0164421857368782,0.0344412909355398,3.05831254493175e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,37403,0.015239899736231,0.00275243712429145,0.00984512297261978,0.0206346764998423,3.13910973924465e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39727,0.0174686283663277,0.00315876679628054,0.0112774454456179,0.0236598112870376,3.25104753883445e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40274,0.0121360168434208,0.00219495269465017,0.00783390956190645,0.0164381241249351,3.27052905885173e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37696,0.0235530893157381,0.00426146701765965,0.0152006139611252,0.031905564670351,3.31927310693664e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39746,0.0271455298165897,0.00491494309556925,0.017512241349274,0.0367788182839055,3.38576189077061e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40213,0.0305986484164618,0.00555008912386748,0.0197204737336815,0.041476823099242,3.57940284742409e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,40277,0.0192672618801752,0.00349694996471987,0.0124132399493242,0.0261212838110261,3.6498620667476e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40065,0.0351790455626541,0.00638625903514107,0.0226619778537776,0.0476961132715306,3.67514233884433e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40123,0.0269359483891683,0.00489021301688445,0.0173511308760748,0.0365207659022618,3.6836662532491e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37756,0.0368301142739012,0.00668968284887681,0.0237183358901027,0.0499418926576998,3.74922730389873e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39727,0.0242165868778329,0.00440318621766249,0.0155863418912144,0.0328468318644514,3.8635616646753e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40126,0.0162402115531769,0.00295364432702975,0.0104510686721986,0.0220293544341552,3.89322904250618e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39966,0.0209517864291203,0.00381197546498795,0.0134803145177439,0.0284232583404967,3.93943785759844e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37697,0.0264788819876771,0.00482258251797883,0.0170266202524386,0.0359311437229156,4.0794314884791e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,40095,0.0233339191223922,0.00425247193209988,0.0149990741354765,0.031668764109308,4.1483472777502e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37470,0.0513446515079286,0.00935876127367208,0.0330014794115313,0.0696878236043259,4.18189035919544e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40116,0.0229516917947614,0.00418493232209179,0.0147492244434614,0.0311541591460613,4.21385855378763e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37808,0.0091182293825753,0.00166353173404515,0.0058577071838468,0.0123787515813038,4.29998850096602e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37808,0.00702294732646084,0.00128199610928843,0.00451023495225551,0.00953565970066616,4.37613664072385e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37730,0.0118355569899414,0.00216095228090477,0.00760009051936799,0.0160710234605147,4.40443403575968e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40100,0.0156514192907059,0.00285853141084936,0.0100486977254412,0.0212541408559707,4.43408809417585e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37697,0.0173228423233487,0.00317543492003621,0.0110989898800777,0.0235466947666197,4.97777336205651e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37470,0.026827014598856,0.00491801951489894,0.0171876963496541,0.036466332848058,4.99121352165969e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40065,0.0530188142044492,0.00973059039169439,0.0339468570367282,0.0720907713721702,5.15153536575357e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,40074,0.0416251380539161,0.00764461566175391,0.0266416913568784,0.0566085847509537,5.25795700690037e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40095,0.0165893615002913,0.00304857871861563,0.0106141472118047,0.022564575788778,5.35770888126297e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39923,0.017255437739877,0.00317194710553715,0.0110384214130242,0.0234724540667298,5.40856115268509e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40065,0.0256262538881045,0.00471181131710711,0.0163911037065746,0.0348614040696345,5.44696984410863e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37631,0.0267662058806041,0.00492245328069358,0.0171181974504446,0.0364142143107635,5.49733499462132e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,40121,0.010598529134834,0.00194957733493244,0.00677735755836645,0.0144197007113016,5.52053921836211e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39746,0.0251728332936033,0.00463151900408963,0.0160950560455876,0.034250610541619,5.56000659128717e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40126,0.0291281177972445,0.00536356155481825,0.0186155371498007,0.0396406984446882,5.69561299172887e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39991,0.0360752406830222,0.00665239621792582,0.0230365440958876,0.0491139372701568,5.95177844085399e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40233,0.0214045280684787,0.00394711518084292,0.0136681823140266,0.0291408738229308,5.95261539869688e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,40274,0.0154589380841034,0.00285126032368132,0.00987046784968798,0.0210474083185188,5.98697307173701e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,40066,0.0123944439658435,0.00228641662745846,0.00791306737602492,0.0168758205556621,6.01788956505625e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39727,0.025142976465078,0.00463883075668722,0.016050868181971,0.034235084748185,6.04656087101572e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40065,0.0350467110007186,0.00646685027794119,0.0223716844559539,0.0477217375454833,6.06725036311673e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,40094,0.00997902130176939,0.0018424373227958,0.00636784414908962,0.0135901984544492,6.17758304131772e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37791,0.0243367197005094,0.00449470313552018,0.0155271015548899,0.033146337846129,6.25128468331409e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40126,0.030791715005296,0.00568908082409525,0.0196411165900693,0.0419423134205227,6.30913301951189e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39746,0.0383565617000505,0.00709188926432397,0.0244564587419755,0.0522566646581255,6.45056239823948e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39691,0.0213330017669674,0.00394784041877996,0.0135952345461587,0.0290707689877761,6.62557124151033e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39991,0.0402999785612353,0.00745876693604009,0.0256807953665967,0.0549191617558738,6.64876379934158e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40126,0.0358874340237485,0.006643416333787,0.022866338009526,0.048908530037971,6.68802286812641e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39815,0.0161448611096828,0.00298952879854024,0.0102853846645439,0.0220043375548217,6.74547691707401e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40065,0.0168939979802799,0.00312865983738303,0.0107618246990091,0.0230261712615506,6.77075683173015e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37723,0.00860638682575375,0.00159426967214481,0.00548161826834993,0.0117311553831576,6.84228850844275e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39955,0.0247498231699287,0.00458565817313956,0.0157619331505752,0.0337377131892823,6.867483947212e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37696,0.0265661345324169,0.00492271367748235,0.0169176157245515,0.0362146533402823,6.90678721112283e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37403,0.0128697884601,0.00238632072861411,0.00819259983201636,0.0175469770881837,7.04487558768935e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37791,-0.0224071363840828,0.00415904902213964,-0.0305588724674765,-0.0142554003006891,7.26325097019501e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39979,0.0218585925765346,0.00405823642644336,0.0139044491807057,0.0298127359723636,7.29987450402459e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,40174,0.01834756430688,0.00340764526675698,0.0116685795840363,0.0250265490297236,7.37978365937386e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39727,0.0318824649667946,0.00592138020978113,0.0202765597556236,0.0434883701779656,7.38036938052059e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40126,0.0297589452115757,0.00553540524570649,0.018909550929991,0.0406083394931605,7.72022398243659e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39727,0.0277182629156114,0.00515641573943276,0.0176116880663232,0.0378248377648996,7.74963019145036e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37343,0.0210309389318536,0.00391419575246669,0.0133591152570189,0.0287027626066883,7.87879794825372e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37470,0.012039992370933,0.00224211673525005,0.00764544356984285,0.0164345411720231,8.01240946293972e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40121,0.011974744364717,0.00223019854386658,0.00760355521873852,0.0163459335106955,8.01416298405467e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40065,0.0403400211029454,0.00751936502261173,0.0256020656586264,0.0550779765472644,8.21863426911465e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39746,0.0273718133591009,0.0051028433347487,0.0173702404229934,0.0373733862952083,8.25685637739993e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40274,0.0339277467812352,0.00632598984470534,0.0215288066856127,0.0463266868768577,8.28948409372611e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37784,0.0290576450876481,0.00542284823047776,0.0184288625559117,0.0396864276193845,8.53714799913029e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37784,0.0328576150536828,0.00613434984058076,0.0208342893661445,0.0448809407412211,8.63389840632231e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,40126,-0.0303190721812853,0.00566338044686716,-0.0414192978571449,-0.0192188465054256,8.74700300697382e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39746,0.0240284797155801,0.00448997269168478,0.0152281332398779,0.0328288261912822,8.84430930562137e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40126,0.0142251920873272,0.00266001295326455,0.00901156669892868,0.0194388174757257,9.028322328712e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37697,0.0369238743728511,0.00690411214696595,0.0233918145647979,0.0504559341809044,9.03601110323627e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37737,0.0138316755836172,0.0025892855957079,0.00875667581602973,0.0189066753512047,9.35003034529035e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40133,0.0133101221339137,0.00249190471223837,0.00842598889792649,0.0181942553699009,9.35470064963639e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37737,0.020838161768958,0.00390106335718174,0.0131920775888818,0.0284842459490342,9.36171215538879e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,37470,0.0128507030392539,0.00241126095749497,0.0081246315625638,0.0175767745159441,1.00152143426663e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37756,0.0211999045408511,0.00397849013480157,0.01340206387664,0.0289977452050622,1.00570135510349e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40066,0.0160666277869387,0.00301540918941632,0.0101564257756827,0.0219768297981947,1.00581499262684e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,40186,0.0411883743556363,0.00773446964378175,0.0260288138538241,0.0563479348574486,1.02171610305904e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40099,0.0419630442691211,0.00788111613112808,0.02651605665211,0.0574100318861321,1.02626494390038e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37362,-0.0354927137563662,0.00666663719617947,-0.048559322660878,-0.0224261048518545,1.03250133181878e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39810,0.0235484844342918,0.00442379869730282,0.0148778389875783,0.0322191298810053,1.03427250531085e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,40100,0.0185624756484191,0.00348886040398983,0.011724309256599,0.0254006420402391,1.0490864398416e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37756,0.0380008673440999,0.00714483978476386,0.0239969813659627,0.0520047533222371,1.06235657074772e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40126,0.0196277442530166,0.00369603112299744,0.0123835232519416,0.0268719652540915,1.10821812613426e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37697,0.0364972523561484,0.00687232563307858,0.0230274941153144,0.0499670105969824,1.10936202427493e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37696,0.0454993702712139,0.00857530949636927,0.0286917636583301,0.0623069768840977,1.13951718293545e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40126,-0.043519988828522,0.00820718254985689,-0.0596060666262415,-0.0274339110308025,1.15669180585106e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40083,0.0369134719906537,0.00697005300332414,0.0232521681041384,0.0505747758771691,1.19963019409996e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37715,0.0368351423558286,0.00695693373794593,0.0231995522294546,0.0504707324822026,1.21089359363709e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37470,0.0127624463228509,0.0024105455904884,0.00803777696549361,0.0174871156802081,1.21334460625234e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,40100,0.0172439023282636,0.00326347338702709,0.0108474944896905,0.0236403101668367,1.28150217686541e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37289,0.0242157739073265,0.00458275793688988,0.0152335683510224,0.0331979794636307,1.28388051165801e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40100,0.0457879107284105,0.00867342611281738,0.0287879955472885,0.0627878259095326,1.31552063221039e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37515,0.0309723380529649,0.00586765213200849,0.0194717398742282,0.0424729362317015,1.3233918801592e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDK,Midkine,40116,0.0223924708018258,0.0042431225487602,0.0140759506062558,0.0307089909973958,1.32807562454361e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,40258,0.0131943594935734,0.00250207413674815,0.00829029418554703,0.0180984248015998,1.35706030406573e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,40100,0.0414707797520424,0.00787046335482399,0.0260446715765874,0.0568968879274974,1.38862305919069e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39815,0.0210174429804803,0.00399075897993813,0.0131955553798016,0.0288393305811591,1.40902757936332e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39746,0.0343630237441519,0.00653579142273984,0.0215528725555819,0.047173174932722,1.47856426157619e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40274,0.0167962360338563,0.00319493872128937,0.0105341561401292,0.0230583159275835,1.48215931024711e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37430,0.0300851255790584,0.00573636678840971,0.0188418466737754,0.0413284044843415,1.59057299274447e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37745,0.0298526587095702,0.00569232549500648,0.0186957007393575,0.0410096166797829,1.59223482720275e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37715,0.0129652592206973,0.00247237484691713,0.00811940452073971,0.0178111139206549,1.59503925572952e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37681,0.0388729000715974,0.00741289315073927,0.0243436294961484,0.0534021706470464,1.59590302333024e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,37430,0.0282088682732057,0.00538030215909652,0.0176634760413765,0.0387542605050348,1.60476090742466e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37784,0.0113322600994439,0.00216452449597791,0.0070897920873272,0.0155747281115606,1.6708422274432e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,40122,0.0252107372500369,0.00481884638272539,0.0157657983398951,0.0346556761601787,1.70125669288955e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39727,0.0270563869730513,0.00517368169749517,0.0169159708459607,0.0371968031001418,1.72100541160653e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37756,0.0287255856015492,0.0054926235667944,0.0179600434106321,0.0394911277924662,1.72222278065314e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39810,0.0224273861763565,0.00428910141703379,0.0140207473989703,0.0308340249537427,1.72735629608345e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37784,0.0310383781807169,0.00593556842631754,0.0194046640651345,0.0426720922962992,1.72803823482942e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39810,0.0140580793532256,0.00269063202304686,0.00878444058805378,0.0193317181183975,1.76600170547477e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,40100,0.0369641894261348,0.00708582587219756,0.0230759707166275,0.050852408135642,1.84523685123111e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,40126,0.0527062392435916,0.0101046808153977,0.032901064845412,0.0725114136417712,1.85133045664257e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39689,0.0331227745887516,0.00635614772527007,0.0206647250472223,0.045580824130281,1.90132693373285e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39669,0.0186680151426254,0.0035839555748645,0.011643462215891,0.0256925680693598,1.92571422830822e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39919,0.0153502698940616,0.00294709743584102,0.00957395891981316,0.0211265808683099,1.92705184879418e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37674,0.0181173619300494,0.00348020467335431,0.0112961607702749,0.0249385630898238,1.96023678359222e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40233,0.0287024255439005,0.00551624824804346,0.0178905789777353,0.0395142721100656,1.98283898573322e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40065,0.02351744763817,0.00451999956232377,0.0146582484960154,0.0323766467803246,1.98604337783458e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40143,0.0149757960192646,0.00288098942823134,0.00932905673993117,0.020622535298598,2.0381415336644e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39727,0.0218942202560781,0.00421211981191553,0.0136384654247236,0.0301499750874325,2.0413871818743e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39792,0.0184189754282298,0.0035483378633572,0.0114642332160497,0.0253737176404099,2.11980732543731e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37782,0.0203720160963899,0.00392469127078668,0.012679621205648,0.0280644109871317,2.12549242314476e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,40248,0.0136675366903691,0.00263637698604074,0.00850023779772928,0.018834835583009,2.19605561559683e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37756,0.0115648951791221,0.00223175239693303,0.00719066048113334,0.0159391298771108,2.22755615396184e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,40185,-0.012206904303643,0.00235980257816336,-0.0168321173568432,-0.00758169125044285,2.33380770584338e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40174,0.0310206793065598,0.00599745495254776,0.0192656675995662,0.0427756910135534,2.34060564598007e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39991,0.0228652954191563,0.00442158289228436,0.014198992950279,0.0315315978880337,2.35367756321118e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37782,0.029568287728016,0.00572441787170008,0.0183484286994839,0.0407881467565482,2.43526254836899e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37756,0.0237984899589939,0.00460932588939664,0.0147642112157765,0.0328327687022114,2.46374460714737e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37756,0.0464543862777172,0.00900150673301268,0.0288114330810123,0.064097339474422,2.49524907800696e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37784,0.0108565156040649,0.0021066908479583,0.00672740154206666,0.0149856296660632,2.59529843676145e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37403,0.0420904811096945,0.00817123399852735,0.0260748624725809,0.0581060997468081,2.62828560706683e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37777,0.0117466273394541,0.00228465003093111,0.00726871327882908,0.016224541400079,2.76351873758142e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37791,0.0355926740969754,0.0069276282385614,0.0220145227493951,0.0491708254445558,2.81917482511071e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39727,0.0365873649297812,0.00712929889929459,0.0226139390871638,0.0505607907723986,2.90237676276423e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37376,0.0294015364808482,0.00573345752471027,0.0181639597324161,0.0406391132292803,2.9697125505667e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39815,0.0340682574478487,0.00664711220097584,0.0210399175339361,0.0470965973617614,3.00712793103455e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,40274,0.0271382769557454,0.00529623157823045,0.0167576630624137,0.0375188908490771,3.02523439334494e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37696,0.0275210608820103,0.00537940564782271,0.0169774258122778,0.0380646959517428,3.16440490649695e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37470,0.0360522834590157,0.00704966811343496,0.0222349339566832,0.0498696329613483,3.19820856945393e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37403,0.0389700566245547,0.00762683468060531,0.0240214606505683,0.0539186525985411,3.27440546367086e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,37403,0.0214625764548306,0.00420388913414809,0.0132229537519003,0.0297021991577608,3.34761509236139e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40065,0.0238462411865784,0.00467216910324468,0.0146887897442188,0.0330036926289379,3.36647724084104e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39746,0.0161150829056608,0.00316078519926189,0.00991994391510753,0.0223102218962141,3.46547712150421e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,37376,0.0208061391803562,0.00408412087625902,0.0128012622628885,0.0288110160978238,3.54782594510215e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37566,0.0139821215539557,0.00274852678302258,0.00859500905923148,0.01936923404868,3.68539179232197e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37349,0.0172525651152694,0.0033917669650951,0.010604701863683,0.0239004283668558,3.69657385346102e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40209,0.0128931563152078,0.00253560185305765,0.0079233766832148,0.0178629359472008,3.72135055150559e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39775,0.0220997932130274,0.00434975986736062,0.0135742638730006,0.0306253225530542,3.80482398801644e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40100,0.0333485908861062,0.00656496340694648,0.0204812626084911,0.0462159191637213,3.82212685615634e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,40032,0.0231400384943596,0.00455701176137576,0.0142082954420631,0.0320717815466561,3.86037655486744e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,37403,0.0185324410117418,0.00365236719896984,0.011373801301761,0.0256910807217227,3.94747581130865e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37430,0.0329779279518276,0.00651056595803891,0.0202172186740713,0.0457386372295839,4.13370339104218e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37697,0.0483033149161239,0.00955111175412885,0.0295831358780313,0.0670234939542164,4.30806715209521e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,40229,0.0111485596989147,0.00221131335595808,0.00681438552123685,0.0154827338765925,4.66768227905754e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37697,0.0135157951490095,0.00268384548905662,0.00825545799045849,0.0187761323075605,4.81660325235564e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39664,0.024202687220218,0.00480661571584295,0.0147817204171658,0.0336236540232702,4.8259210702964e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,37203,0.033366928133073,0.00662995450957917,0.0203722172942978,0.0463616389718482,4.90074493845588e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,40283,0.0142283786120534,0.00282871315077775,0.00868410083652901,0.0197726563875778,4.95891997769244e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37430,0.0375594521538307,0.00746921394803817,0.0229197928156758,0.0521991114919855,5.00751675130089e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,37441,0.0134634874904412,0.00267837901553916,0.00821386461998442,0.0187131103608979,5.05559136326698e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37737,0.0443085980889344,0.00881707239728787,0.0270271361902502,0.0615900599876186,5.09133877312133e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37403,0.0185986021830095,0.00371190976159304,0.0113232590502872,0.0258739453157319,5.49988821295387e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37782,-0.0108903459492229,0.00217402543322671,-0.0151514357983472,-0.00662925610009853,5.53276562209784e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40054,0.012171162061414,0.00243036078238132,0.00740765492794666,0.0169346691948814,5.56090832771519e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37756,0.0495269186210436,0.00989352742462027,0.0301356048687879,0.0689182323732993,5.6286112910016e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39810,0.0386743272697841,0.00773044316873042,0.0235226586590725,0.0538259958804957,5.71099619432659e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39991,0.0118680262524161,0.00237444392740627,0.00721411615469985,0.0165219363501324,5.84872695652389e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37784,0.0124664926192102,0.00249508936878921,0.00757611745638331,0.017356867782037,5.91472018392399e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37696,0.0200825147758389,0.00401985559941392,0.0122035978009876,0.0279614317506902,5.93303066528157e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,40174,0.0266345320537881,0.00534118888567543,0.0161658018378643,0.037103262269712,6.20963728309449e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40097,-0.0202713111538355,0.00407187219792435,-0.0282521806617672,-0.0122904416459038,6.48022661130524e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39746,0.0334942778858695,0.00673255956498444,0.0202984611385,0.046690094633239,6.59664694286226e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39991,0.0402688306055599,0.00809448586156538,0.0244036383168917,0.056134022894228,6.59967950088377e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37808,0.0137647287085398,0.00276671953868712,0.00834195841271303,0.0191874990043665,6.60226008134933e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,37376,0.0285854416124028,0.00574580784453779,0.0173236582371087,0.0398472249876968,6.60838299826678e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40065,0.0405179369922901,0.00815201031792485,0.0245399967691574,0.0564958772154228,6.75577124598185e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37697,0.0147918707009995,0.00297673633277445,0.00895746748876153,0.0206262739132374,6.80843407892758e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39815,0.017493223802523,0.00352274619946501,0.0105886412515715,0.0243978063534744,6.91556187517621e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37470,0.0493210605307984,0.00993909693208926,0.0298404305439034,0.0688016905176933,7.05335989302373e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39991,0.0420100044018055,0.00847042483318196,0.0254079717287688,0.0586120370748421,7.13805895759595e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37784,0.0405906970171879,0.00819443984806922,0.0245295949149722,0.0566517991194036,7.38049944020903e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37737,0.023528154979984,0.00474992521671753,0.0142183015552176,0.0328380084047503,7.3834690492583e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37515,0.030881029670073,0.00623869239889726,0.0186531925682344,0.0431088667719117,7.51700717789453e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37697,0.02994452929786,0.00605271463430217,0.0180812086146277,0.0418078499810922,7.61780558589231e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37725,0.044847879518926,0.00906914473843612,0.0270723558315913,0.0626234032062608,7.7033292920598e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39746,0.0188606661884091,0.00381426958856089,0.0113846977948298,0.0263366345819885,7.70442580205832e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40095,0.0100030922117738,0.00202305237148076,0.00603790956367146,0.0139682748598761,7.71093254210534e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39727,0.0166370726111535,0.00336495143224932,0.0100417678039448,0.0232323774183621,7.72592258217862e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40121,0.0158880838290122,0.00321413706824596,0.00958837517525009,0.0221877924827742,7.76497280784668e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37697,0.0254344166777528,0.00514503189015074,0.0153501541730574,0.0355186791824483,7.76753526521015e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40066,0.020100735329086,0.00406715708249575,0.0121291074473944,0.0280723632107777,7.8043478221632e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,40133,0.0139324119750318,0.00282131590873704,0.00840263279390718,0.0194621911561564,7.96307513844543e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39746,0.0317483468411374,0.0064317977740275,0.0191420232040435,0.0443546704782313,8.0517287422457e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39746,0.0514426089434439,0.0104228921003764,0.0310137404267061,0.0718714774601816,8.07704656738566e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40056,0.0239161695894141,0.00484932445147586,0.0144114936645214,0.0334208455143067,8.22899705240741e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40233,0.0235747249637021,0.00479715617235405,0.0141722988658882,0.032977151061516,8.99883887702548e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37674,0.0289462550460214,0.0058899887690763,0.0174018770586318,0.0404906330334109,9.00835584973519e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40100,0.0194405686295558,0.00395831779151686,0.0116822657581827,0.0271988715009288,9.13781525404447e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37737,0.0288063105488566,0.00586572853707363,0.0173094826161923,0.0403031384815209,9.1713477612352e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40126,0.0200774065850971,0.00409187124468322,0.012057338945518,0.0280974742246762,9.35723002312688e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40100,0.0187796008595276,0.00382964706962768,0.0112734926030573,0.0262857091159978,9.4971555750003e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37470,0.00873920668001764,0.00178395718864382,0.00524265059027574,0.0122357627697595,9.7595085620452e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40274,0.0279062727450742,0.00570116554782054,0.0167319882713459,0.0390805572188024,9.93570821892559e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37756,0.0153382493991648,0.00313468976745331,0.00919425745495631,0.0214822413433733,1.00438914989991e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39815,0.016676533176684,0.0034087317136853,0.00999541901786081,0.0233576473355072,1.00674687361651e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40095,0.018768206604253,0.00383747209355793,0.0112467613008795,0.0262896519076266,1.01438459843735e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37404,0.0140497659582698,0.00287262856531439,0.00841941397025358,0.019680117946286,1.01576741792328e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40274,0.0239589581965388,0.00490726535390479,0.0143407181028854,0.0335771982901922,1.05854997011982e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40100,0.0389197730201809,0.00797324330489077,0.023292216142595,0.0545473298977668,1.06429043402349e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40070,0.0281600713172572,0.00577039658045422,0.016850094019567,0.0394700486149475,1.0708223165987e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40100,-0.0201235672982012,0.00412398870964808,-0.0282065851691114,-0.0120405494272909,1.07327723609281e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37697,0.0207087364677565,0.0042470161801924,0.0123845847545794,0.0290328881809336,1.09477843531862e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40160,0.0356439148754733,0.00731626078457662,0.0213040437377031,0.0499837860132434,1.11621088675639e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37587,0.0221813545089454,0.00455399670941538,0.0132555209584912,0.0311071880593995,1.12474320367852e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40274,0.014915853266186,0.00306347387877242,0.00891144446379203,0.0209202620685799,1.13284890388453e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39990,0.0294121639233431,0.00604268977267128,0.0175684919689074,0.0412558358777788,1.14188681606724e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37784,0.0360767349622276,0.00741375915344954,0.0215457670214665,0.0506077029029887,1.15073767369957e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,40138,0.0434041147518247,0.00893129910189648,0.0258987685121076,0.0609094609915418,1.18654667188463e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37737,0.00895297750884024,0.00184235022313487,0.00534197107149589,0.0125639839461846,1.19001614949839e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40186,0.0133499062363396,0.00275046118257065,0.00795900231850109,0.018740810154178,1.22342931897331e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37515,0.0200830523134947,0.00413757212125477,0.0119734109558354,0.0281926936711541,1.22502725948226e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,40049,0.0291679035334413,0.00601597908962222,0.0173765845177817,0.0409592225491008,1.25657278444604e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40095,0.0314457277291016,0.00649027294967519,0.0187247927477382,0.044166662710465,1.27789561766441e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEP,Leptin,40126,0.0257780789500773,0.00532817141820595,0.0153348629703936,0.0362212949297609,1.32351114208904e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,40065,-0.0200563852718467,0.00414905917714858,-0.0281885412590579,-0.0119242292846355,1.35117183833363e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37756,0.0400265740884802,0.0082797855105149,0.023798194487871,0.0562549536890894,1.3514056081129e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40297,0.0119614074597668,0.00247506738790726,0.00711027537946857,0.016812539540065,1.35914084625785e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37489,0.0259922649140596,0.00537944047602676,0.0154485615810471,0.036535968247072,1.36859215684651e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40100,0.0390017011620712,0.00807441328553756,0.0231758511224175,0.0548275512017248,1.37629728368105e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,40164,0.0405434994197736,0.00839545492916155,0.024088407758617,0.0569985910809303,1.38359955798788e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39746,0.0278663243578057,0.00577073629908613,0.0165556812115969,0.0391769675040145,1.38615731914085e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39815,0.0281800987508229,0.00583983245057193,0.0167340271477019,0.0396261703539439,1.40995436866348e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37403,0.0232108794685065,0.00481341418318766,0.0137765876694587,0.0326451712675544,1.43652891072321e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39746,0.0250845548306717,0.00521361605908981,0.0148658673548556,0.0353032423064877,1.51341068033422e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37784,0.0262674858765938,0.00546182681688199,0.0155623053155051,0.0369726664376825,1.53126436112645e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,37470,0.0174468634544829,0.00362902119060326,0.0103339819209005,0.0245597449880653,1.54465063205705e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37470,0.0358906528866413,0.0074654384018264,0.0212583936190616,0.0505229121542211,1.54480561961265e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39746,0.0121886793993708,0.002535807595949,0.00721849651131076,0.0171588622874309,1.54957411666405e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37756,0.0199322806822692,0.00415088536286409,0.0117965453710556,0.0280680159934829,1.58851252694589e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39810,0.0369300276428892,0.00770122925604108,0.0218356183010487,0.0520244369847297,1.63920673960093e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39746,0.0272867549879162,0.00569404020366209,0.0161264361887385,0.0384470737870939,1.66544739821328e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40194,0.0290203010590224,0.00605624382128821,0.0171500631692975,0.0408905389487473,1.66800722546288e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37737,0.0276256685964143,0.00576585076364724,0.0163246010996657,0.0389267360931629,1.67532404982076e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39746,0.0307455885657387,0.00641939492575994,0.0181635745112492,0.0433276026202282,1.68778237620552e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39991,0.0210538816381838,0.00440245437303335,0.0124250710670384,0.0296826922093292,1.74885585111593e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37784,0.0297152593402466,0.00621445021192084,0.0175349369248818,0.0418955817556115,1.75730373788616e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37376,0.0245133675262404,0.00512663166949055,0.0144651694540389,0.0345615655984419,1.75846531587615e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40065,0.0378975483378237,0.00792650536037177,0.0223615978314951,0.0534334988441524,1.75913814642166e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37737,0.0284042988762526,0.00594903359145809,0.0167441930369947,0.0400644047155104,1.81979265906063e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,40057,-0.0161549009663579,0.00338451511323209,-0.0227885505882928,-0.00952125134442301,1.82983359830399e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,40105,-0.0181792628760234,0.00381009003439303,-0.0256470393434337,-0.0107114864086131,1.84649227453648e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39991,0.0173296378622285,0.00363297759724865,0.0102090017716211,0.0244502739528358,1.85814094805189e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,40248,0.0135195789039508,0.00283649653431015,0.00796004569670292,0.0190791121111987,1.8931584193266e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37756,0.0158447625329846,0.00332412866007196,0.00932947035924355,0.0223600547067256,1.8935207873547e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,40297,0.00652700995441685,0.00137243121080103,0.00383704478124684,0.00921697512758686,1.99401100520843e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,37343,0.0217469306150681,0.00457744797929028,0.0127751325756592,0.0307187286544771,2.04712508989997e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,40064,0.0112977093165304,0.00237879173762518,0.00663527751078499,0.0159601411222757,2.0588770615522e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37370,0.0113356001242731,0.0023867562792673,0.00665755781690917,0.016013642431637,2.06240120296981e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,37470,0.0142628559801834,0.00300353223900061,0.00837593279174223,0.0201497791686246,2.06917139228057e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39717,0.0440117509300908,0.00927371129215881,0.0258352767974595,0.062188225062722,2.09502862222364e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40100,0.0399373194989978,0.00842204794503412,0.0234301055267309,0.0564445334712646,2.13488152950901e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39792,0.0152962291355995,0.00322722861939898,0.00897086104157748,0.0216215972296215,2.15912080143424e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39967,0.0133473203085551,0.0028162692482732,0.00782743258193961,0.0188672080351706,2.16294036626001e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40186,0.0104787563432364,0.00221310902845086,0.00614106264747269,0.0148164500390001,2.21119559226697e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37737,0.038192907132717,0.00807595778347871,0.0223640298770987,0.0540217843883352,2.27711792231458e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40174,0.0124959957239646,0.00264411522904131,0.00731352987504359,0.0176784615728855,2.31008618100996e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37441,0.033904061995202,0.00717422047844121,0.0198425898574572,0.0479655341329468,2.31594458212869e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39991,0.0276927899591905,0.00586405441221519,0.0161992433112487,0.0391863366071323,2.35039407400044e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37403,0.0214668928173708,0.00454633775356532,0.0125560708203828,0.0303777148143589,2.36218753969289e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40065,0.0177605811043171,0.00376221930780163,0.0103866312610259,0.0251345309476083,2.36991010919238e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,40233,0.00921544284436564,0.0019535560401086,0.00538647300575279,0.0130444126829785,2.4108318864743e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37737,0.0209643222419491,0.00444468778869418,0.0122527341761085,0.0296759103077897,2.42123429476437e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,40054,0.0278900997212818,0.00591470687748754,0.0162972742414062,0.0394829252011574,2.43345546573097e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37696,0.0413718168702685,0.00879168575034123,0.0241401127995997,0.0586035209409373,2.55445014596211e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,40121,0.0150912488629325,0.00320761810991047,0.00880431736750797,0.021378180358357,2.56266765075722e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,40126,0.0267689658710816,0.00569058929973413,0.0156154108436027,0.0379225208985605,2.57193952051642e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39746,0.0335449801667774,0.00713143873873395,0.0195673602388588,0.0475226000946959,2.57575204319675e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40095,0.0165843215678688,0.00353315629245542,0.00965933523465622,0.0235093079010815,2.70303094292581e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39781,0.0285285152172653,0.00607827931997245,0.0166150877501193,0.0404419426844113,2.70868931135675e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40160,0.0178878268907307,0.00381418310573719,0.0104120280034858,0.0253636257779756,2.75748465042013e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37376,0.0286103527992615,0.00610303371721805,0.0166484067135141,0.0405722988850089,2.78856653523582e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39746,0.0172263400912214,0.00367638560036087,0.0100206243145141,0.0244320558679287,2.81445487681372e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37579,0.00939000613414363,0.00200588079446921,0.00545847977698399,0.0133215324913033,2.88000157041064e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37756,0.0307014024423749,0.00655932400149479,0.0178451273994451,0.0435576774853046,2.88895098722791e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37696,0.0325907005561232,0.00697013895890314,0.018929228196673,0.0462521729155734,2.95757398629329e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,40095,0.0104234201093787,0.00222943957565415,0.00605371854109653,0.0147931216776608,2.95896802466381e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,40160,0.0224920304339098,0.00481448159543944,0.0130556465068485,0.0319284143609712,3.0112766854023e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,40204,0.0273442868952548,0.00585444161784565,0.0158695813242774,0.0388189924662323,3.02668159522494e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37362,0.0244580195266245,0.00523757135354704,0.0141923796736723,0.0347236593795767,3.04642337687413e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37737,0.0153288905690983,0.00328379704374032,0.00889264836336726,0.0217651327748293,3.07062805237186e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40190,-0.0100300311785692,0.00214926920826135,-0.0142425988267614,-0.00581746353037691,3.0857250628638e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37362,0.0225078528945446,0.00482382657470661,0.0130531528081197,0.0319625529809696,3.10243457161189e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40095,0.0148265361541473,0.00317861933880188,0.00859644225009557,0.0210566300581989,3.11992386392858e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37784,0.0109913995916799,0.00236253669358624,0.00636082767225092,0.015621971511109,3.31294757927121e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39746,0.0333896132046553,0.00717892746958432,0.0193189153642701,0.0474603110450406,3.32999963791528e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39973,0.0264114700023804,0.00568441622454561,0.015270014202271,0.0375529258024898,3.40727783392054e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37696,0.0177285622537168,0.00381636895269547,0.0102484791064337,0.025208645401,3.42685020286671e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40145,0.0119105156052541,0.00256450837421021,0.00688407919180208,0.0169369520187061,3.43889909673129e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,40126,0.0267464527546258,0.00575936713971498,0.0154580931607845,0.0380348123484672,3.44516567971779e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37716,0.012352684843299,0.00266307787043865,0.00713305221723927,0.0175723174693588,3.54302449405515e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37737,0.014527394169824,0.00313548539663611,0.00838184279241722,0.0206729455472308,3.63441857706625e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37652,0.018648859267251,0.004027873486782,0.0107542272331583,0.0265434913013437,3.69239194051383e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40186,0.0331879309744568,0.00717041864756254,0.0191339104252342,0.0472419515236794,3.71353184132609e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,37430,0.0263277919465925,0.0056937268583399,0.0151680873042463,0.0374874965889387,3.80043410529063e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40126,0.049165361611012,0.0106335108344844,0.0283236803754226,0.0700070428466014,3.80103027282759e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37696,0.0233343135815444,0.00504793231182511,0.0134403662503672,0.0332282609127217,3.82634200108484e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37697,0.0190146022278299,0.00411644070745257,0.0109463784412229,0.0270828260144369,3.88878498365706e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37784,0.0155079279008676,0.00335792596277305,0.00892639301383246,0.0220894627879028,3.90504017529022e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40100,0.010660850205447,0.00230913356012088,0.00613494842761004,0.0151867519832839,3.92766904319089e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39991,0.0367005743118232,0.00795077275038715,0.0211170597210644,0.0522840889025821,3.94383752021787e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39661,0.00714466250707762,0.00155137532602064,0.00410396686807717,0.0101853581460781,4.15063665524052e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40230,0.0368482744578806,0.008001803519562,0.0211647395595391,0.0525318093562221,4.15694654375767e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39991,0.00985373556863563,0.00214127112957651,0.00565684415466568,0.0140506269826056,4.22135705039925e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37697,0.0244682067219986,0.00531770732761848,0.0140455003598663,0.0348909130841308,4.23819451419296e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,40095,0.0466398011753797,0.0101405889876966,0.0267642467594943,0.0665153555912651,4.27197843879287e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37784,0.0181053945125422,0.00394130573885259,0.0103804352643911,0.0258303537606933,4.39327674466802e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37362,0.0143391523129647,0.0031223897232294,0.00821926845543511,0.0204590361704944,4.42393258144997e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39810,0.0287865278577555,0.00627332710532371,0.016490806731321,0.0410822489841899,4.4950676656752e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40070,-0.0266213837118248,0.00580612961632841,-0.0380013977598285,-0.0152413696638212,4.57403579827032e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37403,0.0343679936758542,0.00751130961859567,0.0196458268234067,0.0490901605283017,4.79497548588313e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39746,0.0371094481794017,0.00812137552611812,0.0211915521482102,0.0530273442105933,4.93053267169296e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40065,0.0167932210138914,0.00368355197322671,0.00957345914636702,0.0240129828814157,5.17942376189242e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37756,-0.0204673374513433,0.00449323052484448,-0.0292740692800385,-0.0116606056226482,5.28135141481512e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,40126,0.0243913605056899,0.00535509920440506,0.013895366065056,0.0348873549463238,5.28327789648104e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40126,-0.0160261448536392,0.0035189374350074,-0.0229232622262537,-0.00912902748102468,5.29671478906683e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37697,0.0170208462864063,0.00373755082428084,0.00969524667081589,0.0243464459019968,5.31020715220523e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,40095,0.0175008454824536,0.00384575874204517,0.00996315834804507,0.0250385326168621,5.38733808758734e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40100,0.0276724313434929,0.00608203110895832,0.0157516503699346,0.0395932123170512,5.4083468662607e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,40034,0.030062063508933,0.00660751662007753,0.017111330933581,0.0430127960842849,5.41340318458962e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37403,0.0185883083001427,0.00408562936616607,0.0105804747424572,0.0265961418578282,5.42157007306917e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37282,0.0197436050522243,0.00434072636149974,0.0112357813836848,0.0282514287207637,5.45360661957723e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40164,-0.0243874935772262,0.00536454337436818,-0.0349019985909879,-0.0138729885634646,5.50694812502745e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39746,0.0224022216708733,0.00493013373663778,0.0127391595470632,0.0320652837946833,5.56355437108351e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,40194,0.0181511134674905,0.00399501574504212,0.010320882607208,0.0259813443277731,5.57549781828389e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40100,0.0453961880494647,0.0100016205522565,0.025793011767042,0.0649993643318874,5.6974186034132e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40065,0.0233148141597273,0.00513927013249124,0.0132418447000445,0.0333877836194101,5.75942907139788e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37403,0.0125679456135376,0.00277215509554564,0.0071345216262681,0.018001369600807,5.84963468510976e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,40248,-0.0226883157116826,0.00500501769248192,-0.0324981503889472,-0.012878481034418,5.85472008157056e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,37430,0.0187495211372999,0.0041361770750206,0.0106426140702595,0.0268564282043403,5.86563455133259e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37697,0.0193616787661772,0.00427490655425517,0.0109828619198371,0.0277404956125173,5.97395363639573e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,40297,0.0104774386476109,0.00231403757247472,0.00594192500556045,0.0150129522896614,6.00427136955777e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37777,0.0137078081355843,0.00302974374149186,0.00776951040226028,0.0196461058689084,6.10872962260584e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37697,-0.0148736211451187,0.00329015604300051,-0.0213223269893997,-0.00842491530083767,6.2186559029744e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40114,0.0187185608765528,0.00414543176181271,0.0105935146233999,0.0268436071297057,6.3638273987068e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37410,0.0303158634388885,0.00672142700843896,0.0171418665023482,0.0434898603754289,6.52950355607676e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40216,0.02217412442387,0.00491843986653501,0.0125339822854614,0.0318142665622786,6.57996568170782e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37470,0.0137852191703554,0.00306043767110653,0.00778676133498665,0.0197836770057242,6.71621311281699e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,37441,0.0387079474083358,0.00859661119479558,0.0218585894665365,0.0555573053501352,6.76802791437339e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37403,0.0212538565353026,0.00472234743351072,0.0119980555656216,0.0305096575049836,6.83213521490272e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40186,0.0447512057829324,0.00995596884025748,0.0252375068560277,0.064264904709837,7.00953338393555e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37697,0.00773664707748996,0.00172267497261368,0.00436020413116714,0.0111130900238128,7.14666711086694e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37784,0.0138348425382706,0.00308712736037164,0.00778407291194221,0.019885612164599,7.47511074944947e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37756,0.0205223620795965,0.00458433930341997,0.0115370570448934,0.0295076671142996,7.64631122761583e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39727,0.0269306551067042,0.0060188929129629,0.0151336249972969,0.0387276852161115,7.71964242147206e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37362,0.0134619271929215,0.00300877103084097,0.00756473597247321,0.0193591184133698,7.73435882548751e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39815,0.022297216426241,0.00499078176158432,0.0125152841735358,0.0320791486789463,7.96370579196884e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37697,0.0261701965512745,0.00585788610921456,0.014688739777214,0.0376516533253351,7.97889223451913e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37784,0.0109003766912751,0.00244302766651946,0.00611204246489693,0.0156887109176532,8.19278739256552e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40248,0.0229267559006477,0.00514403243897108,0.0128444523202644,0.033009059481031,8.37014155277537e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37362,0.0276588140335256,0.00620638790889686,0.0154942937320878,0.0398233343349635,8.40071816880084e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40248,0.0486452299343323,0.0109248211612887,0.0272325804582065,0.0700578794104582,8.53683898022346e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,40233,0.048742337154946,0.0109470816772575,0.0272860570675212,0.0701986172423708,8.54420078361191e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39770,0.0233540992633042,0.00524528702219097,0.0130733366998099,0.0336348618267985,8.55172599375318e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37756,0.0193577356127957,0.00434946035274972,0.0108327933214062,0.0278826779041851,8.6324268513935e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37784,0.0120870774955985,0.00271616696741056,0.00676339023947384,0.0174107647517232,8.65465662278262e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37784,-0.0296357458734154,0.00666006268756936,-0.0426894687410513,-0.0165820230057794,8.66591867705235e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,40262,0.0227526111731879,0.00511576177088667,0.01272571810225,0.0327795042441258,8.7447135545988e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39746,0.0174740982278737,0.00393114250627905,0.00976905891556672,0.0251791375401806,8.84923735883348e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39815,0.024708406349278,0.00556040154683377,0.0138100193174839,0.0356067933810722,8.9069432443981e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40050,0.0331026760372136,0.0074517938841888,0.0184971600242036,0.0477081920502237,8.9638659173075e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39727,0.0181396123600408,0.00408451074046218,0.010133971308735,0.0261452534113467,9.01395249509133e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,37154,0.0144178027979709,0.00325295451211051,0.00804201195423435,0.0207935936417076,9.40504613359253e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39630,0.0140572228281983,0.0031781083400861,0.00782813048162958,0.0202863151747671,9.79526077614587e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39746,0.0361858341730852,0.00818784231173023,0.0201376632420939,0.0522340051040764,9.96290831645102e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40256,0.0195477391820175,0.00442331378507631,0.010878044163268,0.0282174342007671,9.97023350170146e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39991,0.0258370224824676,0.00585015910287157,0.0143707106408393,0.0373033343240959,1.01005828996624e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40100,0.0391635036803658,0.00887046180838257,0.0217773985359359,0.0565496088247956,1.01664676572636e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37362,0.0451325027866021,0.0102378144194837,0.025066386524414,0.0651986190487902,1.04972479307307e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40126,0.0283910908112407,0.00644175340488473,0.0157652541376666,0.0410169274848148,1.05336015095189e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37737,0.013873946085658,0.00315058411577684,0.00769880121873536,0.0200490909525806,1.07296017539413e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37791,0.0091186390202895,0.00207704724234588,0.00504762642529157,0.0131896516152874,1.14121234557658e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40074,0.0321701427486383,0.00732859073423257,0.0178061049095425,0.0465341805877342,1.14264501502998e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37362,0.0225989952139403,0.00515084076576887,0.0125033473130333,0.0326946431148473,1.1560325351695e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39815,0.0142587531966707,0.00325173874176321,0.00788534526281486,0.0206321611305266,1.16776755391995e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39930,0.0118367516552116,0.00270061257488966,0.0065435510084279,0.0171299523019954,1.17833751278963e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37697,0.0346485552267499,0.00790555182797781,0.0191536736439134,0.0501434368095864,1.18058643604846e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39991,0.0108151719724424,0.00246831291385778,0.00597727866128114,0.0156530652836036,1.18580238743035e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37362,0.0246434143020678,0.005624131526939,0.0136201165092673,0.0356667120948682,1.18670952799295e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,40233,0.0110163840144373,0.00251662596602447,0.00608379712102937,0.0159489709078453,1.2085226371496e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,40248,0.0107781330200458,0.00246291479132336,0.005950820029052,0.0156054460110396,1.21557843273526e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39727,0.0224237788623582,0.00512708507843093,0.0123746921086335,0.0324728656160828,1.23027669144782e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37791,0.00774968675274302,0.00177219703631218,0.00427618056157115,0.0112231929439149,1.23521281227741e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37515,0.0131829075416299,0.003015674610321,0.00727218530540078,0.0190936297778591,1.24371147039263e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40095,0.0436082552757941,0.00998490287892909,0.024037845633093,0.0631786649184951,1.26531579463832e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37362,0.0140129843471018,0.00321308687119589,0.00771533407955782,0.0203106346146457,1.30340729677848e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40095,0.00987350799075149,0.00226420244789512,0.00543567119287705,0.0143113447886259,1.30475470666854e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39746,0.0234750860155545,0.00538431397054378,0.0129218306332887,0.0340283413978203,1.30970181377729e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,40297,0.0192326858178083,0.00441661035920308,0.0105761295137703,0.0278892421218464,1.34130864113698e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40095,0.00835245160930318,0.00191848901648185,0.00459221313699875,0.0121126900816076,1.34732780810146e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,40065,0.0195460410252196,0.00449383913634212,0.0107381163179891,0.0283539657324502,1.37301223415477e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40297,0.0154299720637986,0.00354932722836104,0.00847329069621101,0.0223866534313863,1.38686259526484e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,40027,0.0108203886945622,0.00249086044295072,0.00593830222637876,0.0157024751627456,1.40773113599532e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39746,0.0359644410658541,0.00828408357848577,0.019727637252022,0.0522012448796863,1.42493844332187e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39757,0.0326659457332047,0.00752954931802785,0.0179080290698701,0.0474238623965393,1.44464978055815e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,37430,0.0266609775598972,0.00614646974744269,0.0146138968549095,0.0387080582648848,1.45129424100377e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37470,0.0317974731648787,0.00733087631951395,0.0174289555786314,0.0461659907511261,1.45215656071654e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37696,0.0094679599558475,0.00218349083365288,0.00518831792188786,0.0137476019898071,1.46066696689354e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37756,0.00978270436437862,0.00225688527316767,0.00535920922896999,0.0142061994997873,1.47095425767859e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,40233,-0.013328689634638,0.0030752170792107,-0.019356115109891,-0.00730126415938508,1.47178302831291e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,40095,0.0126849121805513,0.00292752591448067,0.0069469613881692,0.0184228629729334,1.48021728597038e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40100,0.0294042725221127,0.00679308684822031,0.0160898222996009,0.0427187227446245,1.51020731172794e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,40100,0.0173886854753774,0.00402141016611199,0.00950672154979789,0.0252706494009569,1.54154343200483e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40186,0.010310541472675,0.00238562718526098,0.0056347121895635,0.0149863707557866,1.55611806454023e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37470,0.0342372323794468,0.00792847194637369,0.0186974273645544,0.0497770373943393,1.58425389518743e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40100,0.013569249560536,0.00314451010238817,0.00740600975985515,0.0197324893612168,1.60423421858777e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37430,0.016021467369739,0.00371622235125069,0.00873767156128766,0.0233052631781904,1.63551059081473e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,40174,0.0110347450466093,0.00256209636429272,0.00601303617259552,0.016056453920623,1.66547014205769e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,40010,0.0184020858432076,0.00427373659509372,0.0100255621168239,0.0267786095695913,1.67361132862265e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,40100,0.0294080339990336,0.00683972938444313,0.0160021644055251,0.0428139035925421,1.72149947073964e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37737,0.0384099326208458,0.00893597383955079,0.0208954238953263,0.0559244413463654,1.73301220444122e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40186,0.0100280960345299,0.00233510039613922,0.00545129925809706,0.0146048928109628,1.76134249354766e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,40095,-0.00698870788844917,0.00162851962788302,-0.0101806063590999,-0.00379680941779845,1.78578588330971e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39705,0.0207969338340882,0.0048486125025581,0.0112936533290743,0.0303002143391021,1.80376871212566e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37696,0.0193941275326438,0.00453333173192644,0.010508797338068,0.0282794577272196,1.89803204924718e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39531,0.0110646635752854,0.00258663350121589,0.00599486191290229,0.0161344652376686,1.90056492467683e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39810,0.0395871670321385,0.0092746924770238,0.0214087697771718,0.0577655642871051,1.98150021714043e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37403,0.00954005380024998,0.00223825887785458,0.005153066399655,0.013927041200845,2.03796951111211e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37737,0.0228274028294216,0.00536252803558851,0.0123168478796682,0.0333379577791751,2.08763764526661e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40233,0.0172275858710935,0.0040474408932989,0.00929460172022764,0.0251605700219593,2.08931162364061e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40100,0.043670542018757,0.0102622080335221,0.0235566142730538,0.0637844697644603,2.09822173644576e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,40248,0.0160977061599615,0.00378315305344,0.0086827261752191,0.0235126861447039,2.10156912630732e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37430,0.0331314039506369,0.00778818748517175,0.0178665564797002,0.0483962514215735,2.11402364030998e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39700,0.0191193908562659,0.00449630924931617,0.0103066247276062,0.0279321569849256,2.12902211812218e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37430,0.0107475760166097,0.0025280810799163,0.0057925370999738,0.0157026149332457,2.14040407691119e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37696,0.0347430271553045,0.00817414784071663,0.0187216973874999,0.0507643569231091,2.14893669397916e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40174,0.0218722005216234,0.00515257676419429,0.0117731500638026,0.0319712509794442,2.19940403185792e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37470,0.0147420093842134,0.00347551231101738,0.00793000525461939,0.0215540135138075,2.23386775872772e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37343,0.035374816277454,0.00834039255789545,0.0190276468639789,0.0517219856909291,2.23694867672838e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,37244,0.0252106092872635,0.00595893385420573,0.0135310989330203,0.0368901196415067,2.34562003522947e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37362,0.0219713076682309,0.0051936397100138,0.0117917738366038,0.0321508414998579,2.34858656421625e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40164,0.0120778641133078,0.00285629706452189,0.00647952186684489,0.0176762063597707,2.3658089507204e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37756,0.0443026828099781,0.0105017047848166,0.0237193414317377,0.0648860241882186,2.47432262564251e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37430,0.0216733716494397,0.0051422817282804,0.0115944994620102,0.0317522438368693,2.51760162147753e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37782,0.00788099870394069,0.00187416322742997,0.00420763877817795,0.0115543586297034,2.62698860042544e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37697,0.0192708771350037,0.00458839378981503,0.0102776253069662,0.0282641289630411,2.68758473307096e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37784,0.0320541678574877,0.0076338617800155,0.0170917987686573,0.047016536946318,2.6990228966166e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40100,0.0367576569796332,0.0087625947274832,0.0195829713137661,0.0539323426455002,2.74572292256465e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,40095,0.0185918052159794,0.00443853445391667,0.00989227768630277,0.0272913327456561,2.82062178389801e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39815,0.0239133138327226,0.00571594199449744,0.0127100675235076,0.0351165601419376,2.88500683326774e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39955,0.0391189134487746,0.00935443926856052,0.0207842124823959,0.0574536144151532,2.9072876016442e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,37430,0.0325048765357105,0.00777581836837717,0.0172642725336912,0.0477454805377297,2.93096463888017e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37403,0.0150158278849946,0.00359668753282424,0.00796632032065905,0.0220653354493301,3.00060331014974e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37696,0.0245259947779727,0.005875579470881,0.013009859015046,0.0360421305408995,3.00912095397481e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40081,0.0382971125582119,0.00917611829709311,0.0203119206959094,0.0562823044205144,3.01494424995944e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40121,0.0103454753484756,0.00248460053875299,0.00547565829251971,0.0152152924044314,3.1461538356637e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37756,0.0238076372470133,0.00572194435936017,0.0125926263026674,0.0350226481913593,3.19183520396297e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39746,0.0166508300877408,0.00400205748312218,0.00880679742082127,0.0244948627546602,3.191923783487e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,37403,0.0179915533745176,0.00432618046606958,0.00951223966102125,0.026470867088014,3.22039501634042e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,37470,0.0179848505625081,0.00432855258981007,0.00950088748648034,0.0264688136385358,3.27459997785688e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,37403,0.0120639773586164,0.00290824454362817,0.00636381805310519,0.0177641366641276,3.37239494327276e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37756,0.0199139100869842,0.00480415197566132,0.010497772214688,0.0293300479592804,3.41701369228239e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39746,0.0205429584769315,0.00495830692537875,0.0108246769031892,0.0302612400506739,3.44425188308379e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,40178,0.0116198346307923,0.0028071405626745,0.00611783912795027,0.0171218301336343,3.5005334133779e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,40133,0.00927329478174658,0.00224548454262275,0.00487214507820598,0.0136744444852872,3.65035560836476e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40065,0.00914242711953188,0.00221718923709706,0.00479673621482165,0.0134881180242421,3.75200811724003e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,40081,0.0139674079646389,0.00338759602821852,0.00732771974933065,0.0206070961799472,3.75733044679845e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37756,0.0273236958826242,0.00662804929829635,0.0143327192579634,0.0403146725072851,3.77164291593967e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_A,,37756,0.0112887898495878,0.00273900414992496,0.00592034171573491,0.0166572379834408,3.78704465717584e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,40095,0.0228973915782144,0.00555781008964067,0.0120040838025187,0.0337906993539101,3.81055693265179e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40097,0.0108864126547698,0.00264436695425649,0.00570345342442706,0.0160693718851125,3.86087714616746e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,40100,0.0222050599376267,0.00539494070903533,0.0116309761479175,0.032779143727336,3.87640790500101e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37756,0.0166556140340918,0.00404678019309781,0.0087239248556201,0.0245873032125635,3.88216632887334e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37376,0.0188538317846373,0.00458228739746358,0.00987254848560869,0.0278351150836659,3.90421357807956e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39941,0.0116419317671587,0.00283057427223529,0.00609400619357755,0.0171898573407399,3.92699378047534e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,40071,0.0118870186860098,0.00289185108400802,0.00621899056135405,0.0175550468106655,3.96781869440906e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RETN,Resistin,40046,0.0142071634272047,0.00345886577507461,0.00742778650805848,0.020986540346351,4.02070010781988e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37808,0.0223883223937344,0.00545577125825949,0.0116950107275458,0.033081634059923,4.09179803857018e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37808,0.010896027105947,0.00265563184661065,0.00569098868659018,0.0161010655253039,4.10268029786162e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40186,0.0357944394422282,0.00874728951276552,0.0186497519972078,0.0529391268872486,4.29688385809026e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39691,0.0226528726140807,0.00553688523720911,0.0118005775491509,0.0335051676790106,4.31230873460658e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37737,0.028642281576751,0.00700186448304936,0.0149186271899742,0.0423659359635278,4.32675566248001e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40059,0.016412384297427,0.00401586457434243,0.00854128973171583,0.0242834788631381,4.39387081421345e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39746,0.0138213974230539,0.00338253490169446,0.00719162901573274,0.020451165830375,4.40910409131441e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37362,0.00950385689858367,0.00232894753182204,0.00493911973621247,0.0140685940609549,4.51602793510077e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39998,0.0236817542619716,0.00580475083018465,0.0123044426348097,0.0350590658891336,4.53150360412344e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37791,0.0105145846514966,0.00257777875152304,0.00546213829851142,0.0155670310044817,4.55059558833407e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40065,0.0186736289527514,0.004578527464099,0.00969971512311735,0.0276475427823854,4.55476133418871e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37697,0.0266623257985906,0.0065433539835638,0.0138373519908055,0.0394872996063756,4.63386048762517e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37696,0.0221310278101916,0.00543756389956006,0.0114734025670539,0.0327886530533293,4.72807037707469e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39810,0.0299462441182249,0.00736659284169597,0.0155077221485008,0.044384766087949,4.82424022328575e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37515,0.0249312575443236,0.00613477705228694,0.0129070945218412,0.036955420566806,4.85372616384654e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37770,0.0114308715089065,0.00281461689403888,0.0059142223965903,0.0169475206212227,4.90894715367798e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37376,0.0183522268116826,0.00452347639861913,0.00948621307038908,0.0272182405529761,4.99763738016713e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40174,0.00900647036659988,0.00222047992730415,0.00465432970908374,0.013358611024116,5.01414234057055e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37696,0.0142972303136078,0.00352752101647321,0.00738328912132029,0.0212111715058953,5.08423239562084e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37696,0.0144005207904858,0.00355427088730712,0.00743414985136389,0.0213668917296078,5.11565369656623e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40158,0.0373726085830608,0.00923545108795213,0.0192711244506746,0.055474092715447,5.22052741497612e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37606,0.0362017236797759,0.00894869602299469,0.0186622794747063,0.0537411678848455,5.25154412171034e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37430,0.0189037203173757,0.00467413374128025,0.00974241818446646,0.028065022450285,5.27773322430001e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,37430,0.013962740617712,0.00345296574158999,0.0071949277641956,0.0207305534712283,5.29194296546518e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37696,0.0347282527143816,0.00858945641948323,0.0178929181321945,0.0515635872965687,5.30418453842808e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40297,0.0138458940311403,0.00342873769611047,0.00712556814676378,0.0205662199155168,5.41188109377925e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40251,0.0070841420077056,0.00175455883108887,0.00364520669877141,0.0105230773166398,5.42641650925113e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37697,0.0149946334530554,0.00371370628716244,0.007715769130217,0.0222734977758938,5.42941149296262e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37403,0.0205078358459788,0.00508443359760392,0.0105423459946751,0.0304733256972825,5.52779032740636e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40100,0.0310264884596291,0.00769502927426218,0.0159442310820752,0.046108745837183,5.55622870502969e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,40237,0.00732911617288849,0.0018178539492022,0.00376612243245218,0.0108921099133248,5.56252477496712e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,37151,-0.0149718963369909,0.00371673372623183,-0.0222566944404053,-0.00768709823357651,5.65230519200844e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37567,0.0111636129553366,0.00277226281755727,0.00572997783292431,0.0165972480777488,5.68362716104267e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37430,0.0344365882200389,0.00855408916242803,0.0176705734616799,0.0512026029783978,5.71177780547185e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40297,0.0105489369527745,0.00262215907205682,0.00540950517154312,0.0156883687340059,5.77290024321203e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37193,0.0117136350542368,0.0029161372811102,0.00599800598326081,0.0174292641252128,5.93242011555471e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,40126,0.0117304447202777,0.00292214767082233,0.00600303528546591,0.0174578541550894,5.98940601416933e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,40100,0.0277186328292268,0.00690643829225073,0.0141820137764153,0.0412552518820382,6.01167928644828e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40034,0.0125872969304527,0.00313836270987707,0.00643610601909367,0.0187384878418118,6.07996138339451e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37515,0.0124519506944023,0.00310645224520658,0.00636330429379736,0.0185405970950072,6.14670586539075e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39991,0.0204036292605843,0.00509173905318965,0.0104238207163326,0.030383437804836,6.17286474449736e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,37430,0.0173926100751195,0.0043556703124741,0.00885549626267032,0.0259297238875688,6.5575455410514e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37784,0.0239443290961952,0.00600255951528807,0.0121793124462305,0.0357093457461598,6.67013277422132e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,37430,0.0390150653279482,0.00978419935678733,0.019838034588645,0.0581920960672513,6.71226914987105e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37697,0.0117115960393016,0.0029376169531232,0.00595386681118014,0.0174693252674231,6.73390037735978e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37737,0.0332337882522664,0.0083453057213279,0.0168769890384637,0.049590587466069,6.86055653110473e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37515,0.022403299261091,0.00563096990682531,0.0113665982437134,0.0334400002784686,6.97005551637033e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37756,0.0220052356305176,0.00553618063428885,0.0111543215873115,0.0328561496737238,7.08091301243214e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39810,-0.0428331605448322,0.010780833547171,-0.0639635942972873,-0.0217027267923771,7.12719273604651e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37737,0.0132897955051455,0.00334682725569883,0.00673001408397581,0.0198495769263152,7.19898481409996e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,37403,0.00946686330498088,0.00238582959193916,0.00479063730478012,0.0141430893051816,7.28829469931014e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37362,0.0224679783036872,0.00566329302968046,0.0113679239655135,0.033568032641861,7.30845492809696e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40100,0.0305390260722746,0.00769848638350663,0.0154499927606016,0.0456280593839476,7.31419179196329e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37784,-0.0263315834573101,0.00664185897814323,-0.0393496270544708,-0.0133135398601494,7.39369080944507e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39942,0.0344370080977714,0.00869158033172032,0.0174015106475996,0.0514725055479433,7.46227747663366e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37366,0.0163084359787905,0.00411722309046929,0.00823867872147072,0.0243781932361103,7.50285644141701e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39667,0.0155652948516134,0.00393117152076704,0.00786019867091,0.0232703910323168,7.54629587950249e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40297,0.0103340590248742,0.00261088688232915,0.00521672073550904,0.0154513973142393,7.58891908638532e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39842,0.0177237847878428,0.0044850489818159,0.00893308878348362,0.026514480792202,7.79287341789081e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40065,0.0208387192638222,0.00528513602815003,0.0104798526486481,0.0311975858789962,8.08563310230926e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37697,0.0217330252311217,0.0055178132967164,0.0109181111695576,0.0325479392926859,8.23432878907981e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37430,0.0230434519701648,0.00585059448281431,0.0115762867838487,0.0345106171564808,8.23694821103755e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,40126,-0.0100751286962365,0.00255869748700453,-0.0150901757707654,-0.00506008162170762,8.26563957859087e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40065,0.00911284637251903,0.00232229440324389,0.004561149342161,0.0136645434028771,8.7438474011427e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37376,0.0203481516636195,0.0051871043648041,0.0101814271086035,0.0305148762186356,8.79659911827554e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39810,0.0109012607647246,0.00278005736490215,0.00545234832951638,0.0163501731999328,8.84787553441473e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37696,0.0287027330819621,0.00733285744146975,0.0143303324966814,0.0430751336672428,9.11346881457967e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37808,0.00838565863187117,0.00214501558035582,0.00418142809437375,0.0125898891693686,9.29944959942205e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39955,0.0311893087936258,0.0079807202145203,0.0155470971731661,0.0468315204140856,9.34271379990144e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40174,0.00842663452476876,0.00215805742022066,0.00419684198113626,0.0126564270684013,9.47241426645777e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37403,0.0126022680486497,0.00323433721946281,0.00626296709850261,0.0189415689987968,9.81247943088988e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,40095,0.0184226414636551,0.00473080931106572,0.00915025521396626,0.0276950277133439,9.89393350331823e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,40097,-0.056958285492689,0.0146435485655395,-0.0856596406811464,-0.0282569303042316,0.000100804002233019
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37403,0.0170577097260488,0.00439089412557182,0.00845155723992807,0.0256638622121696,0.00010292715242215
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37430,0.0172170114804661,0.00443414792548589,0.00852608154651376,0.0259079414144185,0.000103762384319261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37403,0.0183960161846835,0.00474179300885201,0.00910210188733354,0.0276899304820334,0.000105168527666293
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37515,0.0109293108182443,0.00281987707119076,0.00540235175871042,0.0164562698777782,0.000106789728327742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37430,0.0163243298807293,0.00421685683669087,0.00805929048081525,0.0245893692806434,0.000108827950242534
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,37376,0.0423506000470012,0.010940167489205,0.0209078717681594,0.063793328325843,0.000108873546222756
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37697,0.0125101735173324,0.00323797768904062,0.0061637372468128,0.018856609787852,0.000112271454447821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39834,0.0178275378140782,0.00461852705231026,0.00877522479155011,0.0268798508366063,0.000113848164775987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37697,0.0154117050650086,0.00399948422313871,0.0075727159876567,0.0232506941423604,0.0001170273637564
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40182,0.0334614093093079,0.00868924439794444,0.0164304902893368,0.050492328329279,0.000118150888138988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39746,0.0148201589488741,0.00385071401446869,0.00727275948051544,0.0223675584172327,0.00011923976670947
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40040,0.0244400690632094,0.00635657558401894,0.0119811809185323,0.0368989572078865,0.000121106414331238
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40065,-0.0283463897127875,0.00738168339909784,-0.0428144891750193,-0.0138782902505557,0.000123470775666813
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37730,0.0312276302074384,0.00813762432905503,0.0152778865224905,0.0471773738923862,0.000124900496150874
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39815,0.0365645021426303,0.00953291888769272,0.0178799811227525,0.055249023162508,0.000125756592626617
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,40196,0.0191473949297663,0.00499988250867131,0.00934762521277054,0.0289471646467621,0.0001288654611162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37362,0.0211148386026434,0.00551808699109691,0.0102993881000934,0.0319302891051933,0.000130602508506742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,40065,0.0294454158257236,0.00770836598275438,0.014337018499525,0.0445538131519222,0.00013400656005379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39746,0.0210176074143509,0.00550667446955176,0.0102245254540295,0.0318106893746724,0.000135753078328003
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39991,0.0120259761528919,0.00315195557799281,0.00584814322002602,0.0182038090857578,0.000136488204599782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,40274,0.0194798430393346,0.00510643545018209,0.00947122955697775,0.0294884565216915,0.000136831596510209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39815,0.00950595031686193,0.0024925827291296,0.00462048816776792,0.0143914124659559,0.000137439773797589
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,37372,0.0136684396026186,0.00358643648471929,0.00663902409256883,0.0206978551126684,0.000138964755996987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,37362,0.0126144046241512,0.00331118787387905,0.00612447639134827,0.0191043328569541,0.000139819459899252
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37756,0.0218988070057037,0.00574956448443924,0.0106296606162027,0.0331679533952046,0.000140283748254371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,37455,0.0118480783533815,0.0031111201681635,0.00575028282378101,0.0179458738829819,0.000140568766498266
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37756,0.0125193224061304,0.00328802110822107,0.00607480103401712,0.0189638437782437,0.000140977388424598
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39647,0.0271869998912789,0.00714289820029271,0.0131869194187052,0.0411870803638526,0.000141696077770903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40212,0.0136095045282895,0.00358146795223887,0.00658982734190127,0.0206291817146776,0.00014525227048835
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37376,0.0137795220161434,0.00362655978578017,0.00667146483601426,0.0208875791962725,0.000145587000725627
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,37403,0.0140968640322382,0.00371186691748538,0.00682160487396683,0.0213721231905095,0.000146663033363267
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39477,0.0118842527023256,0.00313041756898918,0.00574863426710685,0.0180198711375444,0.000147401859511809
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37782,-0.0199356289589122,0.00525322958226773,-0.0302319589401569,-0.00963929897766743,0.000148339678877596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39810,0.0186342571603946,0.00491179980936036,0.00900712953404832,0.0282613847867409,0.000148943947460012
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40297,0.0110787201350408,0.00292061479047604,0.00535431514570772,0.0168031251243738,0.000149220578749277
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37756,0.0149754654959689,0.00394955805633452,0.00723433170555324,0.0227165992863846,0.000150292082446304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40233,0.0304644950526251,0.00804936524584733,0.0146877391707643,0.0462412509344859,0.000154458524464481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,37430,0.00933566259813129,0.00246715475046775,0.0045000392872145,0.0141712859090481,0.000155034513301639
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37430,0.0245188243522013,0.00648054272893787,0.011816960603483,0.0372206881009195,0.000155362948825247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37697,0.0118793929578786,0.00315322496799696,0.00569907202060453,0.0180597138951526,0.000165685318734788
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37696,-0.0296207696026271,0.00786368090487572,-0.0450335841761835,-0.0142079550290707,0.000166081533623415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37697,0.00910408358647007,0.00241844631205303,0.00436392881484613,0.013844238358094,0.000167647269307776
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39691,0.0140797076716258,0.00374496833862506,0.00673956972792063,0.0214198456153309,0.000170798295237247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37756,0.0188525475731303,0.00501934920524385,0.00901462313085235,0.0286904720154083,0.000173404597308629
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,37376,0.0251571763452097,0.00670547728110535,0.0120144408742432,0.0382999118161762,0.000176382430202934
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,40100,0.0212636602410008,0.00566977467425107,0.0101509018794687,0.0323764186025329,0.000177221815474436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,40297,0.0276027886909666,0.00738080198162087,0.0131364168069897,0.0420691605749435,0.000184808846365965
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40262,0.0367381837432047,0.00982591040575198,0.0174793993479308,0.0559969681384785,0.000185472482381371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37403,0.0198818374641587,0.0053225378344782,0.00944966330858146,0.030314011619736,0.00018821710312695
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37756,0.0194088356132667,0.00520210519638217,0.00921270942835766,0.0296049617981758,0.000191546305825803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37784,0.0163426863261941,0.00438175725395609,0.00775444210844017,0.0249309305439481,0.000192494332563538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,37282,0.0177317048688213,0.00475495722384714,0.00841198871008093,0.0270514210275617,0.000192992977627779
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39815,0.0109779537363872,0.00294478804578798,0.00520616916664276,0.0167497383061317,0.000193754545636259
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40126,0.017972828610822,0.00482306023998776,0.00851963054044599,0.027426026681198,0.000194888033749752
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37470,0.0210528049382342,0.00564952216208087,0.00997974150055573,0.0321258683759128,0.000194997568816303
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37470,-0.00981409428184631,0.00263476873683825,-0.0149782410060493,-0.00464994755764334,0.000196263938802779
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39746,0.0289516531504286,0.00777448196987177,0.0137136684894799,0.0441896378113773,0.000196847049429839
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37403,0.0117269315436829,0.00315476400424182,0.00554359409536891,0.0179102689919969,0.000202280789821175
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40174,0.00758082963705622,0.00204177883029333,0.00357894312968129,0.0115827161444311,0.000205641857099396
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37697,0.0128067635332208,0.00344921208482733,0.00604630784695921,0.0195672192194824,0.000205694896632134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37791,0.0192701638549767,0.00520214639526072,0.00907395692026573,0.0294663707896878,0.000212854739508102
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37756,0.015058234884247,0.0040668586132614,0.00708719200225467,0.0230292777662394,0.000214204532896514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39727,0.0123108256766156,0.00332506780132193,0.00579369278602459,0.0188279585672065,0.000214296858335702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37430,0.0239198786985838,0.0064631495021092,0.0112521056744498,0.0365876517227178,0.000215670826430966
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37696,0.00819177793164663,0.00221523090099605,0.00384992536569437,0.0125336304975989,0.000218239389875795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37430,0.0115808855534094,0.0031390539480451,0.00542833981524101,0.0177334312915778,0.000225798304909113
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40133,0.00837218111213218,0.00227170916098059,0.00391963115661023,0.0128247310676541,0.000229103239388144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40186,0.0129474507204942,0.00351509457266301,0.00605786535807466,0.0198370360829137,0.000230927068786558
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39815,0.0150855535964282,0.00409787732245415,0.00705371404441803,0.0231173931484383,0.000232833772579277
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39991,0.0187870976628114,0.00511464782315275,0.00876238792943205,0.0288118073961908,0.000240340829681873
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40100,0.0309600903907255,0.0084295008743025,0.0144382686770926,0.0474819121043584,0.000240682101525252
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37697,0.00852806798989293,0.00232407234450986,0.0039728861946536,0.0130832497851323,0.000244026360295988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,40095,0.00728135664784735,0.00198581800422641,0.00338915335956359,0.0111735599361311,0.000246535085901053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39746,0.0188040363904052,0.00513398822723897,0.00874141946501678,0.0288666533157935,0.000250455160485603
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39471,0.0144952910089206,0.00395911312434817,0.00673542928519815,0.022255152732643,0.000251851772638964
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37403,0.0108033024202167,0.00295078231030422,0.00501976909202044,0.016586835748413,0.000252069538318737
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40053,0.00842407891854298,0.00230392572953992,0.00390838448864474,0.0129397733484412,0.000256620609041048
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37515,0.0266683392952189,0.00731727427698411,0.01232648171233,0.0410101968781077,0.000268874988656796
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40233,-0.0392149693072541,0.0107637321406527,-0.0603118843029333,-0.0181180543115749,0.00027007981770309
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,37470,0.0214218319778967,0.00589091369700999,0.00987564113175712,0.0329680228240363,0.00027752112319658
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40297,0.00893674917843239,0.00246213938086103,0.00411095599194478,0.01376254236492,0.000284679010765452
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37515,0.0154593686256778,0.00425899585908533,0.00711173674187053,0.023807000509485,0.000284707371295613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37644,0.0281852266424645,0.00776713378470838,0.012961644424436,0.0434088088604929,0.000285838704176041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,40248,0.00498239045072303,0.00137410059214747,0.00228915329011399,0.00767562761133207,0.000288830715563753
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37403,0.0136117761892824,0.00375739803652658,0.00624727603769029,0.0209762763408745,0.000292703937514175
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40100,0.0205346895493704,0.00567064945357171,0.00942021662036988,0.031649162478371,0.000294139471698818
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39991,0.0174403777364985,0.00482219250437305,0.00798888042792736,0.0268918750450697,0.000299338796813348
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37784,0.0102822523208491,0.00284359446405303,0.00470880717130519,0.0158556974703931,0.000300369672077502
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39810,0.00690935103508448,0.00191229237602125,0.00316125797808284,0.0106574440920861,0.000303494851324999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37696,0.0154626709489965,0.00428015065999469,0.00707357565540696,0.0238517662425861,0.00030420959997924
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,40178,0.0103504301210883,0.00286654647256161,0.00473199903486755,0.0159688612073091,0.00030624289784527
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40143,-0.0143318901087581,0.00397098672437117,-0.0221150240885256,-0.00654875612899062,0.000308156936560898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40297,0.00680733098747525,0.00189424912406642,0.00309460270430507,0.0105200592706454,0.000327025097938501
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39815,0.0141971390709821,0.00395210959328984,0.00645100426813403,0.0219432738738302,0.00032880363040673
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,40233,0.0181185729651793,0.00505968642877045,0.0082015875647892,0.0280355583655694,0.00034335272470923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40248,0.0106414992179177,0.00297270548582274,0.00481499646570513,0.0164680019701303,0.000344973341811751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37376,0.0158746615548759,0.0044380376331517,0.00717610779389858,0.0245732153158532,0.000348890093383089
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40233,0.008381626129309,0.00234589682318858,0.00378366835585939,0.0129795839027586,0.000354117978193926
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37696,0.0167338592513776,0.00468704194830965,0.00754725703269068,0.0259204614700645,0.000357918749178751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37362,0.0208065760020704,0.00583095047589045,0.00937791306932513,0.0322352389348157,0.000360608607192116
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37697,0.0351879814351431,0.00986258071345353,0.0158573232367741,0.054518639633512,0.000361225309367665
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39746,0.0221330722200415,0.00620668577804733,0.00996796809506871,0.0342981763450143,0.000363570842831047
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37403,0.0121081583881268,0.00340397609535208,0.00543636524123674,0.0187799515350169,0.000376363168885076
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,40065,0.0204778306044072,0.00575788780956605,0.00919237049765772,0.0317632907111566,0.000376965202561591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37756,0.0200652582797413,0.00564246040313242,0.00900603588960175,0.0311244806698808,0.000377681400040043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37756,0.0129722728308308,0.00364861850856517,0.00582098055404308,0.0201235651076186,0.000378724234122366
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37470,0.0084180127638463,0.00236844176311251,0.00377586690814579,0.0130601586195468,0.000380414529364773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37362,0.0121324779624701,0.0034208137342078,0.00542768304342284,0.0188372728815174,0.000391523904428598
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37282,0.0198834246715589,0.00560705634346027,0.00889359423837675,0.030873255104741,0.000392306876599955
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37470,0.0200350042512569,0.00565688207578733,0.00894751538271377,0.0311224931198001,0.000398940472726905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,40233,0.00773353216990945,0.00218446129260598,0.00345198803640174,0.0120150763034172,0.00040090377681219
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37362,0.0200556671593083,0.00566483736851231,0.00895258591702417,0.0311587484015924,0.000400960416949992
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37430,0.0122935682466925,0.00347931221623578,0.00547411630287034,0.0191130201905146,0.000411781740926043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39698,0.0200998414265147,0.00569682659523817,0.00893406129984789,0.0312656215531815,0.000419544101843364
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39746,0.0140692464622402,0.00398894637710738,0.00625091156310975,0.0218875813613707,0.00042143516385099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,37470,0.0113150651808888,0.00320944152429895,0.00502455979326284,0.0176055705685147,0.000424047454357959
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37655,0.0211540410529764,0.00601154897981178,0.00937140505254536,0.0329366770534075,0.000434797667346176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37737,0.00975540459433219,0.00277334323918567,0.00431965184552829,0.0151911573431361,0.000436986164787282
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40186,0.025690493686483,0.00730510267173252,0.0113724924498873,0.0400084949230788,0.000438033627573354
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39494,0.00931728060408171,0.00264995868906136,0.00412336157352144,0.014511199634642,0.000439374530134859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40095,0.0129315801348617,0.00367997279148839,0.00571883346354448,0.020144326806179,0.000442589152781404
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39815,0.0177459188447503,0.00506309942263555,0.00782224397638462,0.027669593713116,0.000457991060503863
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39810,0.00614772211778522,0.001754807081225,0.00270830023858422,0.00958714399698623,0.000460733836775177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37808,0.00558899835497707,0.00159744450172305,0.00245800713159989,0.00871998957835424,0.00046903304038211
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37763,0.0141456203000198,0.00405453466889989,0.00619873234897602,0.0220925082510636,0.000486690464994697
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37515,0.02209767134657,0.00634318422400035,0.00966503026752937,0.0345303124256107,0.000496176496138273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37575,0.0318192070804999,0.00915143373406956,0.0138823969617235,0.0497560171992762,0.000508767152620713
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37343,0.0180357550534932,0.00519025311615309,0.00786285894583317,0.0282086511611533,0.000512670966530249
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39700,0.0202756326701202,0.00583787864022746,0.00883339053527443,0.0317178748049661,0.000515879057768505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39727,0.0195090926901896,0.00563132397969002,0.00847169768999715,0.030546487690382,0.000532896716519205
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,40100,0.0292605095594921,0.00845084676795212,0.0126968498943059,0.0458241692246782,0.000536741168432372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37618,0.00786540991788232,0.00227198809720302,0.0034123132473644,0.0123185065884002,0.000538066572017854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37430,-0.00756144081884578,0.00218448242708129,-0.0118430263759251,-0.00327985526176646,0.000539036267945964
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37403,0.0113639634380087,0.00328604914555811,0.00492330711271482,0.0178046197633026,0.000545454259551832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37764,0.0132934454025454,0.00384427152015763,0.00575867322303639,0.0208282175820543,0.000545926817205392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37430,0.011297670015693,0.00327457300514273,0.00487950692561327,0.0177158331057728,0.000562119120443605
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39727,0.0130874800367967,0.00379897910127305,0.00564148099830153,0.0205334790752919,0.000572595153673098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40248,0.0170320642601861,0.00495118013337621,0.00732775119876871,0.0267363773216035,0.000583215178323517
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37697,0.0115094068155148,0.00334780605775828,0.00494770694230854,0.018071106688721,0.000588056888416048
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37700,0.0276714618060497,0.00805369148177409,0.0118862265017725,0.0434566971103269,0.000592459340449396
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40174,0.0240918321671496,0.00701311686313239,0.0103461231154101,0.0378375412188891,0.000593529305753741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,39014,0.0115359246092921,0.00336026505512822,0.00494980510124077,0.0181220441173434,0.000598514196484819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,40100,-0.00940168892879431,0.00274951239411079,-0.0147907332212515,-0.00401264463633715,0.000629189387400935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39815,0.0143199801576235,0.00419051847104385,0.00610656395437758,0.0225333963608695,0.000634249492470631
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,37470,0.0145298796646716,0.00425572965092464,0.00618864954885934,0.0228711097804839,0.000641664366409408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,40174,-0.0106305938448004,0.00311480094513001,-0.0167356036972552,-0.00452558399234554,0.000644307312533479
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,37407,0.0119028553202815,0.00348960715624087,0.00506322529404939,0.0187424853465136,0.000649359785698473
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39727,0.0131341541321749,0.00385309343321173,0.00558209100307987,0.0206862172612698,0.00065434664457236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39991,0.0167224192698034,0.00490639492624658,0.00710588521436007,0.0263389533252467,0.000655371374974064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40100,0.0174511456232717,0.00513208788530476,0.00739225336807437,0.027510037878469,0.000674557278332522
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39955,0.0228468744185588,0.006720465711896,0.00967476162324261,0.0360189872138749,0.000676552811138354
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39746,0.0115833949107701,0.00340759679665254,0.00490450518933107,0.018262284632209,0.000677345946321395
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39746,0.0150183601598126,0.00442578217970444,0.00634382708759193,0.0236928932320334,0.000692109389671408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37586,0.0159611260505567,0.00470583772082617,0.00673768411773736,0.025184567983376,0.000696471094016811
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40095,0.00752017247103439,0.00221804610834578,0.00317280209867666,0.0118675428433921,0.000699506908221149
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,40106,0.00880999546074573,0.00260893031400864,0.00369649204528879,0.0139234988762027,0.000734964711873794
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37737,0.0184909947001237,0.00547576908514536,0.00775848729323884,0.0292235021070086,0.000735242812502438
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,40174,0.0199779731146061,0.00592972442071985,0.00835571324999522,0.031600232979217,0.000755888338845241
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,37403,0.00902992141843707,0.00268034442089645,0.00377644635348003,0.0142833964833941,0.000756777231232987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,40248,0.00708893227208445,0.00210743047884903,0.00295836853354036,0.0112194960106285,0.000770655951477633
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37784,0.0230137540895423,0.00685324862906626,0.0095813867765724,0.0364461214025122,0.000787057183987525
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37808,0.00525973565004593,0.00156932110337833,0.00218386628742441,0.00833560501266745,0.000805690881413587
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39746,0.0251608377957299,0.00751012001638179,0.0104410025636216,0.0398806730278382,0.000809316796282892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40243,0.00934726770097366,0.00279086572271579,0.0038771708844507,0.0148173645174966,0.000812243840979179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37756,0.0085123009034918,0.00254697309005895,0.00352023364697626,0.0135043681600073,0.000833689185301613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,40126,0.0105954883479301,0.00317987927875205,0.00436292496157611,0.0168280517342841,0.000864109272264946
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39746,0.0128872812694108,0.00386823552433205,0.00530553964171997,0.0204690228971016,0.000865634672609221
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39991,0.0292029897275053,0.00876843650334551,0.0120168541809481,0.0463891252740625,0.000869023072895701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40297,0.0170024999772867,0.0051095477764203,0.00698778633550293,0.0270172136190705,0.000877988898408146
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39810,0.00923572858822922,0.0027758311121379,0.00379509960843893,0.0146763575680195,0.000879312390953438
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,40153,0.0110194969331883,0.00331269024682708,0.0045266240494072,0.0175123698169694,0.000881617724639745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40065,0.0159284456763488,0.00479115285317518,0.00653778608412541,0.0253191052685721,0.00088764046947942
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39718,0.015747000695949,0.0047385730621592,0.00645939749411702,0.0250346038977811,0.00089215536798123
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40274,0.00973282586070061,0.00292991605251069,0.00399019039777966,0.0154754613236216,0.000896160978516991
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37515,0.0206194250680515,0.00621435381804073,0.00843929158469167,0.0327995585514113,0.000909017973135789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40297,0.00722071078954062,0.00217725625150069,0.00295328853659926,0.011488133042482,0.000913814968325075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39700,0.00998172121850541,0.00301327494150376,0.00407570233315804,0.0158877401038528,0.000926539799932325
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37470,0.02170855462215,0.0065674301873615,0.00883639145492148,0.0345807177893786,0.000950678711889318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37716,0.0106951051451998,0.0032356688904033,0.00435319412000938,0.0170370161703903,0.000951004188410141
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,40095,0.0117235182951541,0.0035494658896655,0.00476656515140969,0.0186804714388984,0.000959063704431978
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37343,0.0224333161322429,0.00679480147281481,0.00911550524552591,0.03575112701896,0.000964166372756281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37470,0.0287556796087178,0.00871234011974692,0.0116794929740138,0.0458318662434217,0.00096748432561613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40174,0.0219765937109911,0.00666066215897057,0.00892169587940881,0.0350314915425734,0.000970861298196029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37756,0.0248962469299188,0.00754606392598068,0.0101059616349966,0.0396865322248409,0.000972030052866125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,37362,0.0167226022229034,0.00507381582241065,0.00677792321097852,0.0266672812348283,0.000983844605286908
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40164,0.00918477121863398,0.00278898491546608,0.00371836078432046,0.0146511816529475,0.000992619193119406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37515,-0.00975552180774393,0.00296409921504332,-0.0155651562692288,-0.00394588734625903,0.00100016071637439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37403,0.0254434430200438,0.00773154383845602,0.01028961709667,0.0405972689434176,0.00100147961455341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40126,0.0239447528043184,0.00727836635971375,0.00967915473927943,0.0382103508693573,0.00100461010107258
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37515,0.0183005827489506,0.00557723281659215,0.00736920642843001,0.0292319590694712,0.00103600144844095
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40297,0.00806869422520826,0.00245942527381877,0.00324822068852347,0.012889167761893,0.00103764855636382
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37791,-0.0063393192042565,0.00193452582666945,-0.0101309898245286,-0.00254764858398437,0.00105207933704396
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39746,0.0144948883143011,0.00442375232077759,0.00582433376557699,0.0231654428630251,0.00105297325219448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37515,0.0146952370617872,0.00448570638083092,0.00590325255535854,0.0234872215682158,0.00105557750265415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37756,0.0168583214734675,0.0051564848334945,0.00675161119981826,0.0269650317471167,0.0010807106223936
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,40248,0.0166637479352525,0.00509825131918813,0.00667117534964377,0.0266563205208612,0.00108341711963398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,40213,0.00854663118911419,0.00261815633651152,0.00341504476955162,0.0136782176086768,0.00109941639052626
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39955,0.0202441712804953,0.00620839979187169,0.00807570768842675,0.0324126348725638,0.00111349478542082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39727,0.0306771584146915,0.00940943510990516,0.0122346655992774,0.0491196512301056,0.00111555772179906
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37784,0.0201585355270816,0.00620165973504888,0.0080032824463858,0.0323137886077774,0.00115485440655819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37470,0.0104783749569736,0.00322999805956644,0.00414757876022338,0.0168091711537238,0.00118127505734118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,37362,0.018248669204218,0.0056259074989852,0.00722189050620701,0.029275447902229,0.00118294340343672
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,37376,0.0120561217277156,0.00372294397802698,0.00475915153078273,0.0193530919246485,0.00120535080345399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37737,0.020567202308731,0.00636242354857708,0.00809685215351989,0.033037552463942,0.00122966295231623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37808,0.0202452989106919,0.00627340402489003,0.00794942702190747,0.0325411707994764,0.00125325611744555
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39815,0.0140643060018425,0.00435909481437554,0.00552048016566642,0.0226081318380186,0.00125608264826516
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39727,0.00745338622203161,0.00231027303146276,0.00292525108036461,0.0119815213636986,0.00125713024315236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,39093,0.0130513142070881,0.00404566717795722,0.00512180653829195,0.0209808218758843,0.00125810014658842
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37362,-0.0151292546388311,0.00469820156004224,-0.0243377296965139,-0.00592077958114828,0.00128408160874372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39700,-0.0167997236386597,0.00521833898568862,-0.0270276680506094,-0.00657177922671004,0.00128745009132011
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37696,0.0182736006574598,0.00569997754942395,0.00710164466058887,0.0294455566543307,0.00134956814922263
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,37470,-0.0112009311787068,0.0034938739827982,-0.0180489241849913,-0.00435293817242237,0.00134976525055073
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39727,0.00999351197506422,0.00312931427466162,0.00386005599672745,0.016126967953401,0.00140837151935939
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,40100,0.0142359206411738,0.0044587307959949,0.00549680828102375,0.0229750330013238,0.00141169951277578
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37756,0.0126535709852792,0.00396427156316293,0.00488359872147986,0.0204235432490785,0.00141667291285408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37403,0.0288029043111453,0.00902383167380277,0.0111161942304919,0.0464896143917987,0.0014169214866698
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37737,0.0363575505688207,0.0113912204523713,0.0140307584821729,0.0586843426554685,0.0014175908841311
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,37403,-0.0123949385264111,0.00388909309203314,-0.0200175609867961,-0.00477231606602617,0.0014404711467165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39810,0.0158346811936737,0.00497173952894984,0.00609007171693199,0.0255792906704153,0.00145074338688576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37697,0.0119374455008134,0.00374846517103086,0.00459045376559291,0.0192844372360339,0.00145278718263743
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37782,0.0160849668723211,0.00505264935485632,0.00618177413680273,0.0259881596078395,0.00145854646378138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,40065,0.0113266292389266,0.00356780438088577,0.00433373265239054,0.0183195258254627,0.00150294239923306
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,37403,0.00786980030944472,0.00247989259088267,0.00300921083131469,0.0127303897875748,0.00150994109293042
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40186,0.00548657857603792,0.00172925149020487,0.00209724565523637,0.00887591149683946,0.00151263907193178
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37515,0.00977545241781741,0.00308285094418402,0.00373306456721674,0.0158178402684181,0.00152311760760048
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39991,0.0108416735581159,0.00342093561545531,0.00413663975182345,0.0175467073644083,0.00153148665478507
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40297,0.0190604384661335,0.0060148148841695,0.00727140129316127,0.0308494756391057,0.00153299810781252
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37403,0.00937399856114678,0.00296064818110906,0.00357112812617304,0.0151768689961205,0.00154803613102054
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40020,0.0118797157372493,0.00375312304327055,0.004523594572439,0.0192358369020596,0.00155227883816203
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',37362,0.011456345968574,0.0036258935061751,0.00434959469647082,0.0185630972406772,0.00158354524923585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39727,0.0176217619798272,0.00557997510316452,0.0066850107776247,0.0285585131820296,0.00159145167665525
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40174,0.0071934019430057,0.00228115921913914,0.00272232987349298,0.0116644740125184,0.00161685423628538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,37343,0.0118239912673545,0.00376153533327374,0.00445138201413796,0.019196600520571,0.0016737905283223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37696,0.0289647291390705,0.00924521200615424,0.0108441136070082,0.0470853446711328,0.00173439959213542
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,40095,-0.0126663545275798,0.00404966805926494,-0.0206037039237391,-0.00472900513142051,0.0017647233699462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37756,0.0153018262863049,0.00489655465452217,0.00570457916344144,0.0248990734091683,0.00178175923199988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37737,0.0189258710737724,0.00606214702848674,0.00704406289793838,0.0308076792496064,0.00180027720119188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39727,0.0373048036122823,0.0119536211553848,0.0138757061477282,0.0607339010768364,0.00180699536970608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39955,0.0132835021166451,0.00425990877249687,0.00493408092255123,0.021632923310739,0.0018225542640896
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37756,0.0180985596592353,0.00580682121975246,0.00671719006852044,0.0294799292499501,0.00183229983848299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37696,0.0113175689560242,0.00364420582884718,0.00417492553148369,0.0184602123805647,0.00190272567432296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37515,0.0200786665486235,0.00646913061079354,0.00739917055146821,0.0327581625457789,0.0019148262478812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40100,0.00637844043623665,0.00205514909948264,0.00235034820125068,0.0104065326712226,0.00191497330298485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37515,0.0120999528249698,0.00390235882932749,0.00445132951948797,0.0197485761304517,0.00193489925274498
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39746,0.0133052190364199,0.00429211193432619,0.00489267964514056,0.0217177584276992,0.00193922086262905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37737,0.0248633439794008,0.00803558240858017,0.00911360245858361,0.0406130855002179,0.00197783645715871
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37696,0.0101736021152169,0.00329806113488834,0.00370940229083574,0.016637801939598,0.00204162066158082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,40095,-0.00923540239618776,0.00300697750687541,-0.0151290783096636,-0.00334172648271195,0.00213477426652928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,40177,0.0290374679535168,0.00946182746224235,0.0104922861275218,0.0475826497795119,0.00215209212298606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37696,-0.00773119248131483,0.00252560907538553,-0.0126813862690705,-0.00278099869355919,0.00220952268806214
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,40186,0.0108935633553007,0.00356272293849187,0.0039106263958566,0.0178765003147447,0.00223453652672426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37791,0.0111485082324278,0.0036578965967892,0.00397903090272102,0.0183179855621347,0.00230980467118531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39810,0.00772766183326294,0.00253768792608333,0.00275379349813963,0.0127015301683863,0.00232951709759474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37782,-0.00616556911183305,0.00202497785694444,-0.0101345257114442,-0.00219661251222194,0.00233321306276247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39991,0.00872645158227045,0.00286750201973854,0.00310614762358292,0.014346755540958,0.00234448835652912
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37784,0.0120849293453067,0.00397642728920691,0.00429113185846113,0.0198787268321522,0.00237712247010922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,40095,0.0103691382786385,0.00341554104589438,0.00367467782868555,0.0170635987285915,0.002402372803606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37362,0.0126416338189785,0.00416831181601256,0.00447174265959386,0.0208115249783631,0.00242781530832467
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40186,0.00696337469599754,0.00229886964526695,0.00245759019127432,0.0114691592007208,0.00245727728629955
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39746,0.0131337419262819,0.00433699931232476,0.00463322327412534,0.0216342605784384,0.0024634245741471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39821,-0.0188225114022147,0.00622554695902505,-0.0310245834419038,-0.00662043936252561,0.00250338187263017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37282,0.0139767745023865,0.00462849358801572,0.00490492706987565,0.0230486219348973,0.00253502472468202
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,37362,0.0101752803896871,0.00337571801454338,0.00355887308118204,0.0167916876981921,0.00258109979424997
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37696,0.0194010315860045,0.00644260102785521,0.00677353357140828,0.0320285296006007,0.00260565410915691
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37696,0.0077272964938834,0.00257453298935518,0.00268121183474724,0.0127733811530196,0.00269210053246253
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39957,0.00718280252950304,0.00239436460742797,0.00248984789894423,0.0118757571600619,0.00270516498847282
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37756,0.0232677536894282,0.00776341037565999,0.00805146935313461,0.0384840380257218,0.00273060015344101
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,40100,0.016514105095255,0.00551891289156645,0.00569703582778479,0.0273311743627253,0.0027733852851544
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37737,0.01487137922137,0.00497256525376798,0.00512515132398473,0.0246176071187552,0.00278862274184858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37697,0.0109008343631399,0.00364556702369457,0.00375552299669858,0.0180461457295813,0.00279342366286946
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37362,0.00939818119831055,0.00314334924844617,0.00323721667135606,0.015559145725265,0.00279629361744348
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37697,0.0125902122086526,0.00421649002265409,0.00432589176425061,0.0208545326530546,0.00283219291915595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,40297,0.012481724601884,0.00418784152718506,0.0042735552086013,0.0206898939951667,0.00288245894373841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,37441,0.0090463214346947,0.00303542424230557,0.00309688991977578,0.0149957529496136,0.00288546989123356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37362,0.0169650639977097,0.00569483897655592,0.00580317960366008,0.0281269483917593,0.00289705652584275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_DRA,,40047,0.00901004624866181,0.00302599261892617,0.00307910071556652,0.0149409917817571,0.00291008199899393
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37362,0.0138878275002314,0.00466651112210362,0.00474146570090829,0.0230341892995545,0.00292516720483005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37362,0.0128190267420025,0.00430954529105058,0.00437231797154339,0.0212657355124617,0.00293946128993309
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,40143,0.00832753293730865,0.00280142452702894,0.00283674086433193,0.0138183250102854,0.00295730996721646
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,37362,-0.00921597873172682,0.00310706939685235,-0.0153058347495574,-0.00312612271389622,0.0030212290926934
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37362,0.0165601827926323,0.00558640704975199,0.00561082497511841,0.0275095406101462,0.00303856520202765
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37791,0.0149865023436998,0.00505850897644301,0.00507182474987148,0.0249011799375281,0.00305558799805827
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40297,0.00566112613950344,0.0019193651413086,0.00189917046253859,0.0094230818164683,0.00318775906292211
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40233,0.00734268196602784,0.00249146762690669,0.00245940541729074,0.0122259585147649,0.00321206321894706
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40297,0.0095826171016005,0.00326780559727322,0.00317771813094498,0.015987516072256,0.00336799963367264
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39584,0.0190526117728262,0.00650745615404884,0.0062979977108905,0.031807225834762,0.00341864285435911
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37784,0.0257336223043036,0.00879473493805867,0.00849594182570857,0.0429713027828986,0.00343901568805711
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40065,0.0102623647997128,0.00352084840272542,0.00336150193037095,0.0171632276690546,0.00356488326497248
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37784,0.00643009699078196,0.00220898908567208,0.00210047838286468,0.0107597155986992,0.00361011800967239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,37403,0.0152040552005259,0.0052301682704585,0.00495292539042727,0.0254551850106246,0.00365541934518042
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37403,0.00499817195521617,0.00172045055576034,0.00162608886592589,0.00837025504450644,0.0036769486082789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39991,0.00713153162219903,0.00245529593027719,0.00231915159885573,0.0119439116455423,0.00368298847588462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40065,0.0086692673663064,0.00298522210181452,0.00281823204674994,0.0145203026858629,0.00368872572956863
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39815,0.0108482206543257,0.0037422926367746,0.0035133270862475,0.0181831142224039,0.00375103793845886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,40233,0.0159585371200259,0.00550748263893215,0.00516387114771886,0.0267532030923329,0.00376535008206937
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40095,0.00727734358817574,0.00251172004171568,0.00235437230641301,0.0122003148699385,0.00376846203264385
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,37403,0.00636553411823134,0.00220025796942904,0.00205302849815042,0.0106780397383123,0.00382113446929663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40174,0.0108484954470903,0.00375741287511711,0.00348396621186076,0.0182130246823198,0.00389186176231546
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,40164,0.0114580528853392,0.00397560191798133,0.00366587312609582,0.0192502326445827,0.00395578873196993
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,40297,0.0097126536361378,0.00337034124300339,0.00310678479985115,0.0163185224724244,0.00395940106978469
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37756,0.0160894975893898,0.00559178921555866,0.00512959072689484,0.0270494044518848,0.00401676900275585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39727,0.0126947018510854,0.00441650129665643,0.00403835930963877,0.021351044392532,0.00405380654083266
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37784,0.0176642213590554,0.00614874937519595,0.00561267258367134,0.0297157701344395,0.00407473995050516
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,40065,0.0452127153006116,0.0157491941094372,0.0143442948461148,0.0760811357551085,0.00409990723208011
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37706,0.0137873436958821,0.00480460969451476,0.00437030869463314,0.023204378697131,0.00411631544430757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37791,0.0198174788462624,0.00691145325365674,0.00627103046909521,0.0333639272234296,0.00414587970324374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37737,0.0170777035345583,0.00596025261140539,0.00539560841620374,0.0287597986529129,0.00417314024413815
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,40233,0.00851033265818717,0.00297041386175648,0.00268832148914446,0.0143323438272299,0.00417516779466067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37784,0.012885985200728,0.00449874370298282,0.00406844754288165,0.0217035228585743,0.00418515987289305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39621,0.0213138826359153,0.00744651625704203,0.00671871077211294,0.0359090544997177,0.00421204400632358
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,37430,0.0121506773179464,0.00424996279309979,0.00382075024347082,0.020480604392422,0.00425645288730208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37362,-0.0101924487557984,0.00356691600101429,-0.0171836041177864,-0.00320129339381043,0.00427680442702332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39746,0.0116510323527599,0.00408194029784269,0.00365042936898825,0.0196516353365316,0.0043191405732456
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,40133,0.00430912860482603,0.00150979045332579,0.00134993931630749,0.00726831789334457,0.00432122881389087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37403,0.0190289698404274,0.00667168664464009,0.00595246401693284,0.032105475663922,0.00434868052112459
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37403,0.0209032915454199,0.0073335138332853,0.00652960443218066,0.0352769786586591,0.00437361676004829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40100,0.0133318964063253,0.0046847327046675,0.004149820305177,0.0225139725074736,0.00443550748080178
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39815,0.00915214906030046,0.00323025151396185,0.00282085609293524,0.0154834420276657,0.00461356118010161
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37696,-0.024575257929788,0.00868969789581485,-0.0416070658055851,-0.00754345005399086,0.00468967588714717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37430,0.011867067129668,0.0041981205051876,0.00363875093950033,0.0200953833198357,0.00470938827481316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,37501,0.00531639539566397,0.00188108827516418,0.00162946237634219,0.00900332841498575,0.00471704492003239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39727,0.0083380382418457,0.00295879429804239,0.00253880141768262,0.0141372750660088,0.00483779569765494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37430,0.00672354892879336,0.00239218703197807,0.00203486234611635,0.0114122355114704,0.00495189143628222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40174,0.00665925899826958,0.00237181138773212,0.00201050867831462,0.0113080093182245,0.00499631053361472
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37362,0.0209350257282883,0.00747368184046221,0.00628660932098242,0.0355834421355943,0.00509940189162092
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39746,0.00977272982854946,0.00349181616599304,0.0029287701432031,0.0166166895138958,0.00513646310853742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37730,0.0196622987413984,0.00702789013866748,0.00588763406961011,0.0334369634131866,0.00515335961458112
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36990,0.0114730049382646,0.00410276323212862,0.00343158900329248,0.0195144208732367,0.00517525941938483
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37756,-0.00858083285586598,0.00307079621632479,-0.0145995934398626,-0.0025620722718694,0.00520810141700098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNST,Consortin,40126,0.0251977999736219,0.00903212254068922,0.00749483979387106,0.0429007601533728,0.00528045670096125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37697,0.0112898297973171,0.00404820218756949,0.00335535350968086,0.0192243060849532,0.00529710002775059
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39810,0.011487714951307,0.00412384826064244,0.00340497236044783,0.0195704575421662,0.00534813109130761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39815,0.0340165405292332,0.012220082969474,0.0100651779090643,0.0579679031494022,0.00538152425362652
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37515,0.0127489097873037,0.00458487017260527,0.00376256424899733,0.02173525532561,0.00543282067979432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37430,0.0143833424737643,0.00517845198218019,0.00423357658869115,0.0245331083588375,0.00548512023928155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37362,-0.00825894149619706,0.00297446672880821,-0.0140888962846612,-0.00242898670773297,0.00550077814399749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40099,0.00411367456067564,0.00148274151887598,0.00120750118367872,0.00701984793767255,0.00553741917932644
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37697,0.025055973161532,0.00904387624642508,0.00732997571853879,0.0427819706045251,0.00560499329859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,37376,0.0152518196404933,0.00550625324079118,0.00445956328854262,0.0260440759924441,0.00561519992017255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37430,0.00544026223678914,0.00196514825192836,0.00158857166300956,0.00929195281056873,0.00564169395083415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,40074,0.0203580015327148,0.0073700986247786,0.00591260822814875,0.0348033948372809,0.00574728758837886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40069,0.0145499844461533,0.00529703222567814,0.00416780128382419,0.0249321676084825,0.0060245437838742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40100,0.0195973865606159,0.00713754241462893,0.00560780342794319,0.0335869696932886,0.00604551247747663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37282,0.0209663693370779,0.00764281277557577,0.00598645629694943,0.0359462823772064,0.00609133960812519
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,40072,-0.0122707915141721,0.00447446888206207,-0.0210407505230138,-0.00350083250533045,0.0061061155746313
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37376,0.0138990583787912,0.00507361694892444,0.0039547691588993,0.0238433475986831,0.00616213620276651
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,37430,-0.0156520959868935,0.00571514282776855,-0.0268537759293198,-0.00445041604446712,0.00617656593022541
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39810,0.0112158788830936,0.00409927688309735,0.00318129619222279,0.0192504615739644,0.00622505993499638
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39727,0.0154509433342061,0.0056522398366498,0.00437255325437248,0.0265293334140397,0.00627188833330805
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,37343,0.0104245243516431,0.00381465833299306,0.00294779401897668,0.0179012546843095,0.00628927442954194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40065,0.0103005234194811,0.00377659492584113,0.00289839736483248,0.0177026494741297,0.00638947056515856
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37560,0.0143217833556496,0.00525563740444481,0.00402073404293772,0.0246228326683614,0.006438043809067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39691,0.0109064046028351,0.00400396697132653,0.00305862933903511,0.0187541798666351,0.00645896016523128
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37697,0.0132857458378859,0.00490135869126084,0.00367908280301462,0.0228924088727571,0.00672430274294261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39727,0.00808062629517035,0.00298273723329823,0.00223446131790581,0.0139267912724349,0.00675348759921523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,40164,0.0113762926638638,0.0042019394516771,0.00314049133857671,0.0196120939891509,0.00678876821262591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37376,0.0162998620210304,0.006031948067497,0.0044772438087363,0.0281224802333246,0.00689608383974717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37645,0.00655590087112611,0.00242753146544979,0.00179793919884453,0.0113138625434077,0.00692934790180373
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,40248,0.0092625576401285,0.00343029951624319,0.00253917058829185,0.0159859446919652,0.00693678080062414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37697,0.00923131152715599,0.00342561091931215,0.00251711412530417,0.0159455089290078,0.00705212701234582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40114,0.00963735531497372,0.00357768631542184,0.00262509013674691,0.0166496204932005,0.00707306077053114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39991,0.00512094676459966,0.00190143946156753,0.0013941254199273,0.00884776810927201,0.00708468497124721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37791,0.0117694119253192,0.00437356890617819,0.00319721686920997,0.0203416069814285,0.00713202355543588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40297,0.00743295815170433,0.00276535400009129,0.0020128643115254,0.0128530519918833,0.00719809227792049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37737,0.0213339310479752,0.00795108160917586,0.00574981109399054,0.0369180510019599,0.00730229563722332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37737,0.0107362386146674,0.00400333423506707,0.00288970351393592,0.0185827737153988,0.00733124400186972
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37403,0.00793443876704474,0.0029630652220556,0.00212683093181577,0.0137420466022737,0.00742052000881963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37403,0.00758212826373652,0.00283459731525153,0.00202631752584352,0.0131379390016295,0.00748561693524774
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37430,0.016383361337705,0.00612951779292774,0.00436950646356667,0.0283972162118434,0.00753009884384066
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37403,0.00978210616995078,0.00366058069027371,0.00260736801701431,0.0169568443228872,0.00754314850936434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37515,0.00963159815886592,0.00362254166115687,0.00253141650299845,0.0167317798147334,0.00785160921811099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39727,0.0189535488129871,0.00712916503119257,0.00498038535184969,0.0329267122741246,0.00785494433411669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37661,0.00693760908517451,0.0026171937393589,0.00180790935603106,0.012067308814318,0.00804015109527996
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39815,0.0132480628585431,0.00500012301113265,0.00344782175672313,0.0230483039603631,0.00806821686934571
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,40205,-0.00942593538134984,0.00355774944005362,-0.0163991242838549,-0.00245274647884474,0.00807130254236582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37403,0.00992338528314005,0.00374834086301813,0.00257663719162452,0.0172701333746556,0.00812097810685004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39746,0.0167422658647492,0.00632557059444092,0.00434414749964505,0.0291403842298534,0.00813503031980898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,37470,-0.0200198054735124,0.00757359746480974,-0.0348640565045395,-0.00517555444248528,0.00821840930008485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39622,0.0147586506483005,0.0055866169841643,0.00380888135933848,0.0257084199372625,0.00825545644745099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40065,-0.0121614059262031,0.00460852091331466,-0.0211941069162998,-0.00312870493610633,0.00832591497624773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,40095,0.00537506954485391,0.00203808474369207,0.00138042344721744,0.00936971564249037,0.00836480528005897
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40174,0.00606122335688637,0.00229910515286113,0.00155497725727854,0.0105674694564942,0.00838880013153722
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39810,0.00992658445380684,0.00376837571714232,0.0025405680482079,0.0173126008594058,0.00844250480467311
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,37470,0.0114152178486,0.00433395887648735,0.00292065845068474,0.0199097772465152,0.00845099744529093
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40164,0.00913550775948421,0.00347590899647554,0.00232272612639215,0.0159482893925763,0.00859125087334694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40100,0.0134533599629068,0.0051314654934709,0.00339568759570378,0.0235110323301097,0.00875672264446123
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37782,-0.0117990450649199,0.0045132118664924,-0.020644940323245,-0.00295314980659477,0.00895020385828074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37470,0.00912632666548768,0.00350930039471266,0.00224809789185086,0.0160045554391245,0.00931629792127745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39955,0.00746156011220506,0.00288118051626125,0.001814446300333,0.0131086739240771,0.00961332474800464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39746,0.0133413762849454,0.00515639602936475,0.00323484006739048,0.0234479125025003,0.00968100267992582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37756,0.0247394224754381,0.00956251049948777,0.00599690189644209,0.0434819430544341,0.00968851854815952
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39746,0.00674261770477395,0.00260843775656708,0.00163007970190247,0.0118551557076454,0.00974917029858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39815,0.0110592534465451,0.00429819638230746,0.00263478853722244,0.0194837183558677,0.0100914567653527
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,40144,0.00836592936742978,0.00325947404778225,0.00197736023377658,0.014754498501083,0.0102778061713643
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,37430,0.018180750086228,0.00709398102977636,0.00427654726786635,0.0320849529045897,0.0103931128443074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40135,0.0122410383048234,0.00478204395749443,0.00286823214813437,0.0216138444615125,0.0104827688587841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,37362,0.017205026476556,0.00673189991369624,0.00401050264571134,0.0303995503074006,0.0106073950558549
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,37403,0.00895069538013975,0.0035024479340845,0.00208589742933413,0.0158154933309454,0.0106132060280028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,37430,0.00609170747866405,0.00238579558286204,0.00141554813625445,0.0107678668210736,0.010681373750274
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37362,0.0190528933210253,0.00746926437239745,0.00441313515112633,0.0336926514909243,0.0107578209235129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,40100,0.0146826193911727,0.00576195703519373,0.00338918360219304,0.0259760551801525,0.0108375058511888
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39810,0.0252936759009495,0.00993585099305871,0.00581940795455439,0.0447679438473445,0.0109156353275386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39727,0.00876095806265558,0.00344364821677492,0.00201140755777674,0.0155105085675344,0.0109659818906987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39995,0.0124412787477524,0.00489158558585087,0.00285377099948467,0.0220287864960201,0.0109874218526688
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37430,0.0203232835233533,0.00799191202007633,0.00465913596400373,0.0359874310827029,0.0110026163434191
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39975,-0.00489356323702993,0.00193318345659673,-0.00868260281195952,-0.00110452366210034,0.0113722381041537
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37343,0.0123350978090625,0.00488376490078152,0.00276291860353075,0.0219072770145943,0.0115575212636323
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,40100,0.0065169544442734,0.00258074548131882,0.00145869330088852,0.0115752155876583,0.0115723268001049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37696,0.0174146547446904,0.00689835226507434,0.00389388430514468,0.0309354251842361,0.0115990109926723
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37808,0.00370533072993008,0.00146854817525915,0.000826976306422141,0.00658368515343801,0.0116432119843349
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,40248,0.00959512324804831,0.00380477844056739,0.00213775750453622,0.0170524889915604,0.0116833243465019
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40274,0.00697893073730425,0.00276757477511423,0.00155448417808036,0.0124033772965281,0.0116894129511552
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39991,0.00706973451785271,0.00280884045379499,0.00156440722841454,0.0125750618072909,0.0118472619028128
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39570,-0.00850862568845395,0.00338169435929538,-0.0151367466326729,-0.00188050474423499,0.0118769750264571
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39761,0.010085059044274,0.00400934755344561,0.0022267378395206,0.0179433802490274,0.0119003462552565
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37362,0.0246788008640244,0.0098289217399357,0.00541411425375039,0.0439434874742983,0.0120567166686703
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37737,0.0501526204927444,0.0199798752838766,0.0109920649363463,0.0893131760491424,0.0120795435961945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40248,0.0113351125944313,0.00452943994414444,0.0024574103039082,0.0202128148849544,0.0123405297910589
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37782,0.0189815446999283,0.00759431457140865,0.00409668813996735,0.0338664012598892,0.0124508531570727
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40100,0.00946776250116743,0.0037913949566159,0.00203662838620027,0.0168988966161346,0.0125290417592821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40097,0.0152653760127405,0.00612229401163151,0.0032656797499427,0.0272650722755382,0.0126625912815834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37782,0.0109662728637457,0.00442039439803794,0.00230229984359131,0.0196302458839,0.0131197144812058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39815,0.0179234251677432,0.00723188805731764,0.00374892457540068,0.0320979257600858,0.0132084088937141
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39746,0.00731287528038504,0.00295076404479449,0.00152937775258785,0.0130963728081822,0.013211757937135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37791,-0.00957696622217849,0.00387266683786358,-0.0171673932243911,-0.00198653921996587,0.0134121262423663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37791,-0.0153773967321651,0.00622787611293524,-0.0275840339135181,-0.00317075955081201,0.0135568703033529
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40171,0.0050137733168272,0.00203335924287654,0.00102838920078918,0.00899915743286522,0.0136829377562562
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37667,0.00527203449780659,0.00213816369743476,0.00108123365083447,0.00946283534477872,0.0136878275352492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37362,0.00945237764368887,0.00383689070882196,0.00193207185439783,0.0169726834329799,0.0137697592592058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39815,0.0131882299486414,0.00537108096619481,0.00266091125489959,0.0237155486423833,0.0140832208634111
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37282,0.012254007271267,0.00499899563974035,0.00245597581737592,0.0220520387251581,0.0142476119630253
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,37403,0.0182665603923381,0.00745203858368382,0.00366056476831783,0.0328725560163584,0.014250546595026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37515,0.0132651844771354,0.00541527090012584,0.00265125351288876,0.0238791154413821,0.0143149979585387
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39991,0.00726720144366277,0.00296787662360353,0.00145016326139985,0.0130842396259257,0.0143514461673424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37403,0.00839086749070557,0.00344146984419692,0.0016455865960796,0.0151361483853315,0.0147754301640817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37696,0.00555082260619846,0.00228405978024616,0.00107406543691599,0.0100275797754809,0.0151018528297437
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,40297,0.00616275534135767,0.00254367976171503,0.00117714300839622,0.0111483676743191,0.0154137378604952
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,37376,0.00552261827747715,0.00228309707373666,0.0010477480129533,0.00999748854200101,0.0155805881641218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37376,0.0210526914054407,0.00872635032457874,0.00394904476926634,0.038156338041615,0.0158555227928357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37343,-0.0125022291888911,0.00518726239537954,-0.022669263483835,-0.0023351948939472,0.0159586218390023
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37362,0.0204538397470264,0.00849512657495465,0.00380339166011533,0.0371042878339376,0.0160666630022059
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37282,0.0180417562784235,0.0074996185270355,0.00334250396543389,0.032741008591413,0.0161560206023177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,37403,0.0236282417929487,0.00989015539024568,0.00424353722806721,0.0430129463578303,0.0169054558479955
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37697,0.00714040845106923,0.00299122498946501,0.00127760747171781,0.0130032094304206,0.0169949605705546
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,37362,0.00864110467183349,0.00362133627929119,0.00154328556442275,0.0157389237792442,0.0170394479058039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40169,0.0102145932494961,0.00428095811222249,0.00182391534954001,0.0186052711494522,0.0170420585961581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40248,0.00506999136887804,0.00212489076502453,0.000905205469429971,0.00923477726832612,0.0170444146600757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37403,0.0117058606608957,0.00491494415416759,0.00207257011872725,0.0213391512030642,0.0172478754147291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37697,0.0102661363236638,0.00431694483595204,0.00180492444519778,0.0187273482021298,0.0174160993726226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39922,0.0117872699332437,0.00495897006295138,0.00206768860985904,0.0215068512566285,0.017468104392981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37282,0.00828479236713157,0.00348661208584577,0.00145103267887385,0.0151185520553893,0.0175078661488082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37403,0.00626428001227438,0.00263882200599034,0.00109218888053332,0.0114363711440154,0.017616166188057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,40107,0.00550561732248489,0.00232246503059112,0.000953585862526308,0.0100576487824435,0.0177716583548912
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40297,-0.00685437759935573,0.0028968726082561,-0.0125322479115377,-0.00117650728717376,0.0179870866238592
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39727,0.0111484133345934,0.00471561968775837,0.00190579874658694,0.0203910279225998,0.0180841288065369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37697,0.0104850667833703,0.00443905309766404,0.0017845227119488,0.0191856108547918,0.0181907671474516
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37430,0.0114584361992973,0.0048572085840726,0.00193830737451501,0.0209785650240796,0.0183361295444992
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37697,0.010411704424708,0.00442733539223743,0.00173412705592267,0.0190892817934934,0.0187030876825298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38272,-0.00617567146615057,0.00262632437903676,-0.0113232672490626,-0.00102807568323853,0.0187143456210704
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37791,0.00507953589959275,0.00216319265592021,0.00083967829398914,0.00931939350519635,0.0188806234013804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39815,0.0131318845303953,0.00559338248051957,0.00216885486857691,0.0240949141922136,0.0188996205187247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,40095,0.0178046463452963,0.00759999741002071,0.00290865142165569,0.0327006412689369,0.0191563408584097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37784,-0.0116570794222259,0.0049906477822444,-0.0214387490754249,-0.0018754097690269,0.0195172049065998
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37756,0.00865374119210573,0.00371597015729891,0.00137043968379986,0.0159370427004116,0.0198847075733798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37376,-0.00580713822691915,0.00249653251795742,-0.0107003419621157,-0.000913934491722604,0.0200295876587809
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37784,0.00566998236738543,0.00243766826460782,0.000892152568754094,0.0104478121660168,0.0200342128489171
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,37362,0.00998129186814769,0.0042935544490557,0.00156592514799852,0.0183966585882969,0.0201026150749982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40126,0.0167500900683704,0.00720802363078014,0.00262236375204135,0.0308778163846995,0.0201483060428369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37376,0.0163619943835674,0.0070520660917118,0.00253994484381231,0.0301840439233226,0.0203471593561875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37403,-0.00425531754479044,0.00183778701953455,-0.00785738010307815,-0.000653254986502725,0.0206034593805794
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,37362,-0.0082181587716933,0.00355207799889307,-0.0151802316495237,-0.00125608589386289,0.0207042027752398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,40168,0.00781832687854145,0.00337964720813695,0.00119421835059303,0.0144424354064899,0.0207159200436586
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37344,0.0079306805131407,0.00342868039269792,0.00121046694345278,0.0146508940828286,0.0207360104566091
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40186,0.0050856220416149,0.00220624051339415,0.000761390635362364,0.00940985344786745,0.0211734899412607
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,37430,0.00578570740353612,0.00251080969279096,0.000864520405665842,0.0107068944014064,0.0212204355115597
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,37376,0.00939803895550782,0.00408258814508217,0.00139616619114676,0.0173999117198689,0.0213520835003949
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37533,0.0339890433367102,0.0147805119187298,0.00501923997599977,0.0629588466974206,0.0214874166595612
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39746,0.0163139301529411,0.00709462564938731,0.00240846388014198,0.0302193964257403,0.0214912616286745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37343,0.0119204044169023,0.00518895532763775,0.00175005197473231,0.0220907568590723,0.0216196147509397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37784,0.0058869976775891,0.00256262986215261,0.000864243147769984,0.0109097522074082,0.0216200151691322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37515,0.00669875210101769,0.00291825966580686,0.000978963156036247,0.0124185410459991,0.021722470537545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,37376,0.00447814232137567,0.00196104555760541,0.000634493028469072,0.00832179161428227,0.0224142406943114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,40100,0.0110325636242529,0.00483940390047155,0.00154733197932862,0.0205177952691771,0.0226367429313628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37697,0.018162886500598,0.00797489292495009,0.00253209636769583,0.0337936766335002,0.022771742895681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37782,0.0275017630266116,0.0121015467439196,0.00378273140852923,0.0512207946446939,0.0230672030375562
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,37343,0.0166023595855928,0.00730953120334904,0.00227567842702872,0.030929040744157,0.0231434037583979
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40138,0.0126783391038542,0.00558402314238251,0.00173365374478451,0.0236230244629239,0.0231927765518654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39746,0.0102071308637286,0.00450235389323607,0.00138251723298591,0.0190317444944713,0.0234001270363468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37791,0.00735404994159435,0.00324718609857938,0.000989565188378762,0.0137185346948099,0.0235442799935358
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37737,0.00551385537550923,0.00243759830582007,0.000736162696101883,0.0102915480549166,0.023713288254104
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,40297,0.0106460809023034,0.00471381826149682,0.00140699710976961,0.0198851646948371,0.023929070034943
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39800,0.0080888599211543,0.0035856101373277,0.00106106405199201,0.0151166557903166,0.0240894784707161
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39834,0.00798593850665691,0.00354972693184614,0.00102847372023848,0.0149434032930753,0.0244799654391983
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,40118,0.0347302164696828,0.0154617371292927,0.00442521169626907,0.0650352212430966,0.0247048162584768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39727,0.00917141232163666,0.00408377906686731,0.00116720535057673,0.0171756192926966,0.0247300955207035
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37515,0.00782412059930915,0.00348383360339141,0.000995806736661992,0.0146524344619563,0.0247311301311335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37784,0.012032067204443,0.00536494949719347,0.00151676618994381,0.0225473682189422,0.0249313887136798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37282,0.0108769741863312,0.00487035445008618,0.00133107946416225,0.0204228689085001,0.0255461835972288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,40090,0.0191828190267326,0.00861059167127475,0.00230605935103414,0.0360595787024311,0.0259069170351186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37697,-0.00752461820322399,0.0033849044314047,-0.0141590308887772,-0.000890205517670788,0.0262330977430946
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39810,0.00812885636539768,0.00366071158676892,0.000953861655330605,0.0153038510754648,0.0263948195616558
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37362,0.0131118224431507,0.00590533680325255,0.00153736230877571,0.0246862825775257,0.0264133725145129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37430,0.0061057731979824,0.00275007855836111,0.00071561922359463,0.0114959271723702,0.0264211981743433
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37515,-0.00574569613582386,0.00259867084485287,-0.0108390909917355,-0.00065230127991224,0.0270521628820528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37376,0.0160761723747137,0.0072751510802581,0.00181687625740779,0.0303354684920195,0.0271408663949161
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40100,0.00670372873403404,0.00304085330627369,0.000743656253737602,0.0126638012143305,0.0274998264031813
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,40055,0.0162265330076689,0.00736643217675974,0.00178832594121982,0.030664740074118,0.0276257482220771
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,37403,0.00907374493137422,0.00412052496387701,0.000997516002175276,0.0171499738605732,0.0276768881151413
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37559,0.00820289568847067,0.00374109060338067,0.00087035810584456,0.0155354332710968,0.0283502481687751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39727,0.00911527272206434,0.0041641187686603,0.000953599935490147,0.0172769455086385,0.0286116302825958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,37282,0.0131609573500052,0.00601552635032329,0.00137052570337158,0.0249513889966389,0.0286998642072415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,40073,0.0122575172383505,0.00560805627965859,0.00126572693021967,0.0232493075464813,0.0288525052233489
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,37430,0.00531040356858306,0.00243272706395516,0.000542258523230949,0.0100785486139352,0.0290609218603904
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39810,0.0111739411876929,0.00512291988581756,0.00113301821149052,0.0212148641638953,0.0291862197832281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37403,0.0124983879128648,0.00573053906361795,0.00126653134817362,0.023730244477556,0.0292002828763921
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39727,0.0110636742550246,0.00508882320029673,0.00108958078244297,0.0210377677276062,0.0297119863858139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37430,-0.00939300026510727,0.00432276645996547,-0.0178656225266396,-0.000920378003574951,0.0298048114791189
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,37403,0.0102497153676307,0.00471791135011855,0.00100260912139837,0.0194968216138631,0.0298351981117049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,37430,-0.00768948532159546,0.00354516548629416,-0.014638009674732,-0.000740960968458902,0.0301003227887964
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39727,0.00701399899419091,0.00323455980020828,0.000674261785782672,0.0133537362025991,0.0301394300674074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37376,-0.00714216972892405,0.00329973070846979,-0.0136096419175248,-0.000674697540323264,0.0304465097280475
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,40100,0.0114240864580063,0.00527842159116351,0.00107838013932584,0.0217697927766868,0.0304564285374285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37362,-0.00860091130695335,0.00397455259319987,-0.0163910343896251,-0.000810788224281609,0.0304830236763637
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,40095,0.00605761281380243,0.00280134071317517,0.000566985015979091,0.0115482406116258,0.0306026393541652
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40174,0.0124076673299842,0.00575344814688894,0.00113090896208186,0.0236844256978865,0.0310549258491777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37697,0.0059992516101684,0.00279313615274241,0.00052470475079327,0.0114737984695435,0.0317433566148464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40095,-0.00949987692092747,0.00442454703116875,-0.0181719891020182,-0.000827764739836711,0.0318018680574987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37784,0.00596099007351573,0.00278909130053079,0.000494371124475384,0.0114276090225561,0.032595667469434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37697,0.00790945739683999,0.00370499323873272,0.000647670648923873,0.0151712441447561,0.0327948161894068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40297,0.012044934324011,0.00565048220186709,0.000969989208351512,0.0231198794396705,0.0330497483704716
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,40097,0.00516338179892702,0.0024228634129377,0.000414569509569127,0.00991219408828492,0.033095851354486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,37362,-0.00844023771729347,0.00396267084671206,-0.0162070725768491,-0.000673402857737827,0.0331957041851628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37737,-0.0153622714265035,0.00721790331760077,-0.029509361929001,-0.00121518092400597,0.0333258877358558
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37697,0.0193942456732976,0.00911235558985355,0.0015340287171846,0.0372544626294105,0.033326812129247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37480,-0.0117542161383259,0.00552698686981296,-0.0225871104031593,-0.000921321873492484,0.0334641615262288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37515,0.0124366653329052,0.00585033227308151,0.000970014077665435,0.0239033165881449,0.033538208117722
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,37362,0.0197870427262138,0.0093098678845008,0.00153970167259221,0.0380343837798354,0.0335735313915608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37260,0.00451620387185554,0.00212594651989921,0.000349348692853089,0.00868305905085799,0.0336619793371097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37362,0.00693370727543625,0.00329227787713535,0.000480842636250959,0.0133865719146215,0.0352191202672015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,40065,0.0144139746368002,0.00684508925704653,0.000997599692989033,0.0278303495806114,0.0352429144830897
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37430,0.00643351171282921,0.00305525381897702,0.000445214227634244,0.0124218091980242,0.0352477656293901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37697,0.00711529388071982,0.00338362938725244,0.000483380281705037,0.0137472074797346,0.035496957778294
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,40065,0.00337453532356567,0.00160548217109966,0.000227790268210344,0.006521280378921,0.0355795234663186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37282,0.0250798158357593,0.0119334146094908,0.00169032320115729,0.0484693084703613,0.0356037246492106
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37343,-0.00809977788972967,0.00386108492241229,-0.0156675043376578,-0.000532051441801595,0.0359423741248627
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37515,0.0117340355618533,0.00559482576150531,0.000768177069302932,0.0226998940544038,0.0359860796193894
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37696,-0.0187474960240048,0.00894404369055985,-0.0362778216575021,-0.00121717039050751,0.0360933795790448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37403,0.0154219756608024,0.00735835666255012,0.000999596602204169,0.0298443547194006,0.036115296013056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37376,0.00550761067940654,0.00263242867574042,0.000348050474955322,0.0106671708838578,0.0364386145237619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,40274,0.00856592437819893,0.00410270036151268,0.000524631669634089,0.0166072170867638,0.0368250902417533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39675,0.0199802526783174,0.0095760775304877,0.0012111407185615,0.0387493646380733,0.0369521581468963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,40297,-0.0125052592639721,0.00599929231318259,-0.02426387219781,-0.000746646330134207,0.0371347079684843
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37343,0.0134712332442536,0.00646572509428577,0.000798412059453479,0.0261440544290537,0.0372268022621612
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40186,-0.00479688265998065,0.00230271299815192,-0.00931020013635841,-0.000283565183602888,0.0372542093261538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37515,0.00919817662275588,0.00442506068890818,0.000525057672495844,0.0178712955730159,0.0376684983776031
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37282,-0.00527681977051387,0.00253875458284195,-0.0102527787528841,-0.000300860788143654,0.0376824912484372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37737,0.0062384378270108,0.00301470118686389,0.000329623500757572,0.012147252153264,0.0385336043271455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,40100,0.010237237569405,0.00496172895031527,0.00051224882678712,0.019962226312023,0.0391062892811659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37362,0.0116174692947848,0.00563221557777327,0.000578326762349174,0.0226566118272204,0.0391628135019271
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40194,0.0126775891237288,0.00615954347465106,0.000604883913412761,0.0247502943340449,0.0395871011698634
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37791,0.00566722655823584,0.00275494669371906,0.000267531038546485,0.0110669220779252,0.039695108891056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39815,0.0080002101455429,0.00389335729012313,0.000369229856901559,0.0156311904341842,0.0399117350548077
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37782,0.00441581168951026,0.00215072449900564,0.000200391671459204,0.00863123170756133,0.0400751737704271
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,37362,-0.00807601037213919,0.00394547345824995,-0.0158091383503091,-0.00034288239396929,0.040687590612155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37403,0.00970727525358682,0.00474263670632754,0.00041170730918485,0.0190028431979888,0.0406969043116313
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39746,0.00531271367820836,0.00259940471398828,0.000217880438791336,0.0104075469176254,0.0409884899748044
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37697,-0.00849989941953699,0.00415940190074068,-0.0166523271449887,-0.000347471694085244,0.0410188674895429
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40100,0.0145831982557746,0.00714290616396305,0.000583102174407013,0.0285832943371421,0.0412046107096048
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37756,0.00474752273087571,0.00232533522073895,0.000189865698227368,0.00930517976352405,0.0412058567734017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40095,0.00636041252361963,0.00311920143762159,0.000246777705881312,0.0124740473413579,0.0414552574801795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39575,0.0060561418301052,0.00298043987987956,0.000214479665541263,0.0118978039946691,0.0421749036135839
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,40159,0.0254042421028837,0.0125182064062669,0.000868557546600646,0.0499399266591668,0.0424360665238275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,37343,0.00996783739787513,0.00491545705432301,0.000333541571402026,0.0196021332243482,0.0425955078791573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37756,0.00362328154286085,0.0017874603104381,0.000119859334402173,0.00712670375131953,0.0426766210900359
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39746,0.0215312754298267,0.0106439362495475,0.000669160380713504,0.0423933904789399,0.0431041483377005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37808,0.00349647702366484,0.00172934396145733,0.000106962859208463,0.00688599118812121,0.0432115742751115
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37696,0.00988335675156351,0.00489926444996123,0.000280798429639495,0.0194859150734875,0.0436828471574301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37697,0.0062147244387928,0.00308532740481601,0.00016748272535342,0.0122619661522322,0.0439999417992622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37756,0.0063420128734817,0.00315256549239512,0.000162984508387267,0.0125210412385761,0.044271799735986
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,37343,0.0194401968847186,0.00966381555391875,0.00049911839903781,0.0383812753703993,0.0442778076799699
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,40160,0.0145458530143793,0.00723519204705353,0.000364876602154408,0.0287268294266043,0.0444026721860243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39815,-0.00736692147511463,0.00366768283536599,-0.014555579832432,-0.000178263117797278,0.0445966397879762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,40058,0.00524309523301332,0.00261535440900319,0.000117000591367064,0.0103691898746596,0.0450085149257022
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,37403,0.0127152393171399,0.00639222379333665,0.000186480682200025,0.0252439979520797,0.0467031069667018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37697,0.00648610634131885,0.00326295718153084,9.07102655183893e-05,0.0128815024171193,0.0468543667094136
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40233,0.00362602014886769,0.00182629272942043,4.64863992036399e-05,0.00720555389853174,0.047111265691596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40126,0.0120588524189738,0.00607589474210376,0.000150098724450451,0.0239676061134972,0.0471948227637432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39810,0.00909884018911328,0.00458633226205134,0.000109628955492654,0.0180880514227339,0.0472843830438786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37696,0.0213604095941789,0.0108031878885218,0.000186161332676155,0.0425346578556817,0.048036106972408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40100,-0.00910806831529746,0.00462630347630872,-0.0181756231288626,-4.05135017323768e-05,0.0489985991807759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39967,0.00513080601780223,0.00262153728287263,-7.40705662812761e-06,0.0102690190922326,0.0503448564154535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37697,-0.0132748101800361,0.00678378791163996,-0.0265710344868504,2.14141267782398e-05,0.0503868681921951
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,37403,0.0169868084514526,0.00868523389289872,-3.62499786288571e-05,0.0340098668815341,0.0505070934915825
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37714,0.00626931451286704,0.00320575842058158,-1.39719914728567e-05,0.0125526010172069,0.0505283564853138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,37376,0.0100098513918212,0.00512536059207474,-3.58553686452667e-05,0.0200555581522877,0.0508406344307592
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,37475,-0.00516821310728815,0.00264759111104241,-0.0103574916849313,2.10654703549779e-05,0.0509544368620545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37696,0.0112851240526613,0.00578709531959994,-5.75827737546199e-05,0.0226278308790772,0.0511912537915355
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37362,-0.00546593685557718,0.00281930864690787,-0.0109917818035166,5.99080923622481e-05,0.0525534572686369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37782,0.0105293350715674,0.00543106681882667,-0.000115555893332885,0.0211742260364677,0.0525561364146415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,37470,-0.00520714211912464,0.00268915846965341,-0.0104778927196453,6.36084813960425e-05,0.0528469155297447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37282,-0.00428036496504316,0.0022120295459713,-0.0086159428751469,5.52129450605877e-05,0.0530073763790493
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39718,-0.0144347379562409,0.00746265919661894,-0.029061549981614,0.000192074069132199,0.0530993820113327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37376,0.00631604350870293,0.0032717785247029,-9.66423997147622e-05,0.0127287294171206,0.0535714932144443
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37808,0.00479691722348197,0.00248669125916693,-7.69976444852131e-05,0.00967083209144915,0.0537475422359586
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39746,0.00536310539154193,0.00278482457845531,-9.51507822304788e-05,0.0108213615653143,0.0541438204623372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40094,0.00315651514563888,0.00164055526994939,-5.89731834619287e-05,0.00637200347473969,0.0543660739751658
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,36008,0.0168255043642063,0.00874827116633113,-0.000321107121802697,0.0339721158502153,0.0544675798414465
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,37403,0.00677225629366418,0.00352289871918263,-0.000132625195933766,0.0136771377832621,0.0545832162491486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,40100,-0.00687858055635251,0.00357949674180075,-0.013894394170282,0.000137233057576965,0.0546665239214989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,40100,-0.0125591715935136,0.00654129750293385,-0.025380114699264,0.000261771512236731,0.0548783678034386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39815,0.00905060837833976,0.00471864566893353,-0.000197937132769962,0.0182991538894495,0.0551229175390981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37343,-0.0104143612484135,0.0054332987049249,-0.0210636267100663,0.000234904213239278,0.0552897723136812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37756,0.00684442420950373,0.00357750131666952,-0.00016747837116852,0.013856326790176,0.0557457305148528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCT,Secretin,37376,0.007388775188709,0.00386279621214708,-0.000182305387099272,0.0149598557645173,0.0557951215100531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37730,0.00504252654872154,0.00264400310562099,-0.000139719538295601,0.0102247726357387,0.0565219382484741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37362,0.00782451890576609,0.00411034249471896,-0.000231752383883075,0.0158807901954152,0.0569822647396162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39967,0.00725021980339326,0.00381203405761161,-0.000221366949525499,0.014721806556312,0.0571988820384218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39815,0.00704968366828644,0.00371981213743952,-0.000241148121095018,0.0143405154576679,0.0580883779783209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37403,0.0102383296224472,0.00540786272321776,-0.000361081315059571,0.020837740559954,0.0583495191292208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,37362,0.00757267763633553,0.00400040552800007,-0.000268117198544605,0.0154134724712157,0.058383207027318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,37343,0.0145222974581251,0.00769849885261618,-0.000566760293002585,0.0296113552092528,0.0592661663985427
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37515,0.00469415193198048,0.00248893071698845,-0.000184152273316876,0.00957245613727783,0.0593155713794179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39815,0.0120942927645275,0.00642478294562803,-0.000498281808903472,0.0246868673379584,0.0597946670017859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,37376,0.00824036424525845,0.00437933400446063,-0.000343130403484394,0.0168238588940013,0.0599063049102193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39727,0.00979093302567905,0.0052086601095756,-0.000418040789089125,0.0199999068404472,0.0601623746771883
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37756,0.00665761296579121,0.00354602441223811,-0.000292594882195477,0.0136078208137779,0.0604733063633568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,37376,0.00672918551768362,0.00358417393072969,-0.000295795386546562,0.0137541664219138,0.0604759609644362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37784,0.00513427721926166,0.00273532222881365,-0.000226954349213094,0.0104955087877364,0.0605360357511817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,40028,0.0133426672211481,0.00710940305994742,-0.000591762776348892,0.027277097218645,0.0605692121966165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40095,0.00373025355329806,0.00198990329368467,-0.000169956902323893,0.00763046400892001,0.0608677183883768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37576,0.00127674453810993,0.000681262615400022,-5.85301880741136e-05,0.00261201926429397,0.0609408104705858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37343,0.00897758729404307,0.00479865096802982,-0.000427768603295376,0.0183829431913815,0.0613876129118887
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,37343,0.00734819459758797,0.00394182937589231,-0.00037779097916095,0.0150741801743369,0.062322167497032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,37403,0.00466944950171341,0.00250547510604679,-0.000241281706138291,0.00958018070956511,0.0623867082964592
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,37343,0.00776072410405367,0.00417142173645392,-0.000415262499396008,0.0159367107075033,0.0628445550241121
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37430,-0.0056074400069977,0.00302026073979264,-0.0115271510569913,0.000312271042995867,0.0633896008258622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37282,0.00643968573470812,0.00347890887226309,-0.000378975654927533,0.0132583471243438,0.0641831986206241
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40095,0.00488197472832527,0.00263903521331649,-0.000290534289775062,0.0100544837464256,0.0643455276850238
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,37282,0.00658007546120604,0.00355767208683551,-0.000392961828991566,0.0135531127514036,0.0644021050612257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37756,0.00466320032533303,0.00252342032380663,-0.000282703509327973,0.00960910415999403,0.0646291346207884
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37515,0.00357580524104245,0.00193558022992392,-0.000217932009608429,0.00736954249169334,0.0647107131466543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37515,0.00585946908472867,0.00317445373484269,-0.000362460235563015,0.0120813984050203,0.0649410088008556
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37782,0.0111923403276229,0.00606985503018703,-0.000704575531543667,0.0230892561867895,0.0652166610695436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37470,0.013119139927404,0.00713546666181356,-0.000866374729750612,0.0271046545845585,0.0659994704005862
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,40297,0.0066162551705395,0.00360560924616487,-0.000450738951943651,0.0136832492930226,0.0665259775878555
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,37445,0.0128007456098654,0.0069762357820603,-0.000872676522972744,0.0264741677427036,0.0665422815463645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37343,0.00521494490826711,0.00285018984699289,-0.000371427191838948,0.0108013170083732,0.067320384599781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,40126,0.00798076990456978,0.00436237774522144,-0.000569490476064253,0.0165310302852038,0.0673505936744317
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37430,0.00563963319049635,0.00308366496734452,-0.000404350145498917,0.0116836165264916,0.067441494624158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40072,0.00598133679840844,0.00327125896179263,-0.000430330766705109,0.012393004363522,0.0675009497439504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37697,0.0092970302071746,0.00509215034000332,-0.000683584459231902,0.0192776448735811,0.0679093454742857
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37403,0.00430774707550246,0.00236067486023228,-0.000319175650552805,0.00893466980155773,0.0680550343106823
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37331,0.0134804393943217,0.00740237597589645,-0.0010282175184353,0.0279890963070788,0.0686154123415689
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37376,0.00561045330105189,0.00308113948348004,-0.000428580086568989,0.0116494866886728,0.0686448543304189
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37756,0.0105695780228063,0.00580546677220104,-0.000809136850707765,0.0219482928963203,0.0686863320194332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,40248,0.00410739949802614,0.0022573953741106,-0.000317095435230623,0.00853189443128291,0.0688494705035828
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37782,0.00723911608902175,0.00398451238499617,-0.00057052818557074,0.0150487603636142,0.0692681141135036
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39648,0.0107113270146771,0.00589622419260528,-0.000845272402829229,0.0222679264321835,0.069291678596257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39607,-0.0154191808113341,0.00849277043488204,-0.0320650108637029,0.00122664924103472,0.0694568072503134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40066,-0.00339857879961417,0.00187268260655221,-0.0070690367084565,0.000271879109228154,0.0695710053146618
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,37362,0.00815555734675855,0.00449964133102547,-0.00066373966205137,0.0169748543555685,0.0699336531905088
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37343,-0.00583676200373739,0.0032273810733006,-0.0121624289074066,0.000488904899931788,0.0705499202482196
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37430,0.00492395632040972,0.00272267753966476,-0.000412491657333217,0.0102604042981527,0.0705521952754516
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39815,-0.0106430210430888,0.00589425761153153,-0.0221957659616905,0.000909723875513031,0.0709911406921228
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37680,0.00634029329644918,0.00351590342459769,-0.000550877415762295,0.0132314640086607,0.0713609719822331
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37697,0.00936359973161516,0.00519625318848312,-0.000821056517811744,0.0195482559810421,0.0715696029119139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37343,0.016394496636763,0.00910054876682065,-0.00144257894620545,0.0342315722197315,0.0716499211836279
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,37403,0.00958914120547858,0.00532659939198456,-0.00085099360281116,0.0200292760137683,0.0718464874933653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39810,0.0094527908487672,0.00525516011301449,-0.000847322972741205,0.0197529046702756,0.0720757061750396
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39815,0.00544405183842515,0.00303286924193095,-0.00050037187575951,0.0113884755526098,0.0726706406961793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37696,0.00736722227639962,0.0041163063028461,-0.000700738077178748,0.015435182629978,0.0735144846301067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39727,0.00742008582482096,0.0041466750266177,-0.000707397227349726,0.0155475688769917,0.0735692329162916
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39727,0.00786199676795553,0.00440698200506927,-0.000775687961980232,0.0164996814978913,0.0744456900993918
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39662,0.00457758073302184,0.00256819334756931,-0.000456078228214007,0.0096112396942577,0.0747018784181403
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37782,-0.00382303924375035,0.00214590108832014,-0.00802900537685782,0.000382926889357132,0.0748447083555473
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37756,0.00685089112288988,0.00385438989640732,-0.00070371307406848,0.0144054953198482,0.0755210877417518
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37737,-0.00388506745458782,0.00218711234031925,-0.00817180764161356,0.000401672732437907,0.0756988470886415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37362,0.00692564019623226,0.00389954573224475,-0.000717469438967449,0.014568749831432,0.0757544800089301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40148,0.0177689360678566,0.0100293721890542,-0.00188863342268961,0.0374265055584027,0.0764654676755698
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37343,0.00854415603147056,0.00484727788274161,-0.000956508618702997,0.0180448206816441,0.0779796914530514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39815,0.00476215365259735,0.00270222864092516,-0.000534214483615961,0.0100585217888107,0.0780374993860675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37737,0.00571799177651951,0.00324583680912122,-0.000643848369358073,0.0120798319223971,0.0781533568098229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37376,0.0150429258128862,0.00856738375925798,-0.00174914635525943,0.0318349979810318,0.0791400018690659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39815,0.0116888390362278,0.00665853616830027,-0.00136189185364075,0.0247395699260963,0.0791994261953748
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,37343,0.00940558107153541,0.00536844394856856,-0.00111656906765897,0.0199277312107298,0.0797954288940405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,40126,0.0173923513699837,0.00993663638797569,-0.00208345595044866,0.0368681586904161,0.080081670373515
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37403,0.00446361017419387,0.00255292542327881,-0.000540123655432599,0.00946734400382034,0.0804133723330735
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37430,0.00610880887167691,0.00350150980690805,-0.000754150349862873,0.0129717680932167,0.0810744679725792
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37282,0.00818758445398939,0.00469778668759649,-0.00102007745369974,0.0173952463616785,0.0813820318291745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37430,0.00915796758032279,0.00526416783537144,-0.00115980137700523,0.0194757365376508,0.0819389273165269
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39727,0.00938960871498986,0.00539804314657888,-0.00119055585230476,0.0199697732822845,0.08197635094786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37737,0.00790224275720899,0.00455559967851369,-0.00102673261267784,0.0168312181270958,0.0828309999878579
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37282,0.0091042362093857,0.00527490618202714,-0.00123457990738749,0.0194430523261589,0.0843800789595695
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40126,-0.0048870072031,0.00283528947881951,-0.0104441745815862,0.00067016017538624,0.0847932835227155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37515,0.00770042040695863,0.00447195052739932,-0.00106460262674404,0.0164654434406613,0.0851044692787267
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39727,0.00991005689237118,0.00575779865260142,-0.0013752284667276,0.0211953422514699,0.0852431721194331
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,37403,0.00838344756650415,0.00487393190906276,-0.00116945897525887,0.0179363541082672,0.0854457144435974
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37343,0.00595396868379157,0.00346657613692384,-0.000840520544579152,0.0127484579121623,0.0859053326904674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37362,0.0101404882101894,0.00591392833451387,-0.00145081132545779,0.0217317877458366,0.0864281114140431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,37403,0.00392833453888746,0.00229143674692636,-0.000562881485088215,0.00841955056286313,0.0864875940649344
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37697,0.00488012593658708,0.00284702521403795,-0.000700043482927299,0.0104602953561015,0.0865311769947039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40095,0.0046654378933909,0.00272484514616193,-0.000675258593086475,0.0100061343798683,0.0868824742700288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37515,0.0109342614863875,0.006403599892029,-0.00161679430198931,0.0234853172747644,0.0877495943224693
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40126,0.00950301117969292,0.00556892844479586,-0.00141208857210697,0.0204181109314928,0.0879470357449715
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,37403,0.00594132909601584,0.0034969088509739,-0.000912612251893008,0.0127952704439247,0.0893388385770944
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39815,0.00686500968959949,0.00404346755813833,-0.00106018672435164,0.0147902061035506,0.0895652792241567
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39727,0.0104172054951862,0.00616297216002719,-0.00166221993846709,0.0224966309288395,0.0909930374236649
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37362,-0.00583211168361655,0.00346445471274669,-0.0126224429206001,0.00095821955336696,0.0923191458809674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40095,-0.00498866871250877,0.00297750647269071,-0.0108245813989826,0.000847243973965017,0.0938655977888426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37791,0.0192717771573733,0.0115598423936488,-0.00338551393417835,0.0419290682489249,0.0955117393118625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37362,0.00359231644519584,0.0021561692107001,-0.000633775207776351,0.00781840809816803,0.0957248779104155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39815,0.00453117252936835,0.00272825930849153,-0.000816215715275041,0.00987856077401174,0.0967681751477932
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39746,0.00693496721299461,0.00417790988265348,-0.00125373615700622,0.0151236705829954,0.0969524432769421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,40274,0.00378338244642632,0.00228606482374266,-0.000697304608109293,0.00826406950096193,0.0979491974385299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,37376,-0.00523067460332687,0.00316617802704749,-0.0114363835363399,0.000975034329686209,0.0985492824205593
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37515,0.00408873796169439,0.00247707419547747,-0.000766327461441456,0.00894380338483024,0.0988377777930322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39727,0.00904266986238431,0.00548494754726106,-0.00170782733024737,0.019793167055016,0.0992432467025745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37791,-0.0124558647515005,0.00758171908826372,-0.0273160341644974,0.0024043046614964,0.100431058151071
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37696,0.00450707986184751,0.00275178111782782,-0.00088641112909501,0.00990057085279003,0.101471045393155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36783,0.00687511865545025,0.00420055874814411,-0.00135797649091221,0.0151082138018127,0.101715495126508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37282,-0.00693136658154938,0.00424126007304784,-0.0152442363247231,0.00138150316162438,0.102226581478321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37362,0.00714974575766741,0.00437878947371998,-0.00143268161082376,0.0157321731261586,0.102532652671719
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39727,0.00876171471121874,0.00536616446058536,-0.00175596763152857,0.019279397053966,0.102537897386951
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39746,0.00560281116103445,0.0034356043338844,-0.00113097333337898,0.0123365956554479,0.102951421822156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40065,0.00446564184074863,0.0027532558173783,-0.000930739561312839,0.00986202324281009,0.104834357230618
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37327,0.0130009449116413,0.00801939516563491,-0.00271706961300313,0.0287189594362857,0.105001874364729
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37343,0.00866035111938324,0.00535224795789478,-0.00183005487809052,0.019150757116857,0.105670397242482
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39746,0.0126987690514995,0.00787030557302431,-0.00272702987162813,0.0281245679746272,0.106655698808134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,37430,0.00302742377407897,0.00187686433825677,-0.000651230328904305,0.00670607787706225,0.106764006541534
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37372,0.00799402456053191,0.00498081178111155,-0.00176836653044674,0.0177564156515106,0.108526125686426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40095,0.00385478509928494,0.00240267971107744,-0.000854467134426835,0.00856403733299672,0.108652903993953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37808,-0.00303617594488934,0.00189382199564328,-0.00674806705635016,0.000675715166571486,0.108914091011352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37403,0.0125650326152745,0.00785738698872794,-0.0028354458826323,0.0279655111131812,0.109814717951435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37403,0.00570880590372989,0.00358365560272751,-0.00131515907761602,0.0127327708850758,0.111181932683806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37430,-0.00354771888656689,0.00223189709372001,-0.0079222371902581,0.000826799417124323,0.111959939989996
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37515,0.00980770121776744,0.00617421073019308,-0.00229375181341098,0.0219091542489459,0.11219871269624
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,37499,0.0130773292425692,0.00824126798869886,-0.00307555601528055,0.029230214500419,0.112579839981785
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40202,-0.00302383820825591,0.00190806532211205,-0.00676364623959554,0.000715969823083715,0.113039448426264
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40065,0.0035101214626845,0.00221584406823596,-0.000832932911057971,0.00785317583642698,0.11319092268958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37470,0.00380430783874921,0.00240548147959536,-0.000910435861257704,0.00851905153875612,0.113784360060051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39727,0.00518599297846082,0.00328617251387414,-0.0012549051487325,0.0116268911056541,0.114557464652288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,40297,0.00388981463931715,0.00246877551677839,-0.000948985373568497,0.0087286146522028,0.115136865478747
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39727,0.00658977730155141,0.00418733670970558,-0.00161740264947151,0.0147969572525743,0.115568389694346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37282,0.00473318865493155,0.00301254420936257,-0.00117139799541909,0.0106377753052822,0.116170171342177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,37376,0.00462327298702085,0.00294366413576079,-0.00114630871907029,0.010392854693112,0.116303694767078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37376,-0.00494916006880546,0.00315162824550468,-0.0111263514299946,0.00122803129238372,0.116358140031252
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37362,0.0157485302441515,0.010035736062097,-0.00392151243755874,0.0354185729258617,0.116615332742971
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39727,0.00659516194639953,0.00420482705201683,-0.00164629907555346,0.0148366229683525,0.116791264442464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37430,-0.00420253011211001,0.00268898763083054,-0.00947294586853787,0.00106788564431785,0.118108256354927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37362,0.0082438019773581,0.00528175685756324,-0.00210844146346585,0.0185960454181821,0.11859385586923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37343,0.00747202600303688,0.00479254646531046,-0.00192136506897162,0.0168654170750454,0.118998900603979
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,40095,0.0096313425750904,0.00618470877285163,-0.00249068661969879,0.0217533717698796,0.119423510966497
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37696,-0.0226155971192706,0.0145319468504019,-0.0510982129460583,0.00586701870751716,0.119668381866557
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37791,0.00491500680053664,0.00316836181415725,-0.00129498235521158,0.0111249959562849,0.120859040944667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37696,-0.0067175058404951,0.00433311413035331,-0.0152104095359876,0.00177539785499739,0.121100120563137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37403,0.00472148416805167,0.00304829509077177,-0.001253174209861,0.0106961425459644,0.121431780526887
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,37376,0.0100185728036118,0.00647491065181218,-0.0026722520739401,0.0227093976811636,0.121817508047714
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40075,-0.00791689776274058,0.00513050315990191,-0.0179726839561483,0.00213888843066716,0.122825901602746
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39727,0.00556746214941577,0.00362529887998288,-0.00153812365535068,0.0126730479541822,0.124626550738081
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39691,0.00564795674519042,0.00367935684498851,-0.00156358267098706,0.0128594961613679,0.12479497575064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37343,0.00946986941747088,0.00619188331427331,-0.00266622187850481,0.0216059607134466,0.126189725808606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39529,0.00837897245075138,0.00547955276179487,-0.00236095096236657,0.0191188958638693,0.126252115604166
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37403,0.00572735090351099,0.00374996979135333,-0.00162258988754152,0.0130772916945635,0.126709389222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37362,0.0047333848348294,0.00309939698456765,-0.00134143325492319,0.010808202924582,0.126736926501399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,37282,0.0121172435321443,0.00794038237340056,-0.00344590591972083,0.0276803929840094,0.127027613089582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39700,0.011428140860173,0.00749600072068212,-0.003264020552364,0.0261203022727099,0.127388354662525
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37376,0.00932283141686739,0.00613139771201777,-0.00269470809868744,0.0213403709324222,0.12840813476663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37403,0.00414724101197979,0.00272795534487231,-0.00119955146396995,0.00949403348792952,0.128466406295507
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37376,0.0100293711686266,0.00660622830642667,-0.00291883631196966,0.0229775786492229,0.128996254727733
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39991,-0.014839377785122,0.00977944107268681,-0.0340070822875882,0.00432832671734412,0.129184676120807
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37343,0.00629904080771631,0.00415395890614625,-0.00184271864833035,0.014440800263763,0.129444126558871
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37734,0.00296338418716887,0.0019557569345564,-0.000869899404561668,0.0067966677788994,0.129742804943683
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40160,0.011240281826144,0.00743983437260032,-0.00334179354415266,0.0258223571964406,0.130853362158806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39815,-0.0114002965858293,0.00755020727955261,-0.0261987028537524,0.00339810968209385,0.131081443161247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39727,0.0104440555518657,0.00691865892399677,-0.00311651593916797,0.0240046270428994,0.131179193850882
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39810,-0.00384670778940964,0.00254864250735508,-0.00884204710382559,0.00114863152500631,0.131238531572721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37791,0.00412492405015427,0.0027354265118657,-0.00123651191310251,0.00948636001341105,0.131587484924948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,37403,0.00564233570274876,0.00374816009907953,-0.00170405809144712,0.0129887294969446,0.132255562981794
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,37403,0.00742697056951623,0.00493456548913124,-0.00224477778918101,0.0170987189282135,0.132325045113901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37515,0.0086922414953045,0.00577884130018372,-0.00263428745305558,0.0200187704436646,0.132567042161618
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,40297,0.00717990943759705,0.00478736280625112,-0.00220332166265515,0.0165631405378493,0.13369573735619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37737,0.00674900150102476,0.00450035103010357,-0.00207168651797824,0.0155696895200278,0.133725967187803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40248,0.00465343377369605,0.00310413374724712,-0.00143066837090831,0.0107375359183004,0.133865430225738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39991,-0.00452731375204596,0.00302515004837452,-0.01045660784686,0.00140198034276811,0.134528508118126
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40251,-0.00566282871577905,0.00379142694498206,-0.0130940255279439,0.00176836809638578,0.135303381556394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,37282,0.00469779828134479,0.00314620305752843,-0.00146875971141092,0.0108643562741005,0.135418758153824
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,40065,-0.00951133455656515,0.00638259245575399,-0.022021215769843,0.00299854665671268,0.136192051425297
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39810,-0.00347041334522003,0.00232886447305456,-0.00803498771240697,0.00109416102196691,0.136199020255399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37791,0.0062437604706741,0.00419673277281225,-0.0019818357640379,0.0144693567053861,0.136835992911614
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37470,-0.00496427413163557,0.00334239045970112,-0.0115153594326498,0.00158681116937862,0.137502720664101
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37305,0.00430228708598279,0.00289873318550227,-0.00137922995760166,0.00998380412956724,0.137781554430735
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,37362,0.00905746772668945,0.00611474151458909,-0.00292742564190517,0.0210423610952841,0.13856407322297
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37430,-0.00740139433858434,0.00499862456759656,-0.0171986984910736,0.00239590981390493,0.138714492740447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,40100,0.00822126035223654,0.00556174176785467,-0.00267975351275862,0.0191222742172317,0.1393794968451
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37362,0.00406932499660075,0.00275397636498093,-0.00132846867876187,0.00946711867196336,0.13953445280714
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37697,0.00710648148012957,0.00484291054957921,-0.00238562319704568,0.0165985861573048,0.14229132507223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37403,0.00824826717970666,0.00562113634045769,-0.00276916004759041,0.0192656944070037,0.142300664321474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39746,0.0207862837322291,0.0141853232660454,-0.00701694986921981,0.048589517333678,0.142849463062887
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39815,0.00760381562631434,0.00519338999090587,-0.00257522875586116,0.0177828600084898,0.143177969969142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37282,0.00756543707478156,0.00516972616954118,-0.00256722621751915,0.0176981003670823,0.143379293046657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,37362,-0.0116369178297235,0.00795259197279861,-0.0272239980964087,0.00395016243696181,0.14341343642177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40258,0.00778191674621623,0.00532309776693995,-0.00265135487698606,0.0182151883694185,0.143784370460876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37282,0.00947669161768027,0.00651037342801036,-0.00328364030122004,0.0222370235365806,0.145519535909195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37343,0.00423231495255738,0.0029090643145848,-0.00146945110402883,0.00993408100914359,0.145729169729094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37737,0.00448055791660698,0.00307971606874553,-0.00155568557813427,0.0105168014113482,0.145731452427138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37782,0.0029440597908139,0.00202551363880924,-0.00102594694125221,0.00691406652288001,0.146111847228065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37452,0.00665131849585495,0.00458082652748766,-0.00232710149802087,0.0156297384897308,0.14652826441158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39727,0.00368704307219453,0.00254045976580415,-0.00129225806878159,0.00866634421317066,0.146708790530053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37403,0.00614663787757771,0.00424511530070867,-0.00217378811181127,0.0144670638669667,0.147660303010806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37697,0.00692749512510313,0.00478689529961172,-0.00245481966213583,0.0163098099123421,0.147870417745115
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,37376,0.00836883824075389,0.00581959068913134,-0.00303755950994354,0.0197752359914513,0.150445258024779
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37791,0.00420506140282945,0.0029257519479568,-0.00152941241516587,0.00993953522082477,0.150668055986279
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37470,-0.0044004238793522,0.00306173453021671,-0.010401423558577,0.00160057579987256,0.150676021170396
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37782,0.00312416509659879,0.00217476877444218,-0.00113838170130787,0.00738671189450546,0.150869235404598
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37282,0.0107676122108478,0.00750346385127487,-0.00393917693765095,0.0254744013593465,0.151306096309286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39746,0.0128937184786024,0.00903019610531993,-0.00480546588782464,0.0305929028450295,0.153356955437454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39727,0.00670472815949361,0.00470243631023563,-0.00251204700856823,0.0159215033275554,0.153946855349257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,40100,0.00417807026480477,0.00293254750812569,-0.00156972285112158,0.00992586338073112,0.154256996103089
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,37430,0.00810801137756303,0.005694346594154,-0.00305290794697881,0.0192689307021049,0.154508042580454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40065,0.00495115086455452,0.00348650210793126,-0.00188239326699075,0.0117846949960998,0.155601107257132
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39810,-0.00406811873012104,0.00286535066184485,-0.00968420602733694,0.00154796856709486,0.155696999665274
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,37376,-0.00509547230016213,0.00360623909928389,-0.0121637009347586,0.00197275633443429,0.157691510080281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,40121,0.00424718132263093,0.00300677584751531,-0.00164609933849908,0.0101404619837609,0.157811844736028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37697,0.00597396234466921,0.00423150987233975,-0.00231979700511669,0.0142677216944551,0.158038147559027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37362,0.011409958313693,0.00812233980779021,-0.00450982770957582,0.0273297443369618,0.160115975334865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37697,0.00538213507992138,0.00383236972877179,-0.00212930958847134,0.0128935797483141,0.160226711744769
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39727,0.00393057880506642,0.00280827104115373,-0.0015736324355949,0.00943479004572773,0.161640355667078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37376,0.00394776842940821,0.00282978982382856,-0.00159861962529576,0.00949415648411218,0.163017261931476
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37376,0.0092835262355654,0.00666645095430042,-0.00378271763486341,0.0223497701059942,0.16377260813239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40164,0.00438592250805207,0.00315370295446504,-0.00179533528269941,0.0105671802988036,0.164329590633743
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39727,-0.00542146621038784,0.00390081163025152,-0.0130670570056808,0.00222412458490514,0.164600668055433
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37362,0.00398328122516895,0.00286828255386469,-0.00163855258040584,0.00960511503074373,0.164937638064623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37515,0.00634695593394229,0.0045778544580483,-0.00262563880383239,0.015319550671717,0.165633891082599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37737,-0.00798677366171621,0.00576066100094372,-0.0192776692235659,0.00330412190013348,0.165637824741051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,40153,-0.00325783538356833,0.00235543360798933,-0.00787448525522741,0.00135881448809075,0.166649296467878
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,37343,0.00633108204478766,0.00458635610148869,-0.00265817591413016,0.0153203400037055,0.167482350715843
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37791,-0.00356799935422332,0.00258490027613312,-0.00863440389544423,0.0014984051869976,0.167510103074426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,37282,0.00532188216269706,0.00386437431824187,-0.00225229150105701,0.0128960558264511,0.168485177682398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,37282,0.00624368145329626,0.00453738664714998,-0.0026495963751177,0.0151369592817102,0.168829451398392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37430,0.00235251785536726,0.00171110288721269,-0.00100124380356963,0.00570627951430414,0.169200229521132
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37430,0.00560566073709464,0.00409079262953085,-0.00241229281678584,0.0136236142909751,0.170613344737948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,37282,0.00357350400831914,0.00260870101265358,-0.00153954997648187,0.00868655799312016,0.170760703400199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,37362,0.00720986751944303,0.00527183018687383,-0.00312291964682968,0.0175426546857157,0.171454436766514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,37470,0.00389258857568365,0.00284716636315723,-0.00168785749610451,0.00947303464747182,0.171592535285709
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,40100,0.0113975222832702,0.00834870778772741,-0.00496594498067558,0.0277609895472159,0.172214852321322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,37403,0.00304270780934113,0.00223191932424513,-0.00133185406617933,0.0074172696848616,0.172821251276072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37430,0.00648216638584196,0.00475806364951463,-0.00284363836720671,0.0158079711388906,0.173109879227898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37362,-0.0059744643887792,0.00439226990172943,-0.0145833133961689,0.00263438461861048,0.173783271510861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40100,0.00440568183480706,0.00324558168001463,-0.00195565825802162,0.0107670219276357,0.174661077069508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37343,0.0110937401846228,0.00818308107924145,-0.00494509873069041,0.027132579099936,0.175220832712797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,37376,0.00660958455004572,0.00487716581450833,-0.0029496604463906,0.016168829546482,0.175374300667378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37376,0.0041214030411292,0.00304179626224539,-0.00184051763287177,0.0100833237151302,0.175465425031338
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39815,0.00362714530634668,0.00267787096396926,-0.00162148178303307,0.00887577239572643,0.175600513723678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,37377,0.00782940170303144,0.0057808741402372,-0.00350111161183348,0.0191599150178964,0.175644290665814
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39810,0.00901033232429008,0.00669943166497245,-0.00412055373905592,0.0221412183876361,0.178664534213624
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37584,0.00691600853693434,0.00516778377391475,-0.00321284765993857,0.0170448647338072,0.180824133264901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,40248,-0.00433401243996596,0.00324051560956334,-0.0106854230347101,0.00201739815477818,0.18109657619351
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37282,0.00716391306964122,0.00536128161223867,-0.00334419889034658,0.017672025029629,0.181497334504777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37282,-0.00487255038458279,0.00365615756237099,-0.0120386192068299,0.00229351843766436,0.182654909599126
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37343,0.00512308462406391,0.00386193472916808,-0.00244630744510554,0.0126924766932334,0.18467807523485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,37362,0.00425385624198094,0.00321573609391702,-0.00204898650209642,0.0105566989860583,0.185916996947171
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,37403,0.00536081093041196,0.00405763650323854,-0.00259215661593559,0.0133137784767595,0.186469398856058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,37376,0.0102648728333513,0.00777987180700169,-0.00498367590837201,0.0255134215750746,0.18705407194131
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37515,0.00792369741240822,0.00601336164718076,-0.00386249141606607,0.0197098862408825,0.187633286195014
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,40213,-0.0129052228359278,0.00979632221013581,-0.032106014367794,0.00629556869593836,0.187739190910107
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37791,0.003260860340788,0.0024780259234326,-0.0015960704691399,0.00811779115071589,0.188226696973599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40100,0.00589359176453201,0.00448434402769985,-0.0028957225297597,0.0146829060588237,0.188778153779299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39915,-0.0127890882796242,0.00975446567890422,-0.0319078410102764,0.00632966445102813,0.189843161611374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,40126,-0.00626011460890712,0.00478038351450959,-0.0156296662973459,0.00310943707953168,0.190369900420392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37369,0.00418955079948476,0.00320754694550247,-0.00209724121370008,0.0104763428126696,0.191523394766226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37282,0.00539970063638239,0.0041464352191947,-0.00272731239323923,0.013526713666004,0.192853871939696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37362,0.0035285752935921,0.00271200235026478,-0.00178694931292686,0.00884409990011106,0.193248831800559
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37403,0.0075887970580945,0.00584294036921833,-0.00386336606557343,0.0190409601817624,0.194036514564701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,37343,-0.00397103872764066,0.00306029679187354,-0.00996922043971281,0.00202714298443148,0.194448309680763
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39727,0.0065230067085606,0.0050283211748105,-0.00333250279406797,0.0163785162111892,0.194563607013316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37279,0.00671478188097742,0.00518924603741037,-0.0034561403523469,0.0168857041143017,0.195695540603587
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,37282,0.00881654801273473,0.00681436046394851,-0.00453959849660434,0.0221726945220738,0.195751290728337
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,40062,0.00857506465102048,0.00664504325216753,-0.00444922012322789,0.0215993494252688,0.196915215469062
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37376,0.0054919169491015,0.00426373015814577,-0.00286499416086422,0.0138488280590672,0.197750042406072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40297,0.00756755221945349,0.00588598899050841,-0.00396898620194299,0.01910409064085,0.198570356405547
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39946,0.00713922901371087,0.00556385462156661,-0.00376592604455968,0.0180443840719814,0.199460675982004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37403,0.00507255423749217,0.00396001663499039,-0.00268907836708898,0.0128341868420733,0.200236744646203
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,37282,0.00621810112510364,0.00486024968625396,-0.00330798825995412,0.0157441905101614,0.200786780217614
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37808,0.00277808591285285,0.00218054014562477,-0.00149577277257171,0.00705194459827741,0.20267294555298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37376,0.00442456964203279,0.00348736966834945,-0.00241067490793214,0.0112598141919977,0.204556226799751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39810,-0.00359130521903807,0.00283943012034102,-0.00915658825490647,0.00197397781683034,0.205962980321128
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37515,-0.00480742094919058,0.00380203995703017,-0.0122594192649697,0.00264457736658856,0.206097575983588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37376,0.00390686178669978,0.00310346032961131,-0.00217592045933839,0.00998964403273796,0.208099018628862
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37756,-0.00309567630912712,0.00246610647778503,-0.00792924500558577,0.00173789238733153,0.209395918486169
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37343,0.0125471826281886,0.0100182432424471,-0.00708857412700775,0.032182939383385,0.2104346961387
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37282,0.00353490716948356,0.00282574464099183,-0.00200355232686042,0.00907336666582754,0.21097011961682
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,40065,0.00377818417972514,0.0030250001233475,-0.00215081606203597,0.00970718442148625,0.211688753731246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40186,0.00433929838320954,0.00347605309343363,-0.00247376567992038,0.0111523624463395,0.211924908376905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37343,0.0076650533912149,0.00614921384840057,-0.00438740575165021,0.01971751253408,0.212600058764999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,37376,0.00693634897195272,0.00557003069833752,-0.00398091119678882,0.0178536091406943,0.213044749670918
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37737,0.00278462699783627,0.00223763131684007,-0.00160113038317027,0.0071703843788428,0.213354842220162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37696,0.00526370992330142,0.00423726338229155,-0.00304132630599002,0.0135687461525929,0.214168988834621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,40274,0.00406135285347977,0.00327771254592111,-0.0023629637365256,0.0104856694434851,0.215333711821234
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,40140,0.0095205032127097,0.00773596745688104,-0.00564199300277714,0.0246829994281965,0.218460887960259
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37737,0.0023934805135863,0.00194958320263909,-0.00142770256358632,0.00621466359075892,0.219585747338943
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,37443,0.014488878617909,0.0118556816226292,-0.00874825736244434,0.0377260145982623,0.221690388601707
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37430,0.00646784912857961,0.00531169681573057,-0.0039430766302523,0.0168787748874115,0.223374741996712
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37515,0.00429220549025947,0.00352716157887389,-0.00262103120433335,0.0112054421848523,0.223663973669503
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37515,0.00353001888718896,0.00290254981230997,-0.00215897874493858,0.0092190165193165,0.223938879850052
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,40095,0.00454274712222452,0.00373933741423254,-0.00278635420967125,0.0118718484541203,0.224440310754999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37282,-0.00456989926637235,0.00376450204145795,-0.0119483232676299,0.00280852473488522,0.224790987721691
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,40248,0.00206920615429854,0.00171112262618443,-0.00128459419302295,0.00542300650162003,0.226577928054456
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39746,-0.00344457545201402,0.00285461321757281,-0.00903961735845674,0.00215046645442869,0.227578012361456
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37756,0.00258207503342685,0.00214217199282039,-0.00161658207250112,0.00678073213935483,0.22808820829182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37403,0.00425850037933782,0.00353625274652283,-0.00267255500384693,0.0111895557625226,0.228518469042872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,40274,0.00770819622999164,0.00641473041503329,-0.0048646753834736,0.0202810678434569,0.229521048287968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37282,0.00858939710906876,0.00719576482387341,-0.00551430194572313,0.0226930961638606,0.23262760002621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36981,0.0123258527022469,0.0103380451325038,-0.00793671575746058,0.0325884211619543,0.233173741976178
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37343,-0.00653086985041583,0.00547904954273634,-0.0172698069541791,0.0042080672533474,0.233294438256972
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,37376,0.0061007011364068,0.00512750304262599,-0.00394920482714014,0.0161506070999537,0.23414701808464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37791,0.00901167932008862,0.00758795867080706,-0.00586071967469322,0.0238840783148705,0.235000777683391
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37362,-0.00402891932766383,0.00339272312464245,-0.010678656651963,0.00262081799663537,0.235045261638748
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39991,0.00421690150500864,0.00355861162853356,-0.00275797728691713,0.0111917802969344,0.236041488465568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39810,0.00485133198391625,0.00410814953456469,-0.00320064110383055,0.012903305071663,0.237658978850386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,37403,0.00575919919731439,0.00489308330044796,-0.00383124407156361,0.0153496424661924,0.239213861858854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37403,0.00212054019332347,0.00180264474565112,-0.00141264350815272,0.00565372389479967,0.239476875890916
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37362,-0.00314457144634538,0.00268055351169932,-0.00839845632927605,0.00210931343658529,0.240775237639204
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37362,-0.00434379909609803,0.00371159797636747,-0.0116185311297783,0.00293093293758221,0.241889294391119
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40126,0.0027883366021581,0.00238769897746201,-0.00189155339366745,0.00746822659798365,0.242908297652194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37515,0.00438758525110175,0.00376071556373847,-0.00298341725382565,0.0117585877560291,0.243357309169016
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40065,0.0100601729255737,0.00864688754330793,-0.00688772665930988,0.0270080725104572,0.244667022539355
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37421,0.00279506665286725,0.00240462592831831,-0.00191800016663663,0.00750813347237113,0.245106320616352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,37362,-0.00309361693693329,0.00266616346879434,-0.0083192973357702,0.00213206346190361,0.24593784260098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37362,-0.00279347183175162,0.00240794828954276,-0.00751305047925543,0.0019261068157522,0.246027684271122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,40215,0.00419003754706682,0.00361881504041364,-0.00290283993214392,0.0112829150262776,0.246943637889646
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37282,0.00403945458635784,0.00349651456231652,-0.00281371395578254,0.0108926231284982,0.247997152630458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37362,0.00387190633732783,0.00336472864998032,-0.00272296181663361,0.0104667744912893,0.2498631591018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37362,0.00474162573497533,0.00413377495956288,-0.00336057318576792,0.0128438246557186,0.251384296741084
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37762,0.00541952726489672,0.00473136707044918,-0.00385395219318367,0.0146930067229771,0.252044891481539
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39727,0.00470148856388572,0.00410461531733608,-0.00334355745809299,0.0127465345858644,0.252055171136693
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37515,0.00707884988943747,0.0061962003317055,-0.00506570276070531,0.0192234025395803,0.253287901948722
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37515,0.00341071548614045,0.00298797469212222,-0.0024457149104191,0.0092671458827,0.253690857216981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37515,0.0074461823299699,0.00654693868627085,-0.00538581749512096,0.0202781821550608,0.255411482055502
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40160,0.00725240561853509,0.00641244570304221,-0.00531598795942765,0.0198207991964978,0.258076984126789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39722,-0.0115063514573449,0.0101879161385889,-0.0314746670889791,0.00846196417428931,0.258741950407636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BSND,Barttin,37282,0.0032368924246793,0.00286633421216097,-0.00238112263115619,0.0088549074805148,0.258801065388035
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37515,0.00605623512996228,0.00536531040426783,-0.00445977326240266,0.0165722435223272,0.259012949387292
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,37430,-0.001684993875464,0.0014961610616703,-0.00461746955633779,0.00124748180540978,0.260096808301153
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,40126,0.00561767861596969,0.00499406450062672,-0.00417068780525869,0.0154060450371981,0.26066090324233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,40037,0.00561534514504884,0.00500780623132156,-0.00419995506834141,0.0154306453584391,0.262169643606134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37282,0.00248664507005368,0.0022251967741055,-0.0018747406071931,0.00684803074730046,0.263803891603486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40020,0.00542879570192611,0.00486787349219113,-0.0041122363427685,0.0149698277466207,0.264769339251228
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39810,0.00536821333253495,0.00482107476124614,-0.0040810931995075,0.0148175198645774,0.265515930659229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37737,0.00565330582929485,0.0050824238004828,-0.00430824481965144,0.0156148564782412,0.266018669698546
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,37376,0.00436208229666594,0.00392475581953793,-0.00333043910962841,0.0120546037029603,0.266404973940172
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37737,0.00556376067393145,0.00501130914563004,-0.00425840525150343,0.0153859265993663,0.266915301712833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39596,-0.00804867906469408,0.00728429006054654,-0.0223258875833653,0.00622852945397714,0.269204594074405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,37282,0.00431016789548147,0.00390442932646166,-0.00334251358438338,0.0119628493753463,0.269649626496403
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,37362,0.00607698372544829,0.00551379736530651,-0.00473005911055248,0.0168840265614491,0.270420798394967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,37362,-0.00380812678827004,0.00345568122013222,-0.0105812619797292,0.00296500840318911,0.270486482067094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37343,0.00560186632236448,0.00508873998119797,-0.00437206404078354,0.0155757966855125,0.270988753021062
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37737,-0.011998453981174,0.0109221850231199,-0.0334059366264889,0.00940902866414092,0.271988795496778
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,37447,-0.00528267259190759,0.00481614580863291,-0.0147223183768281,0.00415697319301292,0.272719753647249
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39810,0.00780932387556328,0.00712728956968046,-0.00616016368101043,0.021778811432137,0.273230169850598
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37376,0.00331681240370094,0.00304152602449123,-0.00264457860430187,0.00927820341170375,0.275509191606537
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37808,-0.00170090817843151,0.0015614076165533,-0.00476126710687597,0.00135945075001296,0.276022390364704
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39991,-0.00291760196444385,0.00268302689134237,-0.0081763346714749,0.0023411307425872,0.276864009541462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37376,0.00455036864267784,0.00418624165305912,-0.00365466499731804,0.0127554022826737,0.277065108495006
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,37403,0.00523514309548454,0.00482352189814558,-0.00421895982488079,0.0146892460158499,0.277792964794236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37403,0.00440467434883449,0.00406124857138832,-0.00355537285108661,0.0123647215487556,0.278136048139345
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39815,0.00485967992641215,0.00448256717118046,-0.00392615172910155,0.0136455115819259,0.278324731975434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37376,0.00410831390756502,0.00378982112701967,-0.00331973550139354,0.0115363633165236,0.278367729083383
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37697,0.00389349394534213,0.00359332904910229,-0.00314943099089836,0.0109364188815826,0.278591222859536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37782,0.00318090422410348,0.00294393723178097,-0.00258921275018722,0.00895102119839418,0.27994215165395
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39727,0.00759746032713542,0.007033536605454,-0.00618827141955442,0.0213831920738253,0.280080685062121
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37376,0.00490133303560376,0.0045388894555687,-0.00399489029731089,0.0137975563685184,0.280227832060296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37430,0.00743382655735323,0.00690076043197665,-0.006091663889321,0.0209593170040275,0.281389756717015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37282,0.00448715222125453,0.00416702369322253,-0.00368021421746163,0.0126545186599707,0.281579030179298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37808,0.00376346799813584,0.00350152306885058,-0.00309951721681129,0.010626453213083,0.282479731675057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37697,0.00517593372450752,0.00481605871446478,-0.00426354135584345,0.0146154088048585,0.282517907875931
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37403,-0.00268249843796053,0.00249728239190781,-0.00757717192609983,0.00221217505017878,0.282767833867098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37376,-0.00544627051809283,0.00507816872021158,-0.0153994812097075,0.00450694017352188,0.283521323905659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39976,0.0114771133028451,0.0107071959838447,-0.00950899082549046,0.0324632174311806,0.283778679796217
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37784,-0.0034761424327246,0.00324884510192394,-0.00984387883249552,0.00289159396704632,0.284655558319599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,40297,-0.00207861244654786,0.00195798488083603,-0.00591626281298647,0.00175903791989074,0.288429853033173
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37515,0.00320977046650506,0.00302493237779373,-0.00271909699397065,0.00913863792698077,0.28866186403378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37376,0.0050608101173041,0.0047891254320611,-0.00432587572953565,0.0144474959641438,0.290654810051318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37515,0.00627725233512099,0.0059589466215509,-0.00540228304311877,0.0179567877133608,0.292169656934356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37697,-0.00340245584618652,0.00323344191796509,-0.00974000200539809,0.00293509031302506,0.292694615992081
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37282,0.00414927241407436,0.00395750785577996,-0.00360744298325435,0.0119059878114031,0.294448365400575
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37791,-0.00512421928631819,0.0049166444594518,-0.0147608424268437,0.00451240385420733,0.297329137487866
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39810,0.00634166567848402,0.00608718915077759,-0.00558922505704006,0.0182725564140081,0.297518373981126
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37756,0.00466065565242015,0.00448568092682201,-0.00413127896415099,0.0134525902689913,0.298820179618325
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37697,0.00395338477713551,0.00380544844182473,-0.00350529416884095,0.011412063723112,0.298881896641909
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,37343,-0.00461737370490711,0.00444882483909401,-0.0133370703895314,0.00410232297971715,0.299342527238967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40095,0.00486726604681843,0.00469619053210432,-0.00433726739610604,0.0140717994897429,0.300018267282212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,40228,0.00534359832111902,0.00515885960640341,-0.00476776650743166,0.0154549631496697,0.300306672287988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,40233,-0.00664242755582588,0.00643007488945575,-0.0192453743391592,0.00596051922750739,0.301608070337077
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,37376,0.00271108387850386,0.00262578817135881,-0.00243546093735941,0.00785762869436714,0.301864829879455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37343,0.00260167305112659,0.00252442821667201,-0.00234620625355055,0.00754955235580374,0.302748267438615
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39727,-0.00598475046669795,0.00581886272176935,-0.0173897214013659,0.00542022046796998,0.303726923849648
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37434,-0.00416617753681147,0.00408338733527966,-0.0121696167139596,0.00383726164033667,0.307617124350755
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39815,0.00490781120188772,0.00482372899374258,-0.00454669762584774,0.0143623200296232,0.308964484030393
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40174,0.0075031444151804,0.0073754717061106,-0.00695278012879637,0.0219590689591572,0.309021422940641
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37515,0.00367249681998498,0.00361438734640498,-0.00341170237896878,0.0107566960189387,0.309611411465989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37343,-0.00463621674210619,0.00456519941429233,-0.0135840075941191,0.00431157410990677,0.309859813133488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,40160,-0.00544390233919728,0.00536727572802773,-0.0159637627661316,0.00507595808773708,0.310466394416405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,37042,0.005947960739228,0.00586720510228807,-0.00555176126125661,0.0174476827397126,0.310714905378935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40054,0.0152807118532779,0.0150768044224877,-0.0142698248147981,0.0448312485213538,0.310825379112011
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37515,0.00538427344761635,0.00531475981945353,-0.00503265579851258,0.0158012026937453,0.311041022359861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37403,0.00365939346319983,0.00361561995739337,-0.00342722165329118,0.0107460085796908,0.311505910249325
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37343,0.0027641442669122,0.00273270959298997,-0.00259196653534815,0.00812025506917255,0.311794675575066
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37808,-0.00165081730266478,0.00164078867983298,-0.00486676311513743,0.00156512850980787,0.314379888027794
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39815,0.00246402151776674,0.00245684925885196,-0.0023514030295831,0.00727944606511659,0.315915599767966
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37515,0.00333749566598101,0.00332797631527149,-0.00318533791195111,0.00986032924391313,0.315946796382072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,40065,0.0079147911902889,0.00790225408866292,-0.00757362682349043,0.0234032092040682,0.316558855406629
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37403,0.00247323137665601,0.00247179807950505,-0.0023714928591739,0.00731795561248591,0.317048664896967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,37282,0.00618242819416463,0.00619265285157464,-0.00595517139492166,0.0183200277832509,0.318129028979558
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,37343,0.00614040749414745,0.006166676509585,-0.00594627846463914,0.018227093452934,0.319395098737471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,37376,0.00292212200332306,0.00293912230825765,-0.00283855772086193,0.00868280172750806,0.320136403634661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,37282,-0.00381570988407858,0.00384914688692972,-0.0113600377824608,0.00372861801430367,0.321551393939817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,37343,0.00416260542776257,0.00420971361323846,-0.00408843325418482,0.01241364410971,0.322774842848174
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37515,0.00457640313506668,0.00464709214556458,-0.00453189747023991,0.0136847037403733,0.324746185250536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39815,0.00686661964091232,0.00698608769697264,-0.00682611224515406,0.0205593515269787,0.325672555896531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,40264,0.0044549892679469,0.00454002009489308,-0.00444345011804354,0.0133534286539373,0.326474219036582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37282,0.00463141489371232,0.00475066954768898,-0.00467989741975808,0.0139427272071827,0.3296295880392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37376,0.00264472421917778,0.00271584355223986,-0.00267832914321236,0.00796777758156791,0.330167538394643
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37362,0.00512414583368949,0.00527400522561154,-0.00521290440850912,0.0154611960758881,0.331275112118759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39727,0.0059515674011916,0.00614300019181833,-0.00608871297477232,0.0179918477771555,0.332641738494514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37791,-0.00341045441193629,0.00353675614979189,-0.0103424964655284,0.00352158764165582,0.334918625756568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,40160,0.00460305635387386,0.00477502103648144,-0.00475598487762975,0.0139620975853775,0.335067477583734
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37696,0.00662892873376786,0.00688410980060189,-0.00686392647541184,0.0201217839429476,0.335599294660486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39727,0.00403305490368278,0.00419101757116087,-0.00418133953579252,0.0122474493431581,0.335909525475781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40065,0.00171247098703724,0.00177970511898673,-0.00177575104617676,0.00520069302025123,0.335953123999285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39810,0.00281413174053376,0.0029418192003036,-0.0029518338920613,0.00858009737312882,0.338786392730787
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39815,0.00397911739584941,0.00415990755783558,-0.00417430141750834,0.0121325362092071,0.33881460739762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37282,0.0050196820363995,0.00525070373337053,-0.00527169728100674,0.0153110613538057,0.339089355237568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40095,0.00344249414959873,0.00361478559148902,-0.00364248560971975,0.0105274739089172,0.340940801493043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,40079,0.0101777461957381,0.0107200226303488,-0.0108334981597456,0.0311889905512217,0.342424460450922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37697,0.00516453768113485,0.00545088676571428,-0.00551920037966514,0.0158482757419348,0.343417930025683
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37403,0.00733571751330974,0.00776792686142915,-0.00788941913509139,0.0225608541617109,0.345003456387138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,37343,0.00780834765266304,0.00827115851585761,-0.00840312303841787,0.024019818343744,0.345164233947574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37515,0.00320594600144719,0.00340192618672554,-0.00346182932453487,0.00987372132742924,0.346009713232255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,37376,0.00551107489576893,0.00585348357200311,-0.00596175290535718,0.016983902696895,0.346464526802417
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37362,0.00475682232649459,0.00505342939297419,-0.00514789928373483,0.014661543936724,0.346565791260708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37282,-0.00200629923611319,0.00213934888504236,-0.00619942305079623,0.00218682457856984,0.348360565124939
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37430,0.00334528409558508,0.00356926081611635,-0.00365046710400296,0.0103410352951731,0.348648224025352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37430,0.00644054163749707,0.00688114013666206,-0.00704649303036057,0.0199275763053547,0.349305982038567
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,37282,0.00564707739781609,0.00604373260755754,-0.00619863851299669,0.0174927933086289,0.350131081735819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37403,0.00337912767692368,0.00362280955182169,-0.00372157904464683,0.0104798343984942,0.350973283425806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37362,-0.00409800431781474,0.00440435211065969,-0.0127305344547077,0.00453452581907826,0.352158488406198
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37515,0.0071594795534265,0.00770856909960526,-0.00794931588179981,0.0222682749886528,0.353026005302737
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37376,0.00512502667058661,0.00554221903210516,-0.0057377226323395,0.0159877759735127,0.355126408245409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37282,0.00268785768565929,0.00290874954138484,-0.00301329141545499,0.00838900678677357,0.355472709475889
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39810,-0.0049401957929775,0.00534653292244931,-0.0154194003209781,0.00553900873502314,0.355500893755091
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37282,-0.00530325201682473,0.00575169004833411,-0.0165765645115596,0.00597006047791012,0.356528338944258
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37343,0.00550775175266267,0.00597382078703836,-0.00620093698993252,0.0172164404952579,0.35655552358063
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37343,0.00608757188888635,0.00660538896990471,-0.00685899049212688,0.0190341342698996,0.356750918059377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37362,-0.00373375519346863,0.0040761697096407,-0.0117230478243644,0.00425553743742715,0.359686096647012
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37343,0.00556102874531643,0.00612451696873656,-0.00644302451340723,0.0175650820040401,0.363898012896049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,40297,0.00129752411186337,0.001431221599131,-0.00150767022243339,0.00410271844616013,0.364640054032893
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37697,-0.00280583123174884,0.00311529029476955,-0.00891180020949717,0.00330013774599949,0.367783129425274
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39810,0.00806499040033989,0.00902754603781095,-0.00962899983376957,0.0257589806344493,0.37167000156187
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39810,0.00244475598838108,0.00276055591758376,-0.00296593361008308,0.00785544558684524,0.375845479838097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37403,0.00457169143769127,0.00518582061397909,-0.00559251696570775,0.0147358998410903,0.378022869902177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37362,0.00721731185554999,0.00819104421839305,-0.00883713481250038,0.0232717585236004,0.378268022887304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37362,0.0052576433818574,0.00600712772505746,-0.00651632695925523,0.01703161372297,0.381462793294517
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERVV_1,,37362,0.00354877682200619,0.0040578628344415,-0.00440463433349914,0.0115021879775115,0.381838709868711
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39815,0.00275982702629876,0.0031580783662203,-0.00343000657149302,0.00894966062409054,0.382189419803088
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37376,0.00216450133550595,0.00248186698546064,-0.0026999579559969,0.00702896062700881,0.383155711175778
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37362,0.0033300087543645,0.00382250725849089,-0.00416210547227764,0.0108221229810066,0.383683948650802
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,40100,0.00247615039030252,0.00285771875351879,-0.00312497836659431,0.00807727914719934,0.386241378861113
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40233,0.00327425962393841,0.00378849367214229,-0.00415118797346048,0.0106997072213373,0.387455883069548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37470,-0.00235110500695104,0.00273575149979086,-0.00771317794654112,0.00301096793263904,0.390135660623014
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37362,-0.00294835810500554,0.00343174962658579,-0.00967458737311369,0.00377787116310262,0.390278472532323
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37362,0.00603739916146857,0.00709886177529832,-0.00787636991811614,0.0199511682410533,0.395077242076982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37515,0.0029519780887076,0.00347302412057268,-0.00385514918761484,0.00975910536503005,0.395355457945208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39991,0.000869585460203472,0.00102384299878691,-0.00113714681741886,0.00287631773782581,0.395708121917065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39746,0.00404916666865104,0.00477680872301288,-0.0053133784284542,0.0134117117657563,0.39663396834738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37791,-0.00175880236856935,0.0020940185949447,-0.00586307881466096,0.00234547407752225,0.4009698308622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37343,-0.0038810032268021,0.0046334804384713,-0.0129626248862058,0.00520061843260164,0.402270919920449
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37403,0.00338905418554112,0.00405814994403277,-0.00456491970476311,0.0113430280758453,0.403663886753781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37430,0.00282085720216411,0.00340092172980513,-0.00384494938825394,0.00948666379258217,0.406871282207675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37515,0.00371457144764625,0.00448858718469925,-0.00508305943436428,0.0125122023296568,0.407935321576273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37376,-0.00298693828857245,0.00361270516443861,-0.0100678404108721,0.00409396383372722,0.408372965684014
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37343,0.00197699726624049,0.0023958905254613,-0.00271894816366367,0.00667294269614464,0.409295023775303
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37697,-0.00588878619575421,0.00715605330308141,-0.0199146506697938,0.00813707827828535,0.410574120069749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37376,0.0048465397963613,0.00590245041940304,-0.00672226302566865,0.0164153426183913,0.411600812143958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37343,0.00521333316469268,0.00635243208621857,-0.00723743372429571,0.0176641000536811,0.411842019114189
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37430,-0.0179410837226351,0.0219992756523497,-0.0610596640012406,0.0251774965559703,0.414783590251812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37403,0.00479984291571868,0.00588940769102714,-0.00674339615869451,0.0163430819901319,0.415089663535835
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37515,0.00394363249394617,0.0048447895226481,-0.00555215497044411,0.0134394199583365,0.415662883712574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37403,0.00246217181589292,0.00303683331774648,-0.00349002148689019,0.00841436511867603,0.417512954031399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37756,-0.00426307673763007,0.00533229899496633,-0.0147143827677641,0.00618822929250393,0.424025288864964
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37737,0.00250995394843322,0.00314324815571448,-0.00365081243676715,0.0086707203336336,0.424581694625591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37362,-0.00451397672450834,0.00566348671432901,-0.0156144106845932,0.00658645723557651,0.42544745500603
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37343,0.00407925025114545,0.00515007019347355,-0.0060148873280627,0.0141733878303536,0.428330569938402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,37403,0.00223584582584807,0.00282302576698783,-0.00329728467744807,0.00776897632914422,0.428373236862945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,37258,0.00269779499545373,0.00342187722385133,-0.00400908436329489,0.00940467435420234,0.430479587427576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37376,-0.00282675394399831,0.00362079902111394,-0.00992352002538163,0.00427001213738502,0.434993885226175
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37784,0.00325646152723265,0.004180880529944,-0.00493806431145759,0.0114509873659229,0.436056156690114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,37362,0.00481969556501753,0.00624191908470395,-0.00741446584100221,0.0170538569710373,0.440039939646784
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37808,-0.00115200366712482,0.0014925176897967,-0.00407733833912636,0.00177333100487672,0.440215387056503
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40065,-0.00129005933867071,0.00167264261846898,-0.00456843887086991,0.00198832019352849,0.440558488070124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37697,0.00440196399404307,0.00572413322172665,-0.00681733712054116,0.0156212651086273,0.441896076929469
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,37403,0.00278359667438334,0.00362119431752564,-0.00431394418796691,0.00988113753673358,0.442087966702843
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39727,0.0019794498483942,0.00258415536121354,-0.00308549465958435,0.00704439435637275,0.443691168260652
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37343,0.00547169467598255,0.00719181754755224,-0.00862426771721984,0.0195676570691849,0.446777169793766
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37697,-0.00496318115174638,0.00652748337356135,-0.0177570485639266,0.00783068626043385,0.447058097051277
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39727,0.00432866485791004,0.00569562017797843,-0.00683475069092768,0.0154920804067478,0.447266994137568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37362,-0.00326088314028882,0.00429313220169798,-0.0116754222556169,0.00515365597503923,0.447532669106144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37403,0.00142158754398679,0.00188208391405109,-0.00226729692755335,0.00511047201552694,0.450066937418703
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,37403,0.00394141745470708,0.00524431627277376,-0.00633744243992948,0.0142202773493436,0.452329463926104
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37677,0.00322656427537361,0.00429476821581674,-0.0051911814276272,0.0116443099783744,0.452498818640662
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39746,0.00492014856455525,0.00655707728096686,-0.00793172290613979,0.0177720200352503,0.453051289720044
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,40233,-0.00193216440396566,0.00259120890465225,-0.00701093385708406,0.00314660504915275,0.455883101181092
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37362,-0.00331701763030372,0.00444884733513806,-0.0120367584071743,0.00540272314656688,0.455928489884364
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37782,0.00153740303402505,0.00206729788338013,-0.0025145008174,0.00558930688545011,0.457084679299024
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40100,0.00297923703172219,0.00400702341038078,-0.00487452885262414,0.0108330029160685,0.457187899792035
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37282,0.00352116459680216,0.00473792595490034,-0.00576517027480251,0.0128074994684068,0.457382129281194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37362,0.00269187484148491,0.00362416976241264,-0.00441149789284387,0.00979524757581369,0.457642765329576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,40097,0.00184408136557901,0.00248307007996859,-0.00302273599115943,0.00671089872231744,0.457697595833867
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,40027,0.00414406322477941,0.00559256388114256,-0.00681736198226001,0.0151054884318188,0.458707496735408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39746,-0.00218039917324225,0.00295239149226352,-0.00796708649807875,0.00360628815159424,0.460210054726311
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37343,-0.00247545402241435,0.00336829113161435,-0.00907730464037848,0.00412639659554978,0.462396251331496
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,39375,-0.00172479964541117,0.00234745551066075,-0.00632581244630624,0.00287621315548389,0.462501567752323
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37756,0.00235189128786504,0.0032012776982406,-0.00392261300068654,0.00862639557641662,0.462551807237721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,37213,0.00270211510251803,0.00368369509758203,-0.00451792728874275,0.0099221574937788,0.463246356372958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37282,0.00348484918226592,0.00475644705746057,-0.00583778705035679,0.0128074854148886,0.463780405977392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37697,-0.00287074232183687,0.0039185860812931,-0.0105511710411713,0.00480968639749762,0.463817549909015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,40065,-0.00198419555885759,0.00271036683848287,-0.00729651456228403,0.00332812344456884,0.464132934761793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37697,0.00174067630595753,0.00239102803694879,-0.0029457386464621,0.00642709125837717,0.466624434398515
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37697,-0.00292489888447123,0.00402480746563398,-0.0108135215171138,0.00496372374817137,0.467411742069475
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39746,-0.00197778479891063,0.00273018510534604,-0.00732894760538888,0.00337337800756761,0.468822579514237
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37756,0.00223508642019376,0.00308563728773187,-0.0038127626637607,0.00828293550414823,0.468862620787615
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37362,-0.00289486262935162,0.00399978085653054,-0.0107344331081515,0.00494470784944824,0.469229084581696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37791,0.00347229465075854,0.00480641281643785,-0.00594827446945965,0.0128928637709767,0.470043089162107
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,37282,0.00362391709970847,0.00503413812377949,-0.00624299362289932,0.0134908278223163,0.471619121396018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37515,-0.00367544144374901,0.00511500423115245,-0.0137008497368078,0.00634996684930979,0.472424436191215
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37791,-0.00268315780619939,0.00374399705464281,-0.0100213920332993,0.00465507642090052,0.473598952917413
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39727,0.00434256224700183,0.00608175385994817,-0.00757767531849659,0.0162627998125002,0.475218772664603
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39815,0.00295045695502155,0.00414613658094176,-0.00517597074362429,0.0110768846536674,0.476713427374647
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39727,0.0030558844711778,0.00430326404993692,-0.00537851306669857,0.0114902820090542,0.477633273983883
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37756,-0.00487899459169939,0.00691273110312033,-0.0184279475538152,0.00866995837041647,0.480325871891199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37362,-0.00228314147625674,0.00327360231877615,-0.00869940202105799,0.0041331190685445,0.485539983069379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37362,0.00267616908277448,0.00384058393532026,-0.00485137543045324,0.0102037135960022,0.485932331817363
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39746,0.00348368933016057,0.0050470694039704,-0.00640856670162141,0.0133759453619425,0.490053728585593
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,37376,0.00228042036535131,0.00330715364731518,-0.00420160078338644,0.00876244151408907,0.49049481769216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39727,0.00188709197568334,0.00273691346426444,-0.00347725841427495,0.00725144236564164,0.490521412879209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37515,0.00493114542306113,0.00719772288383957,-0.00917639142926444,0.0190386822753867,0.493294249582227
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37362,-0.00378633521894698,0.00554577082144298,-0.0146560460289752,0.00708337559108126,0.494781616537581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37343,0.00445840532985485,0.00655403517458275,-0.00838750361232735,0.017304314272037,0.49635618207841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37362,0.00232301663644611,0.00343001950496103,-0.00439982159327751,0.00904585486616972,0.498252839948335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,37282,-0.00239787914980098,0.00356238962598145,-0.00938016281672464,0.00458440451712266,0.500889602530429
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39727,0.00311997038073919,0.00463878565597534,-0.00597204950497248,0.0122119902664509,0.501222518363471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39305,-0.00161493794637971,0.0024075030649687,-0.00633364395371837,0.00310376806095894,0.50236237649113
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37362,-0.00215383675385068,0.00322553298706381,-0.00847588140849575,0.00416820790079438,0.504307677044341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37282,0.00163870054867852,0.00245569939333481,-0.00317447026225771,0.00645187135961474,0.504589317806669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37376,0.00357813702071815,0.00536864101350516,-0.00694439936575195,0.0141006734071883,0.505110865497726
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37515,0.00330201327662618,0.00495573578040661,-0.00641122885297078,0.0130152554062231,0.505230290662129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39991,0.00193779750936415,0.00291571676321438,-0.00377700734653603,0.00765260236526433,0.506313565840158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,37282,0.00197934314368592,0.0030144408447265,-0.00392896091197801,0.00788764719934986,0.511436849817166
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37282,-0.00334860944392816,0.00510633915676089,-0.0133570341911795,0.00665981530332319,0.51198067778594
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39810,0.00335673444191019,0.00512473644009925,-0.00668774898068434,0.0134012178645047,0.512473534431997
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37362,-0.00395602459847664,0.00604882085113304,-0.0158117134666974,0.00789966426974412,0.513113255402563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39727,-0.0035917808521717,0.00552537645979498,-0.0144215187133699,0.00723795700902646,0.515668545257504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37515,-0.00463521903258411,0.00714619560712289,-0.018641762422545,0.00937132435737675,0.516590574175619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,37362,0.00340211821175202,0.00524569705049169,-0.00687944800721169,0.0136836844307157,0.516638181769482
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37662,0.00288773210402908,0.00447249536661457,-0.00587835881453549,0.0116538230225936,0.518507780844242
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39949,-0.00357646854549964,0.00554787292459311,-0.0144502994777021,0.00729736238670286,0.519159797632826
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,40095,-0.00170063907946462,0.00265290552955873,-0.00690033391739973,0.00349905575847048,0.521501061132049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,37343,-0.00194414201293665,0.00304815687284196,-0.00791852948370689,0.00403024545783359,0.523609321896246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37696,-0.00242621085777362,0.00380799937230673,-0.0098898896274948,0.00503746791194756,0.524047723839199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,37362,-0.00214802933822763,0.00338213156732198,-0.0087770072101787,0.00448094853372345,0.525367206625436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37258,-0.00270839500581197,0.0043391181293324,-0.0112130665393035,0.00579627652767953,0.532519855376584
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37343,0.00295979730054318,0.00474660067117836,-0.0063435400149664,0.0122631346160528,0.532926652661312
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37343,0.00175303607016728,0.0028440278936184,-0.00382125860132479,0.00732733074165935,0.537646709705871
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37282,0.0026064826756791,0.00426127055247948,-0.00574560760718069,0.0109585729585389,0.540768300816165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40143,0.00248215915887673,0.00407748984282913,-0.00550972093306838,0.0104740392508218,0.542701050532265
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37376,-0.0021332369512512,0.00351935320018318,-0.00903116922361022,0.00476469532110782,0.544429379963974
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39815,-0.00312829705000114,0.0051638578894377,-0.013249458513299,0.00699286441329676,0.544652411567941
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37515,-0.00148000378472299,0.00244647907338851,-0.00627510276856446,0.00331509519911848,0.545221024794749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37515,0.00309327103765083,0.00518025708701312,-0.00706003285289487,0.0132465749281965,0.550432985266601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39638,0.00350235862315408,0.00587351507050794,-0.00800973091504148,0.0150144481613496,0.55098581302406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37282,0.00182852816364944,0.00307933243476393,-0.00420696340848787,0.00786401973578675,0.552651890793057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,40072,-0.00134464512527066,0.0022782009558586,-0.00580991899875351,0.00312062874821219,0.555050127281611
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37696,0.0128582280902512,0.0217924879364555,-0.0298550482652016,0.055571504445704,0.555180405211553
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37782,0.00127622678857109,0.00216833400067854,-0.00297370785275885,0.00552616142990102,0.556156503492819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,37376,0.00206943471842857,0.00353351171935858,-0.00485624825151425,0.00899511768837138,0.558114579453082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37515,0.00333903980255963,0.00572479960675805,-0.00788156742668614,0.0145596470318054,0.559729155949017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37362,-0.00200902602001136,0.0034653912859686,-0.00880119294050982,0.0047831409004871,0.562100066476447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37403,0.00139773470581962,0.00242795247811906,-0.00336105215129374,0.00615652156293297,0.564838429229315
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39727,-0.00254951869242881,0.00446334447895998,-0.0112976738711904,0.00619863648633274,0.567863928645315
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,37362,0.00172882949546652,0.00306238925047704,-0.00427345343546848,0.00773111242640151,0.572399100191482
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37697,0.0021392613558946,0.0037962234225339,-0.00530133655227186,0.00957985926406105,0.573087958394983
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37362,-0.00190489440022757,0.00339231630971058,-0.00855383436726031,0.00474404556680516,0.574444621350959
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40118,-0.00361224351670288,0.00649185107065739,-0.0163362716151914,0.0091117845817856,0.57792669089537
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37791,0.00128713820406045,0.0023218162783809,-0.00326362170156611,0.00583789810968702,0.57933703513566
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37782,-0.00315732492936768,0.00571690092348103,-0.0143624507393905,0.00804780088065514,0.580766403133226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39815,-0.00265955265837035,0.00487497721099732,-0.0122145079919251,0.00689540267518439,0.585381975631571
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37403,0.00209897634100886,0.00385829543454176,-0.005463282710693,0.00966123539271072,0.586439490184319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,37282,-0.00262211067939887,0.00483187095017681,-0.0120925777417454,0.00684835638294766,0.587366563339562
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37756,0.00167337521460333,0.00308607389679595,-0.00437532962311674,0.0077220800523234,0.587666169713701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37376,0.00319242624137418,0.00589053128769869,-0.00835301508251525,0.0147378675652636,0.58785611802172
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37376,-0.00177117930891237,0.0032681660541075,-0.00817678477496307,0.00463442615713834,0.587862986308569
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,37403,0.00215189169847845,0.00398326644626128,-0.00565531053619366,0.00995909393315056,0.589045695900416
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37362,0.00214250835129155,0.00398344615301796,-0.00566504610862366,0.00995006281120675,0.590687829293311
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37403,0.00246440797968002,0.00458219493808053,-0.00651669409895782,0.0114455100583178,0.590708771579882
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,40040,0.00150400644137191,0.00280316366366579,-0.00399019433941304,0.00699820722215686,0.591593792734686
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37343,0.00124676261108874,0.00233507806092936,-0.0033299903883328,0.00582351561051028,0.593400836437306
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39815,-0.00131831880851065,0.00248910498731444,-0.00619696458364695,0.00356032696662566,0.596372205557365
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40100,0.00329206433693325,0.00622608291464267,-0.00891105817576639,0.0154951868496329,0.596983823933098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37362,0.00214886845155517,0.00407506892756584,-0.00583826664647387,0.0101360035495842,0.597979920249352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,37362,0.00179215365193722,0.00341032970214315,-0.00489209256426335,0.00847639986813779,0.599239503800739
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37362,-0.00205626075312408,0.00395432690843287,-0.00980674149365251,0.00569421998740435,0.603070594590582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37362,-0.00210600045507092,0.00407335757740214,-0.0100897813067791,0.00587778039663727,0.605152233569753
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,37258,-0.00151288659378154,0.0029637005864167,-0.00732173974315827,0.0042959665555952,0.609729523638346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,40027,-0.00309641255696665,0.00608536281544791,-0.0150237236752446,0.00883089856131125,0.610878896855022
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,37376,0.00252340779874917,0.00499542782946706,-0.00726763074700627,0.0123144463445046,0.613466677974919
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37343,0.00208043544859191,0.0041852348573298,-0.00612262487177451,0.0102834957689583,0.619134560087295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37258,0.00342457815357123,0.00691332996638194,-0.0101255485805374,0.0169747048876798,0.620355440997989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37784,0.00113941655262703,0.0023149242861995,-0.00339783504832398,0.00567666815357805,0.622582765520298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39727,-0.00332031703721335,0.00681473172818774,-0.0166771912244613,0.0100365571500346,0.626104907947768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37756,0.00126271460006991,0.00259165809891409,-0.00381693527380172,0.00634236447394153,0.626108563225176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37756,-0.00154395919325056,0.00316963380870918,-0.00775644145832055,0.00466852307181944,0.626188658399832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39815,0.00219962758648814,0.00453464809247119,-0.00668828267475538,0.0110875378477317,0.627632695239928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40100,0.0026512422069007,0.0054694016153837,-0.00806878495925136,0.0133712693730528,0.627866994212223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40100,0.00213964330160152,0.00443011347794376,-0.00654337911516824,0.0108226657183713,0.629118762494007
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37343,0.00347914356966989,0.00723057574561028,-0.0106927848917263,0.017651072031066,0.630403116483543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,37282,0.00219432199644313,0.00456900738737255,-0.00676093248280707,0.0111495764756933,0.631049080407795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37587,0.00104001504397923,0.00217285759054377,-0.00321878583348656,0.00529881592144502,0.632203219366848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37362,0.00243265117662584,0.0051175859071546,-0.00759781720139717,0.0124631195546488,0.634544633340353
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40121,0.0116270307562898,0.0245881414504205,-0.0365657264865344,0.059819787999114,0.636311462390346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37376,0.00167359044500212,0.00356516525199763,-0.00531413344891324,0.00866131433891748,0.638771246384223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37376,-0.00195233756738764,0.00415917297083266,-0.0101043165902197,0.00619964145544438,0.638787925728592
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40213,0.00164646017782872,0.00352134546240638,-0.00525537692848779,0.00854829728414523,0.640101698995948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37362,0.00190625265971143,0.00408006524112913,-0.00609067521290167,0.00990318053232453,0.640356581922976
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40081,-0.00108907083650121,0.00237221229589671,-0.00573860693645876,0.00356046526345634,0.646172321928405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37343,-0.00128225692897411,0.00279606314254011,-0.00676254068835272,0.0041980268304045,0.646533696063304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37756,-0.00297739712517785,0.00658702786779195,-0.0158879717460501,0.00993317749569437,0.65126973166734
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37515,0.0028357815761642,0.00628459456058925,-0.00948202376259074,0.0151535869149191,0.651833118046041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37515,0.00166964746101711,0.0037008252984887,-0.00558397012402075,0.00892326504605496,0.651885012671956
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37784,0.00236266236378491,0.00531058417172866,-0.00804608261280325,0.0127714073403731,0.656401495296936
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,37403,0.0011263136708146,0.00256174613969335,-0.00389470876298436,0.00614733610461357,0.660186086731142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37737,-0.00149451518375679,0.00340245319013508,-0.00816332343642155,0.00517429306890796,0.660490179435229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37343,0.00222597929085495,0.00507343760062789,-0.00771795840637572,0.0121699169880856,0.660848825990131
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40069,0.0024998007460915,0.00570123117374064,-0.00867461235444016,0.0136742138466232,0.661053977016461
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37343,0.00273206522552808,0.00628186342912032,-0.00958038709554775,0.0150445175466039,0.663632724898645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,37403,0.0019893468891612,0.00457448582004029,-0.00697664531811778,0.0109553390964402,0.663657651853332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37343,-0.00258343145829193,0.00595085654365045,-0.0142471102838468,0.00908024736726295,0.664203002230834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37343,0.00332143589728721,0.00765444187219254,-0.0116812701722102,0.0183241419667846,0.664351854435462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39727,0.00159305736778243,0.00368033883742439,-0.00562040675356937,0.00880652148913423,0.665125376048704
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37376,0.00284012293492184,0.00657786050614468,-0.0100524836571217,0.0157327295269654,0.66591577665738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,40025,0.00280989249599133,0.00651527080345416,-0.00996003827877882,0.0155798232707615,0.666272266581124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37515,-0.00161827359794106,0.00377554259804007,-0.00901833709009959,0.00578178989421748,0.668206753605357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37697,0.00159294015046399,0.00371905195729007,-0.00569640168582454,0.00888228198675253,0.668425943525054
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37376,-0.00188127383633612,0.0044060672075648,-0.0105171655631631,0.00675461789049088,0.669405758528573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37737,-0.000947041623045371,0.00222088751419142,-0.00529998115086055,0.0034058979047698,0.669805206932629
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,40095,0.000893231304528152,0.00213718675468655,-0.00329565473465748,0.00508211734371379,0.6759914295556
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,37343,0.00221459744322183,0.00531504004060596,-0.00820288103636585,0.0126320759228095,0.676929530738101
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37282,0.00127376359826733,0.00307536812326014,-0.00475395792332255,0.0073014851198572,0.678747395047954
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39815,0.00417071982702913,0.0100867917173632,-0.0155993919390027,0.0239408315930609,0.679258333853142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39810,0.00173174434796108,0.00418849416188776,-0.00647770420933893,0.00994119290526109,0.679280720746404
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,37343,0.00152084439173777,0.00368618362470421,-0.00570407551268249,0.00874576429615802,0.679921466247179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37430,0.00145355441262302,0.00353230796793693,-0.00546976920453336,0.0083768780297794,0.680710726730975
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37784,-0.000863347725967745,0.00209907936903267,-0.00497754328927178,0.00325084783733629,0.68086044465773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,37362,0.00172183438513408,0.00422245582607526,-0.00655417903397344,0.00999784780424159,0.683441725626771
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37756,0.000805749222824148,0.00198105347635646,-0.00307711559083452,0.00468861403648281,0.684214573775886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39815,0.00217342995753595,0.00535112030847714,-0.00831476584707924,0.0126616257621511,0.684628099958229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40226,0.00217749890802748,0.00536257803485923,-0.00833315404029662,0.0126881518563516,0.684708069134389
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37756,-0.0014783468658316,0.00367785638717435,-0.00868694538469332,0.00573025165303012,0.687720779545151
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37282,0.00271280296115402,0.00680717947650841,-0.0106292688128025,0.0160548747351105,0.690252922953662
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37515,0.00149506309458974,0.00379961721633133,-0.00595218664941968,0.00894231283859915,0.693973413959094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39810,0.000890903063915506,0.00227752918077326,-0.00357305413040008,0.0053548602582311,0.695676367451388
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,37282,0.00204755452904886,0.00525044229540775,-0.00824331236995032,0.012338421428048,0.696559634598867
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37362,-0.00187630521380428,0.00486575654105447,-0.011413188034271,0.00766057760666248,0.699788708078222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37696,-0.00218797673307325,0.00572245152081472,-0.0134039817138701,0.0090280282477236,0.702208245111107
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37515,0.00190541151367267,0.00500875849009707,-0.00791175512691758,0.0117225781542629,0.703642877655053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37470,0.00170243827709545,0.00449204766836567,-0.00710197515290126,0.0105068517070922,0.704701944941999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39599,-0.00187773884187573,0.00495642286884168,-0.0115923276648054,0.00783684998105396,0.7048048594255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39691,0.00107299125500577,0.00284592018739812,-0.00450501231229454,0.00665099482230609,0.70615813581448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37282,-0.00302730536527811,0.00803664501843073,-0.0187791296014023,0.0127245188708461,0.706411930563003
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37282,-0.0024403686108597,0.00664207510288416,-0.0154588358125127,0.0105780985907933,0.713318847210309
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37470,0.000664572453332977,0.00183760870807302,-0.00293714061449015,0.0042662855211561,0.717618950927765
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37376,-0.00213334263790978,0.00590444777306293,-0.0137060602731131,0.00943937499729356,0.717872787945694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39746,0.00232855668901288,0.00645086824567404,-0.0103151450725082,0.014972258450534,0.718128391593162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37756,-0.00223080816519737,0.00618352408722762,-0.0143505153761635,0.00988889904576877,0.718279757075028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40199,-0.00244517384281247,0.00680553066359542,-0.0157840139434595,0.0108936662578345,0.719381352873736
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,37403,0.00116305539479249,0.00326094958828071,-0.0052284057982377,0.00755451658782268,0.721350990115429
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37737,0.00119341334176359,0.00335296589400925,-0.00537839981049454,0.00776522649402171,0.721900384079474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39746,-0.00106868976009168,0.0030054436960198,-0.0069593594042905,0.00482197988410713,0.722156516068495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40164,0.00101116882692933,0.00285418199649961,-0.00458302788620991,0.00660536554006856,0.723136636773931
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40297,0.000725148239326732,0.00206447363974288,-0.00332122009456931,0.00477151657322277,0.725404791701066
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,40297,-0.00164653114499052,0.0046903776360564,-0.0108396713116611,0.00754660902168002,0.7255596514941
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,40204,-0.00213011852931887,0.00613674919112042,-0.0141581469439149,0.00989790988527716,0.728514356628641
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37470,-0.00109570834650065,0.00315671126366574,-0.0072828624232855,0.0050914457302842,0.728518504355584
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,37343,0.0014750756084956,0.00426023111007703,-0.00687497736725537,0.00982512858424658,0.72916568037328
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39815,0.00119149117620437,0.00346035657253912,-0.0055908077059723,0.00797379005838104,0.730605750690672
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,37403,-0.00124614350448817,0.00364243162454764,-0.00838530948860155,0.0058930224796252,0.732267213141378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,40038,-0.00139546393483549,0.00409284803061936,-0.00941744607484942,0.00662651820517846,0.733144457743157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37282,-0.000929865112687272,0.00273912570105874,-0.0062985514867624,0.00443882126138786,0.734257369516799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37282,-0.000863457307223894,0.00254504640846034,-0.00585174826780617,0.00412483365335838,0.7344120671641
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37282,0.00163025817240569,0.00485254566996814,-0.00788073134073187,0.0111412476855432,0.736907001396015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37343,0.00211067813865151,0.00632150754236637,-0.0102794766443866,0.0145008329216896,0.73846919259188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39810,-0.00154869392607386,0.00466757794492155,-0.0106971466981201,0.00759975884597237,0.740046176721752
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40164,-0.00161213731791585,0.00488809093853716,-0.0111927955574487,0.00796852092161698,0.74154853894335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37282,0.00177324965745085,0.00540000837237557,-0.00881076675240526,0.012357266067307,0.742630434882562
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,37282,-0.00167919913326523,0.00513805937776759,-0.0117497955136897,0.00839139724715924,0.743812518005333
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37403,0.000771498514125126,0.00236479087389847,-0.00386349159871588,0.00540648862696613,0.744245127413724
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37376,0.001343005752028,0.00412329381510384,-0.00673865012557552,0.00942466162963152,0.744647633320016
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37282,-0.00113810728995365,0.00352399477828799,-0.00804513705539811,0.00576892247549082,0.74673124199662
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,37362,-0.00128689169599649,0.00399904966460984,-0.00912502903863177,0.00655124564663878,0.747609895336364
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39727,0.00129994096416446,0.004070232004711,-0.0066777137650691,0.00927759569339802,0.749444555674886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37362,-0.00139427420399244,0.00437984515924543,-0.00997877071611349,0.0071902223081286,0.750233182748871
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,37282,-0.00120874062120449,0.00379719788314325,-0.00865124847216527,0.00623376722975629,0.750244082180433
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,37376,0.00228265016306959,0.00732839374324928,-0.012081001573699,0.0166463018998382,0.755440553244314
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37697,-0.00169563578544427,0.00547376426682409,-0.0124242137484195,0.00903294217753095,0.756736873663176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37343,0.00129748392188136,0.00421987113084869,-0.00697346349458207,0.0095684313383448,0.758490595125586
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37376,-0.00173815004710374,0.00565988349421724,-0.0128315216957695,0.00935522160156205,0.75877222898656
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37403,-0.00201117713739593,0.00661133399470918,-0.0149693917670259,0.0109470374922341,0.760979336426357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37515,0.00172142597744239,0.00566233959438684,-0.00937675962755581,0.0128196115824406,0.761122677226133
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,37430,0.00133156803914815,0.00440343706892885,-0.00729916861595239,0.00996230469424868,0.762357423985931
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37737,0.00157236065759192,0.00522048982686108,-0.0086597994030558,0.0118045207182396,0.763274134837619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39892,-0.0044149287261344,0.0146775170677494,-0.0331828621789232,0.0243530047266544,0.763574612776454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37376,0.0012590061314552,0.00421728512607029,-0.00700687271564256,0.00952488497855297,0.765299862724298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,40297,0.00111343934915719,0.00373098566706069,-0.00619929255828177,0.00842617125659616,0.765378643017842
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37499,-0.00253647291867135,0.00850133764322334,-0.0191990946993891,0.0141261488620464,0.765431925643159
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37282,-0.00159704379384626,0.00536505081593625,-0.0121125433930813,0.0089184558053888,0.765955719611489
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,37343,0.00160561878628781,0.00546622855376908,-0.00910818917909958,0.0123194267516752,0.768965675469137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37756,0.000877205807467185,0.00303453252171274,-0.00507047793508979,0.00682488955002416,0.772528912490218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,40248,0.00107786369737143,0.0037747228408004,-0.00632059307059736,0.00847632046534022,0.775228254342261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37756,-0.000777523897430152,0.00274684856487929,-0.00616134708459356,0.00460629928973325,0.777134984433379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40121,0.00219206563284387,0.00778415513350291,-0.0130648784288218,0.0174490096945096,0.778249274794346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37782,0.00139739727381104,0.00497499114549213,-0.00835358537135354,0.0111483799189756,0.77880344541549
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37737,-0.000657923195624388,0.00237417559570835,-0.00531130736321276,0.00399546097196398,0.781694975757048
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37762,0.00239858663391211,0.00884469934110695,-0.0149370240746575,0.0197341973424817,0.786249751019075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40126,0.00111727706401795,0.00414706192270672,-0.00701096430448721,0.00924551843252311,0.787614563206684
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,37282,0.000720603275806301,0.0026749573454464,-0.00452231312126865,0.00596351967288125,0.787634914766075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37362,-0.000874019520061786,0.00329985095329847,-0.00734172738852678,0.00559368834840321,0.79111664017898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37260,0.00108144342945616,0.00410692920766059,-0.00696813781755861,0.00913102467647092,0.792306899752864
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39746,-0.0011246325618627,0.00432235628632461,-0.00959645088305893,0.00734718575933354,0.794720955765139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37784,-0.000630009928126657,0.00247658010368087,-0.00548410693134115,0.00422408707508784,0.799200471221849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,37282,0.00156698910688203,0.00621339166442607,-0.0106112585553931,0.0137452367691571,0.80089403455751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,37376,0.00103508394126808,0.00410637433248663,-0.00701340975040572,0.00908357763294188,0.800992817678306
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,37362,-0.00115620839851302,0.0046000590460426,-0.0101723241287565,0.00785990733173049,0.801550284962025
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,37376,0.00126416361026026,0.00505010400274163,-0.00863404023511334,0.0111623674556339,0.80234056613532
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40233,0.000983584617612062,0.0039518818483294,-0.00676210380511357,0.00872927304033769,0.80344896400915
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37362,0.000421182825722831,0.00169815961335651,-0.00290721001645594,0.0037495756679016,0.80412047211692
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37791,0.000825636296011054,0.00335196124642249,-0.00574420774697703,0.00739548033899914,0.805442660061167
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37489,0.00106823370761707,0.00441428537293932,-0.00758376562334399,0.00972023303857814,0.808788068731316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,40126,0.000854609104299999,0.00356275970492148,-0.00612839991734609,0.00783761812594609,0.810432013629458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,37403,-0.00096057595272875,0.0040580740440728,-0.00891440107911143,0.00699324917365393,0.812887576220954
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37362,-0.000757248029143522,0.00320230031231059,-0.00703375664127227,0.00551926058298523,0.813071717332222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,37343,-0.00153548026475046,0.00665541770022064,-0.0145800989571829,0.011509138427682,0.817542732620888
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37376,-0.000680966091453111,0.00297991548200273,-0.00652160043617846,0.00515966825327224,0.81924671930966
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37362,0.0006844991051232,0.00299834515698267,-0.00519225740256283,0.00656125561280923,0.819422627700505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37362,0.00103589775689976,0.00455340275486874,-0.00788877164264297,0.00996056715644249,0.820038805658382
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37362,-0.00113905524705009,0.00504542783860487,-0.0110280938107156,0.00874998331661545,0.821391746492818
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37282,0.00152345258871095,0.00691384164605366,-0.0120276770375542,0.0150745822149761,0.825603487237004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37376,0.000615662220670704,0.00279627723406949,-0.00486504115810549,0.0060963655994469,0.8257406048383
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37493,-0.0010194448970001,0.00468193489686584,-0.0101960372948572,0.00815714750085694,0.827635037129425
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,37362,0.000945987385702784,0.00443863950888389,-0.00775374605170963,0.0096457208231152,0.83123241935798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,37362,-0.000618171079350274,0.00290515326532939,-0.00631227147939588,0.00507592932069533,0.831498549473798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37171,0.000570380974178426,0.00268379309076408,-0.00468985348371917,0.00583061543207602,0.831698600861658
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37362,0.00066532533385438,0.00319200647719783,-0.00559100736145336,0.00692165802916213,0.834892749684954
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39746,-0.00208493397929887,0.0101744489751396,-0.0220268539705726,0.0178569860119748,0.837638439149834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,37230,0.000597244198105285,0.00294200054644035,-0.0051690768729178,0.00636356526912837,0.839133459226185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37756,0.000732841149911663,0.003659332690085,-0.00643945092265493,0.00790513322247825,0.841275350257041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39815,-0.000523303949525384,0.00263412293062888,-0.00568618489355798,0.00463957699450721,0.842528645446354
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37282,-0.000423219190641313,0.00217654734523488,-0.00468925198730167,0.00384281360601904,0.845830376916879
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37515,0.00278361518310227,0.0143902051756849,-0.0254211869612402,0.0309884173274447,0.846618819645215
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37362,0.000611305809758671,0.00318729397716585,-0.00563579038548638,0.00685840200500373,0.847906108474807
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,37282,-0.000667713240626229,0.00352372695710725,-0.00757421807655644,0.00623879159530398,0.849711295846431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,37343,-0.00101575003753089,0.00542758512294709,-0.0116538168785072,0.0096223168034454,0.851549224348149
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37756,0.000523572972977497,0.00283999308936122,-0.0050428134821705,0.00608995942812549,0.853736109122734
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37784,0.000385972165996986,0.0020951586440671,-0.00372053877637454,0.00449248310836851,0.853842908074167
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37376,-0.00077619220588391,0.00436416291596657,-0.00932995152117838,0.00777756710941056,0.858838917811536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,37362,0.000548897349731841,0.00308734554538718,-0.00550229991922704,0.00660009461869072,0.858891152102889
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,37362,-0.0012504571268378,0.00711925902831097,-0.0152042048223273,0.0127032905686517,0.860576167355949
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40095,0.00063731554018029,0.00362969756071442,-0.00647689167881996,0.00775152275918055,0.8606233221301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40100,-0.000773020876418784,0.00443950978342672,-0.00947446005193515,0.00792841829909759,0.861771030150237
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37343,0.000947134202158007,0.00559554039714977,-0.0100201249762555,0.0119143933805715,0.865590149710659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37515,-0.00116768612839226,0.00710494617868678,-0.0150933806386184,0.0127580083818338,0.869459469957977
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,40197,0.000608038916286379,0.00371631883313786,-0.00667594599666382,0.00789202382923658,0.87003773147589
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37403,0.00128407343287628,0.00785067372641415,-0.0141032470708954,0.016671393936648,0.870078359429509
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39727,-0.00079864529765317,0.00498295081786438,-0.0105652289006674,0.00896793830536101,0.872666119355428
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,37343,0.00121676803248198,0.00765046246041819,-0.0137781383899377,0.0162116744549016,0.87363588794363
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37515,-0.000711428627415924,0.00457814028996024,-0.00968458359573799,0.00826172634090614,0.876510860170117
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,37362,-0.000465855499595408,0.00306371154086324,-0.00647073011968735,0.00553901912049654,0.879145200835453
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37376,-0.000844732922974672,0.00560702481938016,-0.0118345015689598,0.0101450357230104,0.880249295509163
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40121,-0.000416070518220439,0.00283664580052456,-0.00597589628724857,0.00514375525080769,0.883388910054383
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37403,-0.00033705775306105,0.00234062303427747,-0.0049246789002449,0.0042505633941228,0.885499999051819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37737,-0.000675891811361468,0.00474059192708826,-0.00996745198845446,0.00861566836573152,0.886627685546716
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37403,0.000350998884061553,0.00246341336677809,-0.0044772913148235,0.00517928908294661,0.886699325813782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37515,-0.000954999233039805,0.00693561030159796,-0.0145487954241718,0.0126387969580922,0.890483550949346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37343,-0.00036102988155288,0.00265674686358541,-0.00556825373418029,0.00484619397107453,0.891909008864934
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,40126,-0.000785496071583278,0.0058608315523802,-0.0122727259142485,0.0107017337710819,0.893384779645549
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37779,0.000406640605559602,0.00304321120753871,-0.00555805336121627,0.00637133457233547,0.893703338613922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37775,0.000272665849669592,0.00204241070952902,-0.00373045914100729,0.00427579084034647,0.893798424116769
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,37357,-0.000723896949054271,0.00576316059000885,-0.0120196917054716,0.0105718978073631,0.900044478720596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,37282,-0.00123197858010294,0.0098462541292038,-0.0205306366733424,0.0180666795131365,0.900429283112723
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,37403,-0.000536314294164611,0.00432511553203745,-0.00901354073695801,0.00794091214862878,0.901317205228251
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37282,0.000530414048056448,0.00440164057167421,-0.008096801472425,0.00915762956853789,0.904086022611378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39523,-0.0009415063434022,0.00781380218697918,-0.0162565586298814,0.014373545943077,0.904094445916601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,37362,-0.00045632471774315,0.00379207876830592,-0.00788879910362275,0.00697614966813645,0.904218624593708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37282,0.000405304331044153,0.00345677161616334,-0.00636996803663599,0.00718057669872429,0.90666427193224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37362,0.000547155652772609,0.00473210711695978,-0.00872777429646855,0.00982208560201377,0.907950581029548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37376,0.000311938818978547,0.00270502473137379,-0.00498990965451408,0.00561378729247117,0.908194635474756
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37343,0.00048654730324272,0.00425598850043832,-0.00785519015761639,0.00882828476410183,0.908985406631243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37258,-0.000856368424711303,0.00750804009488948,-0.0155721270106947,0.0138593901612721,0.909191873872121
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37489,-0.000482948542622868,0.00426810136543465,-0.00884842721887479,0.00788253013362906,0.909910986301485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37515,0.000532479485885601,0.00473433814449304,-0.00874682327732076,0.00981178224909197,0.91045106424497
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37808,0.000289726785252034,0.0027215248513807,-0.00504446192345414,0.0056239154939582,0.915220957108076
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37403,-0.000309215084131503,0.0029775433244598,-0.0061452000000727,0.0055267698318097,0.917290738346903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37343,-0.000497542811885528,0.00483384209928921,-0.00997187332649239,0.00897678770272133,0.918020876587622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37282,0.000547675182913523,0.00539828777439393,-0.0100329688548986,0.0111283192207256,0.919192054870833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37362,-0.000304377529016506,0.00303931069152546,-0.0062614264844064,0.00565267142637339,0.920229260576421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,37403,0.000870190354596393,0.00881080967365444,-0.0163989966057663,0.0181393773149591,0.921327221783229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37670,0.00021712478648331,0.0022656592673678,-0.00422356737755758,0.0046578169505242,0.923654708949872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39810,0.000377144418228146,0.00410746286599875,-0.0076734827991294,0.00842777163558569,0.926842796927458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37343,0.000258574507138741,0.00287043628644551,-0.00536748061429446,0.00588462962857194,0.928223489696284
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39713,0.000646520142950825,0.00729631881082698,-0.0136542647262701,0.0149473050121717,0.92939374938418
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37343,0.000282556529416213,0.00363455872683287,-0.00684117857517621,0.00740629163400864,0.938034782784017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39746,-0.000844925364667209,0.0120376149796791,-0.0244386507248382,0.0227487999955038,0.944043009445624
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40100,0.000834793224492491,0.0126199161711619,-0.0239002424709848,0.0255698289199698,0.947260146535407
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37403,-0.000321939543389646,0.00523120286289992,-0.0105750971546735,0.0099312180678942,0.950928385830235
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37403,-0.000190552418945126,0.00310527059150951,-0.00627688277830376,0.00589577794041351,0.951070116607477
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,37282,0.000244780833230912,0.00403508136289246,-0.00766397863803831,0.00815354030450014,0.951628407291032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37362,0.000239548364429483,0.00439268131486747,-0.00837010701271075,0.00884920374156972,0.956510948846537
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37343,-0.000409560065588985,0.00799678506553744,-0.0160832587940424,0.0152641386628644,0.959154522612049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39815,0.000265152556791884,0.00559022627353398,-0.0106916909393347,0.0112219960529185,0.962169977593269
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37343,-0.000168300135780974,0.00358127477483195,-0.0071875986944516,0.00685099842288965,0.96251835718878
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,37343,0.000190336589548419,0.00406717762170612,-0.00778133154899558,0.00816200472809242,0.962674789016645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37362,0.000231277834043578,0.00526726674194724,-0.010092564980173,0.0105551206482602,0.964978010973936
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37697,0.000197660582096639,0.0045313221478766,-0.0086837308277415,0.00907905199193478,0.965207208536177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,40297,-0.000178897962336896,0.00412335252591281,-0.008260668913126,0.00790287298845221,0.965393960966032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37756,0.000544506847580944,0.013483081563917,-0.0258823330176964,0.0269713467128583,0.967787232376345
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39727,-0.000102278209956792,0.00276565658593757,-0.00552296511839442,0.00531840869848084,0.970500216435854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37808,-5.47138658620974e-05,0.00159610011085047,-0.00318307008312901,0.00307364235140481,0.972654608236611
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,40153,-7.94088591505985e-05,0.00270330297047935,-0.00537788268129013,0.00521906496298893,0.97656608102404
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40233,0.000173278815838776,0.00604979912878437,-0.0116843274765786,0.0120308851082561,0.97715041498228
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39746,0.000107342128865262,0.00392018956981503,-0.0075762294279722,0.00779091368570272,0.978155514164365
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40126,-0.000147983335817987,0.00647492105543737,-0.0128388286044752,0.0125428619328393,0.981766348071988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37756,6.19787990803473e-05,0.00399053216019027,-0.00775946423489258,0.00788342183305327,0.987608417270043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37515,2.87237283756705e-05,0.00371420026188734,-0.00725110878492352,0.00730855624167486,0.993829747799528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37362,3.11422336675459e-05,0.00411456654861386,-0.00803340820161562,0.00809569266895071,0.993961164872431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37343,1.34787343943393e-05,0.00461916456724899,-0.00904008381741368,0.00906704128620235,0.997671819202473
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTN,Titin,37362,1.33260040588441e-05,0.00552876495659632,-0.0108230533108699,0.0108497053189876,0.99807689478813
